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Gonadotrophin-releasing hormone (GnRH) is a hypothalamic neuropeptide that is 
secreted in pulses and acts via GnRHRs on the pituitary gonadotroph. It activates 
signal transduction cascades, causing a largely PKC-mediated activation of 
extracellular signal-regulated kinase (ERK) and Ca2+-mediated activation of nuclear 
factor of activated T-cells (NFAT), both of which mediate GnRH effects on 
gonadotrophin secretion. Their activation was monitored by high content imaging 
(fluorescence staining for ppERK and nuclear translocation of an NFAT1c-EFP 
reporter). Also, GnRH effects on Egr1-zsGreen and NFAT-RE-asRed (transcriptional 
readouts for ERK and NFAT activation) were monitored. These responses were 
compared in HeLa, MCF-7 and LβT2 cells. Results revealed that effects of GnRH 
mediated by type I GnRHR are dependent upon cellular model, with differences in 
response kinetics, sensitivity to inhibitors and effects on transcription. Single cell 
measures of GnRH effects revealed marked cell-cell variability, implying that GnRHR 
signalling mechanism can be differently constructed between different cell types and 
between genetically identical cells within a given cell type. For further exploration of 
cell-cell heterogeneity, a mathematical approach that considers its impact on 
information transfer was used. The mutual information (MI) between GnRH 
concentration and measured responses (I(response; GnRH)) was used to quantify (in 
Bits) information transfer via GnRHRs. MI values for GnRH effects differed between 
HeLa and LβT2 cells, extending the idea of cell-context-dependent GnRH signalling 
to the amount of information transferred via the GnRHR. One bit of information can 
resolve two different signal values. However, the MI values for GnRH sensing were 
<1 Bit despite 3 Bit inputs irrespective of the cellular model used. Sensing joint 





information transfer had been underestimated by ignoring response dynamics. This 
was explored by live cell imaging, tracking cells and calculating MI taking response 
trajectory into account in LβT2 cells. The I(NFAT1c-EFP-NF; GnRH) was ~0.4 Bits 
at 30 min and increased to >0.5 Bits by consideration of trajectories. The I(Ca2+; 
GnRH) was ~0.8 Bits at ~24 sec and increased to 1 Bit by consideration of trajectories. 
These responses were also tracked in cells receiving two pulses of GnRH and this 
revealed little information gain from the 2nd pulse (for both readouts). This implies 
that the unknown sources of cell-cell heterogeneity are relatively stable over the time 
course examined in this work. Most information loss occurs upstream of Ca2+, and 
when cells were stimulated with ionomycin, the MI value was greater than any MI 
value reported for GnRH signalling. This suggests that the GnRHRs and their 
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1.1. The hypothalamo-pituitary-gonadal axis 
Almost all body functions are regulated directly or indirectly by the small part in the 
brain called hypothalamus. It is situated below the thalamus and above the brain stem 
and found in all mammalian brains [1]. It connects the nervous system to the endocrine 
system through the pituitary gland. The cycle of mammalian reproduction is 
controlled by a complex interplay between the hypothalamus, pituitary, and gonads 
[2, 3]. In 1930, Moore and Price were the first people to describe the nature of 
hypothalamo-pituitary-gonadal (HPG) axis by putting forward the idea that the 
cyclical nature of ovarian changes could be a result of a reciprocal interplay between 
the ovary and the anterior pituitary gland [2]. After that in 1932, Hohlweg and 
Junkmann demonstrated that the hypothalamus mediates the feedback action of the 
ovarian hormones and on the pituitary gland [4]. 
Gonadotrophin-releasing hormone (GnRH) is also known as a luteinising hormone-
releasing hormone (LHRH), or GnRH I. It is the critical peptide hormone that controls 
gonadotrophin secretion and reproductive function in mammals [5]. GnRH was first 
isolated from mammalian hypothalamus four decades ago [6] by Roger Guillemin and 
Andrew Schally (Nobel Prize winner in 1977) and was described as the decapeptide 
pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 [5]. Their discoveries have 
advanced our understanding of GnRH action leading subsequently to the development 
of agonist and antagonist analogues.  
The human gene GNRHI is located on chromosome 8 and encodes a 92-amino acid 
pre-prohormone [7]. GnRH is synthesised and stored in neurons within the 
hypothalamus and is secreted in a pulsatile manner into the hypophyseal portal 





the release of luteinising hormone (LH) and follicle-stimulating hormone (FSH) that 
mediate gonadal steroid production [8]. These, in turn, provide feedback to the 
hypothalamus and pituitary to maintain the functional system [9]. The proper response 
of the pituitary gonadotrophs to stimulation is vital for proper action of this axis [2]. 
In humans and other mammals, GnRH neurons are generated in the medial olfactory 
placode during embryological development and migrate to the hypothalamus through 
the olfactory bulb [10, 11]. GnRH neurons project to the median eminence and release 
GnRH into the hypophysial portal blood through which it is transported to the anterior 
pituitary gland [12]. The median eminence subserves neurosecretion into the 
hypophysial portal blood, which is an essential system to hypothalamic control of the 
anterior pituitary gland cells [1, 3]. GnRH cells are found in the medial preoptic area 
(POA) and the arcuate nucleus of the hypothalamus [2, 13]. In rodents, GnRH cells 
are spread throughout the septal region of the brain [1, 14]. The GnRH neurons share 
location with other central regulators, allowing many neuroendocrine and metabolic 
inputs to influence the GnRH network. Studies have shown that GnRH neurons are 
connected to thousands of other neurons in more than 50 functionally different brain 
areas [15-17]. For example, studies in rodents showed that brain injections of GnRH 
stimulate sexual behaviours, indicating that these neurons are participated in neural 
circuits which control the sexual behaviour. In addition, Simerly in 2002 have reported 
that some brain areas that include vomeronasal inputs project axons to the anterior 
hypothalamus, suggesting that they synapse on GnRH neurons [18]. Overall, GnRH 
neurons are thought to integrate information from various sources that in turn, have 






1.2. Regulation of GnRH and gonadotrophin secretion  
Thousands of neurons release the neurohormone GnRH into the hypophyseal portal 
blood system [19, 20]. Through this system, GnRH is transported to the anterior 
pituitary gland where it binds to GnRHRs localised on the cell surface of gonadotrophs 
to modulate pituitary gonadotrophin (LH and FSH) secretion [12]. GnRH secretion 
occurs in synchronized pulses, typically less than 10 minutes in duration with intervals 
of 30 min to many hours in humans [21, 22]. LH and FSH are both glycoproteins 
consisting of a common α subunit (αGSU) and a distinct β subunit (LHβ and FSHβ) 
[12]. These gonadotrophin hormones travel through the peripheral circulation, acting 
on the gonads to control reproduction [23] (Figure 1.1).  
There are many neurotransmitters and peptides involved in GnRH regulation [24-27]. 
In 2001, kisspeptin was recognised as the ligand for the G protein receptor 54 (GPR54) 
[28-31]. It is a 145 amino acid polypeptide that is encoded by the KISS1 gene. It has 
recently been identified as a main regulator of the mammalian reproductive axis [32]. 
Its action occurs through the kisspeptin receptor (KISS1R), stimulating the secretion 
of GnRH [32]. Kisspeptin neurons are found in the arcuate and anteroventral 
periventricular (AVPV) nuclei of the hypothalamus. These neurons projected to the 
medial preoptic area of the hypothalamus where the GnRH neurons are located [32]. 
Around 75% of GnRH neurons can express the GPR54 (i.e. kisspeptin receptor). The 
primary action of Kisspeptin occurs at the level of the hypothalamus stimulating 
GnRH secretion. However, a few studies have reported that kisspeptin can act directly 
on pituitary gonadotrope cells [32-37]. Mutations with KISS1R resulted in pubertal 
disorders in humans [38, 39]. For instance, a girl with an activating mutation in 





and this resulted in delayed puberty [40]. Similar cases were reported in animal 
models characterised by pubertal delay [38, 41-43].  
Kisspeptin cooperates with other neuropeptides like neurokinin B (NKB) and 
dynorphin to regulate the secretion of GnRH pulses [44] NKB is a hypothalamic 
neuropeptide that binds to the neurokinin 3 receptor (NK3R) [44]. Genetic studies 
demonstrated that patients with mutations in TAC3 and TACR3 genes, that encode 
NKB and its receptor (NK3R), respectively exhibited hypogonadotropic 
hypogonadism (HH, characterised by absent testes or ovaries or a reduction in their 
functions) due to the lack of circulating gonadotrophins [44]. Recently, a study 
suggested that NKB signalling mediates menopausal hot flushes [45]. β-endorphin (an 
endogenous opioid neuropeptide) is involved also in the regulation of the reproductive 
system. Studies revealed that changes in β-endorphin levels contribute to many 
reproductive dysfunctions [46]. For example, high levels of beta-endorphin can cause 
polycystic ovarian syndrome (PCOS), and low levels of β-endorphin are associated 
with menopause [46-49].  
Dynorphin and Kisspeptin are co-localized with neurokinin B in the same 
hypothalamic neuronal population (termed KNDy neurons). Studies suggested that 
NKB has a stimulatory role in releasing LH. This effect is thought to be mediated by 
auto synaptic inputs of NKB on KNDy neurons which in turns stimulate the secretion 
of GnRH in a kisspeptin-dependent manner [50, 51]. This connection highlights the 
role of these neuropeptides in controlling GnRH and gonadotrophin secretion [50, 51]. 
In addition to the KNDy system, other neurotransmitters and peptides are shown to 





vasoactive intestinal polypeptide (VIP), catecholamines, neurotensin and 
gonadotrophin-inhibitory hormone (GnIH) [52, 53].  
Luteinising hormone and FSH act on the gonads to control reproduction. In males, LH 
stimulates testosterone production and acts on Leydig cells within the testes, whereas 
FSH acts on Sertoli cells to regulate spermatogenesis. Testosterone provides negative 
feedback to the hypothalamus and pituitary suppressing synthesis and secretion of LH 
and FSH [116]. In females, ovulation and corpus luteum formation are stimulated by 
LH, whereas FSH stimulates ovarian follicle formation and oestrogen secretion. 
Oestrogen provides either negative or positive feedback to the hypothalamus and 
pituitary, depending on the phase of the menstrual or oestrous cycle [116, 194]. In 
many species, both oestrogen and progesterone can inhibit gonadotrophin secretion 
during the luteal phase [195]. However, during the follicular phase, the level of 
oestrogen increases GnRH secretion, initiating the preovulatory gonadotrophin surge 
[196]. Gonadotrophins are secreted at the end of follicular phase and before ovulation, 
whereas both are suppressed during the luteal phase. FSH is increased during the 
transition phase from the luteal to follicular phase, driving the selection of dominant 
follicle [197].  
The oestrogen alpha receptor (ER-α) is an essential receptor for sex-steroid mediated 
control of gonadotrophin secretion, [54]. However, GnRH neurons do not express ER-
α receptor in many species. The absence of this receptor indicates that there is a need 
for an intermediate signalling pathway to mediate gonadal steroid feedback [196, 
198]. It is most likely that the ER-α input is upstream of the GnRH neurons, including 
possibly on KNDy neurons. The accumulated evidence since the discovery of KNDy 





and secretion by integrating endocrine, nutrient, and environmental signals, and 
thereby controls the downstream HPG axis [26, 54]. Overall, an integrated set of 
interactions between the hypothalamus, pituitary gland and gonads control the 
reproductive system in mammals. These components are regulated through feedback 
mechanisms that coordinate the processes causing gonadotrophin secretion, gamete 
































The diagram shows the HPG axis. The peptide hormone GnRH is released into the 
hypophyseal portal circulation from hypothalamic neurons. It acts then on 
gonadotrophs in the anterior pituitary for the synthesis and secretion of the 
gonadotrophins (LH and FSH). The gonadotrophins act on gonads stimulating the 
synthesis of gametogenesis and steroid hormone. These in turn feedback to the 
pituitary and hypothalamus.    





1.3. Gonadotrophin-releasing hormone peptide 
The structure of the decapeptide GnRH was first described in mammals as pGlu-His-
Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 [5, 55-57]. In humans, the GnRH gene is 
located, on chromosome 8p11.2-p21 as a single gene copy. It consists of four exons 
that are separated by three introns [58, 59]. Numerous forms of GnRH have been 
identified in vertebrates and invertebrates and they are thought to have different 
physiological functions [60-65]. Most vertebrates express at least two types of GnRH. 
There are three distinct forms of GnRH and these include GnRH I which was first 
characterised in mammals. The second form was isolated from chicken brain and is 
referred to as GnRH II [66]. It is thought to be the earliest form that was conserved 
from primitive fish. The third form is termed GnRH III, and this has been described 
in fish [5]. Most vertebrate classes express GnRH I and GnRH II, whereas GnRH III 
is specific for teleosts [5]. Notably, although GnRH I and GnRH II are expressed by 
mammals (including humans), their distribution pattern different [67-69]. The GnRH 
II is expressed in some areas of the brain (e.g. hippocampus, caudate nucleus, and 
periaqueductal grey region), but the vast majority of it is expressed outside of the brain 
[67, 68]. The length of all known forms is 10 amino acids and the most common 
structural differences are at amino acids 5-8 [70]. Some major known functions of 
amino acids are shown in Figure 1.2.  
 
1.4. Extra-pituitary actions of GnRH and GnRHRs 
Gonadotrophin-releasing hormone acts via GnRHRs on pituitary gonadotrophs to 
control the synthesis and secretion of gonadotrophins [23]. However, GnRHR 





regulate some extra-pituitary reproductive tissues by the activation of locally 
expressed GnRHRs [3]. The GnRHR expression in peripheral tissues was reported for 
the first time in 1981 in human placenta, by radioreceptor assay [72]. Later, a study 
demonstrated that GnRHR mRNA and the cDNA are found in human placenta cells 
[73]. The GnRH mRNA expression has also been reported in other normal 
reproductive tissues including breast, endometrium, prostate, and gonads, and in 
tumours derived from these tissues [1, 83]. Likewise, GnRHR mRNA has been shown 
in these tissues and in non-reproductive tissues such as skeletal muscle, blood, larynx, 
kidney and liver [74]. The physiological role of GnRH in many of these extra-pituitary 
sites is unknown. However, is thought to act in an autocrine or paracrine manner for 
cellular process regulation [75].  
The neuropeptide hormone has a direct role in cell proliferation and a novel role in 
controlling tumour progression [76]. In cells derived from hormone-dependent 
cancers, GnRHRs were thought to mediate anti-proliferative effects. In the ovary, 
GnRH mediates steroidogenesis [77]. In human placenta, the peptide hormone 
contributes to early pregnancy [78]. GnRH can also influence the binding of 
spermatozoa to the zona pellucida of oocytes during fertilisation, such an effect can 
be inhibited by using GnRH antagonists [79, 80]. The diversity in actions shown by 
GnRH might be due to the divergence of signalling pathways that are caused by 
GnRHRs activation [76]. 
Early works showed that GnRHRs are expressed in testes in rat and  mediate the effect 
of GnRH on steroidogenesis in vitro [81]. However, blockade of testicular GnRHRs 
did not change the function of Leydig cells in vivo [82]. No evidence was found for 





is also reported in different brain areas such as the hippocampus, preoptic area, arcuate 
nucleus, where it is thought to regulate the releases of GnRH from the hypothalamus 
[74, 75]. GnRHRs are also expressed in heart in rodent and human [76, 84].  
Notably, the nucleic acid sequence encoding transcripts of GnRHRs are similar in the 
pituitary and extra-pituitary sites [76, 85-87]. However, the expression level of the 
receptors in pituitary tissue is higher than in extra-pituitary cells [88, 89]. Moreover, 
GnRHRs can apparently signal via Gi in extra-pituitary sits rather than via Gq [90]. 
Furthermore, as detailed in section 3.1, there are different types of GnRHRs. Type I 
GnRHRs have a high affinity for GnRH, and type II GnRHRs have a low affinity for 
GnRH with nanomolar and micromolar dissociation constants (Kd) respectively [76, 
91]. The pituitary cells express type I, whereas both type I and II have been reported 
to be expressed in extra-pituitary tissues [30-33]. 
 
1.5.  Therapeutic use of gonadotrophin-releasing hormone analogues 
Gonadotrophin-releasing hormone and its analogues have been broadly used in 
clinical medicine since they were identified in early 1971. The GnRH analogues are 
classified into two forms, agonist and antagonist. The agonists form was designed to 
mimic the effect of GnRH on gonadotrophin secretion. The antagonists were designed 
to block GnRH effects by GnRHR competition [24, 70]. The rapid degradation of 
GnRH was the main reason for the synthesis of GnRH analogues with agonistic or 
antagonistic properties to increase their potency and duration.  
Pulsatile administration of GnRH agonists can be used to treat delayed puberty or 





was successfully used to induce puberty in HH patients [93]. In recent years GnRH 
agonists have been used in young female patients who undergo chemotherapy, as a 
promising therapeutic way to treat iatrogenic ovarian failure [94]. Paradoxically, the 
agonists can have both stimulatory and inhibitory effects, as secretion of 
gonadotrophins can be inhibited by sustained stimulation [70]. High doses of GnRH 
agonists can be exploited to treat hormone-dependent cancers of the breast, ovary, and 
endometrium [95]. The agonists cause a reduction on the secretion of gonadotrophin 
and gonadal steroids leading to medical castration [95]. Cases like endometriosis, 
uterine leiomyomata, premenstrual syndrome, and POS were successfully treated 
using GnRH agonists on a continuous basis [24, 70], as they can inhibit ovulation and 
production of gonadal steroid in females [96]. Several treatment schedules use GnRH 
agonists in assisted reproductive technology (ART), especially in ovarian 
hyperstimulation in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) 
treatments [95, 97]. Few side effects have been reported using the agonist (e.g. 
menstrual cycle disruption, a decrease in bone density) however, these effects are 
reversed after stopping treatment [9, 24] 
Recently, the antagonist form of GnRH has been introduced into IVF and appeared to 
be an alternative option in preventing premature LH surge [98]. Unlike GnRH agonist, 
GnRH antagonists induce an immediate reduction in the levels of gonadotrophin by 
blocking competitively GnRHR [99]. Thus, GnRH antagonists prevent endogenous 
GnRH from releasing LH and FSH from the pituitary cells [98]. However, the 
suppression effect on gonadotrophin secretion can be rapidly reversed once the 
treatment discontinued [98, 100]. The difference between the two analogues make the 
antagonist form the logical choice to apply in IVF [100]. Moreover, the inhibitory 





hyperstimulation (COH) for ART [99]. Like GnRH agonist, GnRH antagonists have 
growth inhibitory effects on many cancer cells [101]. In recent study, the effect of 
GnRH antagonists on treated prostate cancer cells have shown to be rapid compared 
to GnRH agonists [102]. Overall, GnRH analogues are clinically exploited to treat 









The diagram represents the structure of GnRH I in a folded conformation as bound to GnRHRs. Major functions of individual amino acid 
residues are shown on the right. The figure is adapted from [62]. 





1.6. The mechanism of action of GnRH 
1.6.1. Structure of GnRH receptors 
Gonadotrophin-releasing hormone receptors were first cloned from a murine 
gonadotroph cell line [104]. Subsequently, GnRHRs have been cloned from numerous 
species including the rat, sheep, cow, and human. GnRHRs belong to the rhodopsin-
like G-protein-coupled receptor (GPCR) superfamily [105]. The human genome 
encodes > 800 GPCRs [106], and they are implicated in most physiological processes. 
Mutations in many GPCRs are known to cause disease, and most pharmacological 
drugs target GPCRs [107]. GPCRs can be activated by a broad range of stimuli 
including ions, light, odorants, classical neurotransmitters, peptides and glycoproteins 
[108].  
These receptors (GnRHRs) are located on the surface of the pituitary gonadotrophs, 
which constitute approximately 8–15% of anterior pituitary cells [109]. Three types 
of GnRHRs have been identified based on their sequence homology, and they have 
been shown to have distinct functions and distributions [19]. These are named 
GnRHRs I, GnRHRs II and GnRHRs III [12]. The type I GnRHRs have a high affinity 
for GnRH-I, while the type II and type III receptors have a higher affinity for GnRH 
II than for GnRH I [110]. The type I GnRHRs of humans, rats, mice, pigs, and horses 
share over 80% amino acid sequence homology [111]. The type II GnRHRs are 
functional in some mammals including monkeys, dogs and pigs, but in mice, sheep, 
and cows the receptor is absent [112, 113]. Some primates possess functional type I 
and II GnRHRs. However, although in humans both types I and II genes exist, only 
type I GnRHRs are expressed as functional protein. The human type II GnRHR gene 





Therefore, the type I GnRHR is the predominant GnRHR in the human. In humans 
and some species, the type I GnRHR is also expressed in extra-pituitary tissues 
including breast, endometrium, and gonads [5, 76].  
As stated above, GnRHRs belong to the GPCR family. These receptors have a 
characteristic seven transmembrane (7TM) α-helical domain structure with the TM 
domains, connected by three intracellular (ICLs) and three extracellular loops (ECLs).  
In general, the ECLs are implicated in ligand recognition and binding although they 
could have a role in GPCR signalling [115-117]. The TM domains are involved in 
receptor trafficking and ligand binding [118]. The ICLs and carboxy terminus are 
implicated in GPCR coupling to G proteins and -arrestin for signalling pathways 
activation [115, 119], in addition to receptor internalisation, recycling and 
desensitisation [120, 121]. These receptors undergo conformational changes when 
they bind to ligand [122]. Mammalian type I GnRHRs have peculiar features that 
distinguished them from other GPCR (Figure 1.3). These receptors lack the C-terminal 
intracellular tail that is found in all other known GPCR [123]. It was experimentally 
demonstrated that the type I GnRHRs are resistant to rapid homologous 
desensitisation upon GnRH stimulation and exhibit slow internalisation [122, 124, 
125]. Moreover, when the C-terminal tail of a non-mammalian GnRHRs was fused 
into the rat GnRHRs, rapid desensitization and internalization occurred [126, 127]. 
Another structural difference between mammalian type I GnRHRs and type II or III 
GnRHRs is that the intracellular loop 1 is longer in type I mammalian GnRHRs than 







The diagram shows the human GnRHR imbedded in the cell membrane, with 7TM α-
helical domains connected to three ICLs and three ECLs. Residues that are implicated 
in receptor structure or in the formation of a binding pocket are shown in green 
(including residues forming disulphide bonds and glycosylation sites). Residues that 
are important for the activation of receptor are shown in blue. Residues implicated in 
























1.6.2. Gonadotrophin-releasing hormone receptor signalling 
G-protein-coupled receptors provide a mechanism to transfer information between the 
extracellular and intracellular environments [129]. Heterotrimeric G-proteins are 
guanine nucleotide-binding proteins, acting inside cells as a molecular switch by their 
ability to bind to and hydrolyse guanine triphosphate (GTP) to guanine diphosphate 
(GDP). Heterotrimeric G-proteins are made up of α, β and γ subunits. There are more 
than 20 Gα subunits [120] and these are divided into four major families based on 
amino acid homology and effector coupling [130, 131]. These are Gαq/11, Gαs, Gαi and 
Gα12/13. In general Gαq/11 couples to phospholipase C (PLC) isozymes, Gαs activates 
adenylyl cyclase (AC), Gαi inhibits AC, whereas the role of Gα12/13 in GnRHR 
signalling is unknown yet  [132]. In the inactive state, Gα is bound to the G-protein 
βγ subunits and GDP. The interaction of the activated receptor with G-protein 
promotes the exchange of GDP for GTP, and this leads to dissociation of Gα from the 
βγ subunits. These subunits re-associate again when the GTP is hydrolysed forming 
the inactive heterotrimeric which terminates the signal [19].  
GPCRs can be activated by a broad range of stimuli including light, glycoproteins, 
neurotransmitters, amino acids, and peptide hormones [61]. Activation of the 
heterotrimeric G-protein regulates the intracellular concentration of second 
messengers by modulating the activity of one or more effectors. These second 
messengers could be Ca2+ for ion channels, cyclic adenosine monophosphate (cAMP) 
for AC, inositol 1,4,5 triphosphate (IP3) and diacylglycerol (DAG) for PLC [19, 133].   
In general, GnRHRs interact with multiple G-protein forming a complex network of 
signalling proteins (Figure 1.4). In the pituitary gonadotrophs, GnRHRs act mainly 





involved in extracellular signal-regulated kinase (ERK) regulation and LH expression 
[134, 135]. A recent study in LβT2 cells showed that Gαs is involved in the signalling 
in addition to Gαq/11 [132]. In another words, the gene induction of FSHβ is mainly 
depended on Gαq/11, and the LHβ gene expression is depended on Gαs [132]. In 
contrast, no evidence was shown for Gαi involvement in GnRHR signalling in 
gonadotrophs. However, in reproductive tumour cells, Gαi was reported to have a role 
in the activation of ERK and cell proliferation inhibition [136]. GnRHR-mediated G-
proteins activation can be shifted from Gαs to Gαi by increasing GnRH concentration 
in hypothalamic neurons [137]. Accordingly, the ability of GnRHRs to activate 
distinct G-proteins appears to be cell context-dependent. Binding GnRH to GnRHRs 
on the cell surface of the gonadotroph stimulates a variety of distinct signalling 
cascades. ERK and nuclear factor of activated T cells (NFAT) pathways are the two 
main pathways that are proven to be mediated GnRH effects on gonadotrophins 
sections [138-141]. Therefore, the focus on this work is on the mechanism that 
mediates their activations. As explained, GnRHR directly activates intracellular 
signalling. However, a study in 2003 suggested that crosstalk with the EGFR might 
happen at the level of the pituitary. Roelle et al, showed that EGFR can be stimulated 
via GnRHR but the mechanism is still to be determined [71]. EGF is a protein with 53 
amino acid residues, it acts via ErbB family tyrosine kinase receptors (TKR). It is 
capable of activating the ERK pathway through binding to and inducing 
phosphorylation of the EGFR, which in turn results in the phosphorylation and 










Activation of the GnRHR causes the activation of multiple G-protein subunits. 
Signalling downstream of PKC leads to transactivation of the epidermal growth factor 
(EGF) receptor and activation of MAPKs, including ERK, JNK and p38. Active 
MAPKs translocate to the nucleus, leading to the activation of transcription factors 






1.6.3. Mitogen activated protein kinase pathways 
The family of mitogen-activated protein kinases (MAPKs) is made up of three central 
protein kinases. These are ERK, c-Jun N-terminal kinase (JNK) and p38 [142, 143]. 
Each of these functions in a three-tier system [2]. The MAPKs are conserved 





serine/threonine kinases and are activated by a MAPK kinase (MAPKK). The 
MAPKK is a dual-specificity kinase which phosphorylates at Ser/Thr and Tyr sites 
and targets a Thr-X-Tyr motif on the MAPK. The X is glutamate (for the ERK 
module), proline (for the JNK module) or glycine (for the p38 module) [144]. 
Phosphorylation of the MAPK causes a conformational change and a significant 
increase (>1000-fold) in activity [139, 145, 146]. The MAPKK, is activated by a 
MAPKK kinase (MAPKKK) which is initiated as a result of receptor activation, or 
due to the interactions with GTP-binding proteins or other kinases [147]. At the end 
of these cascades, MAPKs phosphorylate their target proteins. Most of these are 
nuclear proteins including transcription factors that are implicated in many aspects of 
cell function [144]. Other members of the MAPK family have been identified 
including BMK (big mitogen-activated protein kinase) or ERK5. The ERK5 was 
recognised as a significant mediator of growth factor-induced cellular responses [148, 
149]. The MAPKs signalling models are summarised in Figure 1.5.  
Upon GnRH binding, the ERK, JNK, p38 and BMK cascades are activated [143, 145, 
150]. In gonadotrophs and gonadotroph-derived cell lines GnRH causes a rapid 
increase in ERK (within 5 min), but its effects on JNK is slower (measurable by 10 
min) [142, 151-153], and a similar effect is reported for BMK [154]. GnRH effects on 
p38 responses are variable, either like ERK or slightly delayed [143]. However, the 
mechanisms by which GnRH activate ERK are still unclear. In many models, 
GnRHR-stimulated ERK activation is largely mediated by PKC but in some cells of 
neuronal origin, it is mediated by transactivation of EGF receptors [151]. Although 
ERK is activated by a single kinase (MEK), it can be inactivated by at least 13 
phosphatases [123]. Studies in mice with Raf1 deletion revealed that Raf1 was not 





GnRH can cause perturbation of fertility in female due to the deficiency in LH 
biosynthesis and a failure in ovulation. In contrast the effect on LH in male mice was 




The flow chart shows the MAPK family members and their functions. There are 
multiple MAPKKKs, MAPKKs, MAPKs in each module, and these can be activated 





1.6.4. Ca2+/calmodulin-dependent kinase pathway 
GnRH typically causes a pronounced increase cytoplasmic [Ca2+] concentration in its 
target cells. This is thought to activate the ubiquitous Ca2+ sensor, calmodulin, leading 
in turn to activation of CaMKs. The CaMKII is a common mediator of Ca2+ signalling 





in many cell types [123, 140, 153, 157-160] that is activated by binding two Ca2+-
calmodulin molecules [7]. Studies in LβT2 and primary pituitary cells revealed that a 
single pulse of GnRH causes a rapid and transient increase in CaMK II activation 
[161, 162].  
 
1.6.5. The nuclear factor of activated T cells pathway 
In addition to CaMKII, Ca2+-calmodulin activates a serine/threonine protein 
phosphatase called calcineurin (Cn, also known as protein phosphatase 3). The Cn 
dephosphorylates several target proteins including Ca2+-dependent transcription 
factors of the NFAT family. It does so by dephosphorylating NFAT proteins exposing 
a nuclear localization sequence so that the NFATs translocate to the nucleus where 
they bind NFAT response elements and regulate transcription [140]. Studies showed 
the importance of this cascade in regulating expression of the immediate early gene 
products, Jun and Fos.  Both of which are important for the expression of αGSU and 
FSHβ by GnRH [163, 164]. NFAT is a protein that belongs to a family of five 
members. These are NFAT1, 2, 3 and 4 (which are also known as or NFATc2, NFAT2 
or NFATc1, NFAT3 or NFATc4 and NFAT4 or NFATc3, respectively) as well as 
NFAT5. All these forms are regulated by Ca2+-calmodulin except NFAT5 that is 
activated in response to osmotic stress [165].  
 
1.6.6. The protein kinase A pathway 
Many GPCRs act via Gs to activate AC or via Gi to inhibit AC [132]. Adenylyl cyclase 





controls the activity of protein kinase A (PKA) [132]. PKA phosphorylates and 
regulates numerous target proteins including the transcription factor CREB (cAMP 
response element binding protein).[111]. The question of whether GnRH activates Gs 
and/or Gi has remained controversial for decades. Although the levels of cAMP that 
are regulated by GnRH have little effect on gonadotrophin secretion, the 
gonadotrophin subunit promoters contain cAMP response elements (CRE), which 
might provide a mechanism for gonadotrophin subunit transcription to be activated by 
the cAMP/PKA pathway [5]. However, since CREB is regulated by ERK, PKC and 
PKA, the activation of CRE in gonadotrophin promoters could be mediated by PKC 












In the anterior pituitary, GnRH binds to GnRHRs on the cell surface, stimulating a 
variety of distinct signalling cascades, that regulate several cellular functions. These 
pathways are detailed above, and the figure is reformatted from [167]. 
 
 
1.7. Regulation of gonadotroph gene expression 
Micro array studies have shown that GnRH can influence the expression of over 200 
genes in its target cells [168, 169]. It regulates genes that are associated with the 
components in the signalling network such as the PKA, PKC subunit isoforms and 
GnRHRs [1]. These genes are implicated in several aspects of cellular function such 
as metabolism, cell growth, ion transport, signal transduction, and transcriptional 
regulation [170]. Studies in LβT2 cells showed that the main class of proteins affected 






by GnRH treatment are transcription factors [170, 171]. Furthermore, the rapid 
increase in Ca2+ is implicated in the regulation of gene expression, as blocking Ca2+ 
channels in rat pituitary cells prevented the increases in the expression of αGSU, LHβ 
and FSHβ [172]. Most work in gene expression in gonadotrophs has focussed on the 
transcriptional control of gonadotroph signature genes. These encode αGSU, LHβ, 
FSHβ, and GnRHRs and are detailed below.  
 
1.7.1. Gonadotrophin-releasing hormone receptor expression  
Gonadotrophin-releasing hormone receptors are expressed by gonadotrophs that are 
found in the pars distalis and pars tuberalis regions of the anterior pituitary [132]. The 
number of GnRHRs determines the responsiveness of gonadotrophs to GnRH and it 
varies markedly under different physiological conditions (i.e. through the oestrous 
cycle and puberty) [19, 94, 173]. In vitro studies showed that, there are many factors 
that mediate GnRHR gene expression (e.g. gonadal steroids, activins and inhibins), 
and GnRH is the main factor that affect the expression of GnRHR gene [174, 175] at 
the level of mRNA [176]. Studies in rat pituitary cultures demonstrated that the 
expression levels of GnRHR gene are GnRH pulse frequency dependent. The levels 
of GnRHR mRNA were increased at all pulse frequencies and were greater with high 
pulse frequency (every 30 minutes) [138, 177]. Pulsatile GnRH treatment increases 
the number of receptors [178], while continuous treatment results in receptors 
internalisation [124, 179-181]. During the oestrous cycle both GnRH binding and 
GnRHRs expression fluctuate. The expression of both increases before ovulation 






At low cell surface densities of GnRHRs, the expression of FSHβ is optimally 
stimulated, and the opposite is true for LHβ that is preferentially stimulated at high 
cellular densities of the GnRHR [138, 185]. The number of the receptors is regulated 
(in part) at the transcriptional level. However, changes in GnRHR protein degradation 
and compartmentalisation could be significant [186]. Mutations of the GnRHR gene 
can disrupt pubertal development, leading to HH and impaired fertility [187-189].  
Reporter studies with the 5' flanking region of the GnRHR gene have helped in 
understanding the molecular mechanisms that mediate GnRHR gene regulation [113, 
190]. Such studies identified distinct DNA regions responsible for basal and/or 
GnRH-stimulated expression of the GnRHR gene [190]. The 5’ flanking regions have 
been cloned from several mammalian species and show a high degree of cDNA 
sequence homology (i.e. 56% homology in rat and human, and 82% homology in rat 
and mouse) [191, 192]. Several cis regulatory elements have been characterised within 
this region. These include a GnRHR activating sequence (GRAS), an activator protein 
1 (AP1) sits, a NR5A1- binding site and a Pitx1-binding site. Mutations in any of these 
sites can have a significant effect on basal activation of the GnRHR promotor (in rat, 
mouse and human) [191, 192]. Both basal and GnRH-stimulated Gnrhr transcription 
depend largely on the PKC pathway with consequent activation of ERK. However, 
the mechanism of which steroid hormones regulate Gnrhr transcription is still 
unknown.  
 
1.7.2. α-glycoprotein subunit expression 
The α-glycoprotein subunit (αGSU) gene is expressed during early development of 





of the FSH and LH glycoprotein hormones [193]. Characteristic of the protein coding 
and 5'-flanking promoter sequences have been previously described [194, 195]. In 
humans and rodents, the  promoter regions display a high degree of similarity [171]. 
Androgens are involved as a negative feedback on regulators of αGSU gene 
transcription [196]. Knowledge about the regulation and expression of this gene has 
been enhanced by the availability of the mouse gonadotroph-derived αT3-1 cells 
[197]. These cells express gonadotrope αGSU, GnRHRs, but not LHβ or FSHβ-
subunits. In general, work on pituitary derived cells and other different model systems 
revealed that the effect of GnRH on αGSU expression is largely dependent on the 
number of GnRHRs [185, 198, 199] 
GnRH activates numerous signal transduction pathways in gonadotrophs, but its 
effects on αGSU transcription are mediated predominantly by its ability to increase 
Ca2+ and activate the PKC pathway [200]. However, in αT3-1 cells, the ERK pathway 
was shown to be involved in the regulation of basal and GnRH-stimulated αGSU 
transcription [201]. Nevertheless, differences have been recorded between species 
[202]. For instance, in mouse, ERK-mediated the GnRH effect on αGSU promoter 
[202]. GnRH can activate another MAPKs including JNK and p38, and JNK but not 
p38 was reported to mediate GnRH effects on αGSU expression in LβT2 cells, αT3-1 
cells and rat pituitaries [151, 172, 203, 204]  
The humans basal αGSU promoter expression is mediated by several regions. These 
are the pituitary glycoprotein hormone basal element (PGBE), that contains the α-
basal elements (αBE1 and αBE2), the gonadotroph-specific element (GSE), and 
cAMP response elements (CREs) [205]. In αT3-1 cells, the PGBE is the main 





GnRH and are found to mediate GnRH effects on αGSU. The basal αGSU promoter 
is less active in LβT2 compared to αT3-1 cells, but the αGSU promoter activity was 
similar after stimulating cells with GnRH or a PKC activator [206]. Mutation studies 
demonstrated that two regions (between −398 and −244, and between −244 and −195 
base pairs (bp)) of the human αGSU promoter are involved in basal transcription 
regulation. Deletion of these regions that contain SF-1 binding site abolishes the basal 
αGSU expression [206]. Thus, the upstream regions of -195 bp are essential for 
GnRH-mediated responsiveness in gonadotrophs [207, 208], and the CRE (which is 
the downstream of -195 bp), is not directly implicated in mediating these effects. The 
SF-1 is involved in mediating the transcriptional response to cAMP [208], but this is 
not the case in extra-pituitary tissues. Furthermore, other studies showed that in other 
tissues the SF-1 could be phosphorylated by activators of PKA or ERK signalling 
pathways [209, 210]. In humans, the αGSU promoter is highly sensitive to oestrogens. 
However, the mechanism appeared to be indirect, as the oestrogen response elements 
(ERE) is not functional [211]. Androgens seem to inhibit the activity of αGSU 
promoter at the CRE site via protein-protein interactions between c-Jun and activation 
transcription factor 2 [212]. Overall the human αGSU promoter is regulated by distinct 
response elements. 
 
1.7.3. Luteinising hormone-β subunit expression 
The luteinising hormone-β subunit (LHβ) gene promoter structure has been 
extensively characterized, giving us a great deal of information about its expression 
following GnRH stimulation. The proximal regions contain the following sites, two 





1, in addition to a homeodomain element which is binding site for Pitx1 [213, 214]. 
The latter is expressed mainly in the pituitary and thought to play a crucial role in the 
development of pituitary [215]. The interactions between them are essential for GnRH 
induction of the promoter [216]. These regions, in rat and human, share a high degree 
of homology [215, 217]. The expression level of LHβ changes through the oestrous 
cycle [172]. For example, in mouse and rat, LHβ mRNA increases at the time of 
preovulatory gonadotrophin surge [218, 219]. The periovulatory changes in the LHβ 
mRNA are coincident with the increase in GnRH secretion [220, 221]. The synthesis 
of LHβ mRNA was shown to be highest during proestrus (as opposed to FSHβ that 
was found to be greatest during late proestrus and oestrous) [220].  
Egr1 is a key factor in regulating the expression of LHβ after pulsatile GnRH 
stimulation [216]. Studies in LβT2 cell line revealed that the expression of Egr1is 
stimulated at a high GnRH pulse frequency [150]. In mice with Egr1 deficiency or 
SF-1 knock out, a reduction in the expression of the LHβ gene and infertility was seen 
in both cases. However, treating SF-1 knockout mice with GnRH at high doses, 
induced the expression of LHβ [222-225]. In rat pituitaries, GnRH induces an increase 
in the expression of Egr1 mRNA, which is dependent on ERK. In mice with pituitary-
specific knockouts of ERK reduced fertility. However, the effect was much more 
pronounced in female than male, indicating that ERK signaling is not required for 
male fertility [226]. 
 
1.7.4. Follicle stimulating hormone-β subunit expression 
Compared to the LHβ and αGSU gene promoters, the follicle stimulating hormone-β 





an ideal cellular model. Most studies on gonadotrophin regulation were conducted 
using αT3-1 cells. This cell line does not express LHβ or FSH β-subunits. However, 
LβT2 cells express the β-subunit of LH (in addition to GnRHR, αGSU and SF-1) and 
are a model for more mature gonadotrophs (as compared to αT3-1 cells). Also, by 
treating LβT2 cells with activin FSH can be expressed [150]. Numerous local and 
gonadal factors are involved in the regulation of FSHβ transcription and secretion (e.g. 
activins, inhibins, follistatin and many steroids) [172, 227-229]. Both activins and 
inhibins belong to the transforming growth factor-β (TGF-β) family and are produced 
by the pituitary and gonads [230]. Inhibins can suppress FSH secretion independently 
of LH [172]. Follistatin is a glycoprotein hormone that binds activins with high-
affinity and blocks activin receptor engagement. Notably, follistatin and activin are 
also produced in extra-pituitary sites. However, the mechanism of their effect in the 
pituitary is mainly autocrine and paracrine [172]. FSHβ mRNA increases during the 
proestrus FSH surge [172, 220, 221]. However, the increase occurs after the increase 
of LHβ. Studies in mouse and rat showed that the FSHβ mRNA was greatest during 
late proestrus and oestrous [218, 219]. 
Since the development of LβT2 cell line, several groups have conducted experiments 
for further investigation of the gonadotrophin regulation, and this led to the discovery 
of a GnRH-RE in the proximal FSHβ promoter region. It is relatively conserved in 
humans and has a partial (CRE)/AP-1 sit [231-233]. This site is thought to provide 
GnRH responsiveness to the FSHβ promoter  [234-236]. Furthermore, a study in 2010 
on LβT2 cells revealed that the expression of FSHβ in response to low GnRH pulse 
frequencies is largely dependent on binding CREB to the CRE/AP1 site [237]. In 
2015, it was shown that mice with cFos deficiency exhibited a significant reduction 





were recovered by GnRH treatment [238]. A more recent study, in 2017, has identified 
cJun dimerisation protein 2 (Jdp2) as a novel repressor of GnRH-mediated FSHβ 
expression in LβT2 cells [239]. Jonak and his group found that Jdp2 acts as a negative 
regulator. It does that by binding directly to the FSHβ promoter forming a complex 
with cJun to stop cJun-cFos dimerisation, and indirectly by reducing the expression 
of cJun [239]. 
 
1.8. Desensitisation to GnRH  
The amount of GPCRs localised on the plasma membrane is tightly controlled by 
endocytic pathways [240]. These pathways are clathrin-dependent, clathrin-
independent, caveolin-dependent and caveolin-independent mechanisms [241, 242]. 
Typically, upon GPCRs activation, cytoplasmic signalling is initiated and GPCR 
kinases are activated (GRKs) [243]. This causes agonist-bound receptor 
phosphorylation and facilitates binding to β-arrestins. The process occurs in the C-
terminal tails and within seconds preventing more G-protein coupling and causing 
receptor desensitisation. Thus, arrestins act as terminators of GPCR signaling [244] 
[245]. Next, the GPCR/arrestins complex is internalised via clathrin-coated vesicles 
(CCV), from where it can be recycled to the cell surface or directed to the lysosome 
for degradation [241, 244].  
The internalization process is dynamic and involves adaptor proteins. As explained, 
the formation of the vesicles is mediated by clathrin [246]. Clathrin molecules have 
heavy and light chains and three such dimers form a clathrin triskelion. The CCV is 
coated with these clathrin polymers and association adaptor proteins which together 





plasma membrane is initiated by recruitment of dynamin with polymerised actin. The 
dynamin creates a coil around the vesicles’ neck that twists upon GTP hydrolysis to 
facilitate the separation of the vesicle [248]. A summary of these steps is shown in 
figure 1.7. 
Sustained stimulation with GnRH cause desensitisation of GnRH-stimulated 
gonadotrophin secretion as well as internalisation of GnRHR into CCV and a 
reduction in the number of cell surface of GnRHRs [249]. It was therefore expected 
that this model (Figure 1.7) would be relevant to GnRHR regulation. However, the 
GRK-mediated phosphorylation of GPCR typically occurs in the C-terminal tail, and 
the type I mammalian GnRHR lack this feature. The absence of the C-terminal tail 
raised the question of how this type of receptor is regulated [76, 120]. Early work 
revealed that the mammalian GnRHRs are internalised through coated and uncoated 
membrane vesicles. However, the nature of the coated structure is not defined yet. 
Some studies demonstrated that the internalisation process may occur in a clathrin-
dependent manner [250]. Studies in rat GnRHRs demonstrated the mechanism of 
internalisation is dynamin-dependent, but it is dynamin-independent for human 
GnRHRs [110, 251]. In general, mammalian type I GnRHRs do not undergo rapid 
homologous desensitisation, do not show agonist-induced internalisation and they are 
arrestin-independent. 
Type II GnRHRs possess the C-terminal tail and do undergo rapid desensitisation. 
Where studied, these receptors do recruit β-arrestins, and internalise through clathrin-
coated pits in different ways [110]. For instance, studies on a bullfrog showed that the 
internalisation was independent of β-arrestin but dependent on dynamin. In a 





caveolin and independent on β-arrestins [166]. In COS-7 cells (fibroblast cells derived 
from monkey) transfected with chicken GnRHRs, the internalisation shown to be in a 
clathrin-independent [252]. Addition of Xenopus laevis C-terminal tail to the human 
GnRHR (which lacks the tail) facilitated arrestin- and dynamin-dependent 









Following agonist binding, G-proteins and effectors (E) are recruited (1). The active 
receptors are phosphorylated (P) on S and T residues in their C-terminus or ICLs by 
GRKs (2). This causes the recruitment of β-arrestins (β-ARR). Arrestins target the 
receptor to clathrin-coated pits (3) that are removed by dynamin (shown in red), 
forming a clathrin-coated vesicles (CCV) (4). The clathrin is removed from the CCV, 
and the uncoated vesicle merges with early endosome (5). The receptor is 
dephosphorylated by GPCR phosphatases (GRP, 6), and is then recycled back to the 
cell membrane (7) or targeted to lysosomes for degradation and down regulation (8).  
 
 
1.9. GnRHR trafficking to the plasma membrane 
The synthesis of protein is regulated at the transcriptional, translational and post-
translational levels by multiple signalling pathways [253]. Proteins are synthesised 
and processed in the endoplasmic reticulum (ER) and Golgi apparatus [254]. In the 
ER a strict quality control system (QCS) checks the correct folding and structural 





integrity of nascent proteins before their translocation to the Golgi [255]. 
Consequently, only properly assembled and folded proteins reach their destination. In 
addition, the QCS also stops the aggregation of defective proteins that might interfere 
with normal cell function. The strict system does this using several strategies including 
the action of endogenous protein chaperones [255].  
GnRHRs are subjected to structural and conformational scrutiny at the ER prior to 
trafficking to the plasma membrane [256]. Any mutations in these integral membrane 
proteins could result in misfolding and degradation of the defective protein receptor 
[253]. Molecular chaperones can prevent accumulation or interactions between 
misfolded proteins and other molecules [257] 
The expression levels of human GnRHR (hGnRHRs) at the cell surface are found to 
be relatively low, compared to other GnRHRs. The reason for that is thought to be 
related to the inefficient exit from the ER. An early study demonstrated that when 
MCF-7 cells (breast cancer cells) were transduced with hGnRHRs Xenopus laevis 
GnRHRs, the proportion of the expression level of hGnRHRs was < 1% compared to 
40-60% in Xenopus laevis GnRHRs [256, 258]. The low expression level of hGnRHR 
is a consequence of the absence of a consensus N-glycosylation site which is found in 
rodent (e.g. mouse and rat). The addition of this site to the hGnRHRs increased their 
expressions at the surface [259], and fusing the Xenopus laevis C-terminal tail to 
hGnRHRs had shown to have a similar effect on hGnRHRs (increasing the expression 






1.10. Dynamics of GnRH signalling 
Gonadotrophin releasing hormone is secreted in pulses which are required to establish 
and maintain normal gonadal function [77]. Its effects on LH and FSH secretion are 
largely dependent on pulse frequency [138, 260, 261]. Early studies showed that high 
levels or continuous stimulation of the pituitary with GnRH suppress gonadotrophin 
secretion [138]. This can be restored by restoration of GnRH pulses [262-264]. The 
pattern of GnRH secretion develops during life phases. It is transiently active during 
the neonatal period, quiescent during infancy and childhood, then increases during 
puberty [23]. GnRH has a half-life of approximately 2-4 min in blood, due to rapid 
degradation by peptidase [265]. As a result of this rapid degradation, GnRH is not 
easily detected in the general circulation. However, circulating LH and electrical 
activity in hypothalamic neurons are often used as measurements from which the 
dynamic of GnRH secretion can be inferred [94, 266] However, in some species 
GnRH pulses have been measured directly in the portal circulation [266-270].  
In humans and other primates, GnRH pulses are less than 10 min in duration with 
intervals of 30 min to many hours [21]. The frequency of GnRH pulses differs under 
different physiological situations which contributes to changing reproductive status 
[271]. For instance, increasing GnRH pulse frequency in males stimulates 
gametogenesis and gonadal steroid at puberty. In females, the GnRH pulse frequency 
differs over the menstrual cycle. It increases before ovulation generating the 
preovulatory gonadotrophin surge [7]. GnRH has different effects during different 
time-scales. Within seconds of stimulation, GnRH increases the cytoplasmic Ca2+ 





secretory vesicles. However, its effect on the expression of αGSU, LHβ, and FSHβ 
occurs over hours to days. 
Gonadotrophins are secreted by exocytosis and this can occur via constitutive or 
regulated secretion pathways [272]. In constitutive secretion proteins are packaged 
into small vesicles in the Golgi, which move to the cell surface and fuse directly with 
the plasma membrane, so constitutive secretion does not require an extracellular 
stimulus [272, 273]. In contrast, with regulated secretion, proteins are packaged tightly 
into dense vesicles that fuse in the plasma membrane after appropriate stimulation 
[272]. The primary stimulus for this regulated exocytosis is an increase in the [Ca2+]i. 
However, there is an important difference between LH and FSH secretion. The 
majority of LH is released through the regulated pathway and is dependent on GnRH-
induced Ca2+ mobilisation [272]. Whereas, FSH tends to be constitutively secreted 
and is dependent on the rate of FSH synthesis. Thus, GnRH-stimulated increases in 
[Ca2+]i has a rapid and pronounced effect on LH secretion and relatively minor effect 
on FSH secretion. Consequently, when gonadotrophins were measured in 
hypophyseal and peripheral blood there was high synchrony between pulses of GnRH 
and LH and much less synchrony between pulses of GnRH and FSH [273]. 
Overall, disruption of signalling pathways of GnRH, FSH, and LH can result in 
reproductive disorders. For example, rapid GnRH pulses result in an increase in the 
ratio of LH to FSH that contributes to excessive ovarian androgen production and 
ovulatory dysfunction seen in a case termed POS. This syndrome also was shown to 
be associated with obesity, and impaired glucose tolerance. On the other hand, low 






1.11. Heterogeneity, noise and information in cell signalling 
Cells receive information via signalling pathways that are devoted to conveying 
environmental information [274]. Cell signalling pathways have traditionally been 
investigated using conventional metrics that depend largely on measuring the average 
responses from a large number of cells [152]. These include measurements of 
hormone secretion from large populations of cultured cells, levels of proteins in cell 
populations by western blotting, or measurement of reporter gene expression in cell 
populations. These traditional methods are useful in mapping the signalling pathways 
but ignore cell-cell variability that often has physiological implications [152]. The 
recent advance in biological research methods has provided researchers with several 
methods to give a better view of the behaviours of single cells. For example, imaging-
based experimental readouts have been increasingly used, and these revealed marked 
cell-cell variability [153, 275]. Early GnRH signalling studies revealed cell-cell 
heterogeneity in secretory responses of gonadotrophs to GnRH  as well as in Ca2+ 
responses of gonadotrophs and gonadotroph-derived cell lines to GnRH [276-278]. In 
general, variability between cells in dynamic responses to stimuli was seen 
ubiquitously [279-282]  
The biological system is diverse in nature. Such diversity can generally be perplexing 
[283], particularly, when it is displayed by the same type of cells that have identical 
genomes. If it is assumed that if the genetic composition of a cell defines the 
phenotypic responses to environmental input, the same type of cells would be 
expected to display similar responses to the same input [283]. However, this is not the 
case as such heterogeneity is seen in genetically identical cells. Recent studies 





source of variability [284-287]. The heterogeneity appears to be an intrinsic feature of 
the signalling pathways and responses measured [288]. Heterogeneity is an inevitable 
consequence of the stochastic nature of biochemical processes [288]. For example, 
any given molecule of ERK2 is either inside or outside the nucleus and has either been 
activated or not by dual phosphorylation. Thus, when measuring the response of 
ERK2 in a single cell, variability in the amount and activity of signalling proteins is 
seen between cells.  
Little is known about the biological importance of this heterogeneity. However, it is a 
central aspect to be considered when studying the behaviour of cells [289]. This is 
because each cell has to sense environment for the appropriate decision [286], and the 
decisions taken by individual cells are what defines the activity of tissues in health 
and disease. A recent study in PC12 cells stimulated by growth factors (NGF and 
EGF) demonstrated this diversity [290].The study measured the response of individual 
cells to the activity of ERK and Akt. The results revealed that cells use a combinatorial 
signalling system to control cell fate and that this was dependent on the activities of 
ERK and Akt between different cells within the cell population [290]. A similar 
observation has been reported related to the responses of single cells to therapy and 
outcomes to medical intervention [291]. It was shown that, if a drug is designed to 
target rapidly proliferating cells, then variability between cell can leave some 
relatively unresponsive cells unaffected or unscathed, which might reduce the 
sensitivity to the follow-up treatments [285] as can be seen in cancer stem cells [291] 
Many studies have reported that such heterogeneity has a remarkable impact on 
cellular function and development. It shapes the mechanism of signal transduction, 





of transferred signals or degrade the concentration of ligand via networks. It possibly 
drives cells to dramatical changes in phenotypic states as seen in pathological cases 
like cancer [286], and contributes to producing random mutations [285, 289]. On the 
other hand, stochasticity can lead identical cells to generate different molecule number 
and different physiological states [285]. This in turn, offers a mechanism for a 
population to increase the variety of its phenotypic and can even provide adaptability 
to a stressful or fluctuating environment [293-295]. Consequently, cell-cell 
heterogeneity can be advantageous to a biological system as well as disadvantageous 
in certain circumstances.   
 
1.12. Information theory 
Despite the functional importance of cell-cell heterogeneity, analytical methods for 
interrogating its impact have been lacking. Recently, a statistical measure derived 
from information theory named mutual information (MI) has increasingly being 
applied in cell biology. MI can be used to explore the influence of various sources of 
noise on the information transmitted through signalling pathways [283, 296]. 
Information theory was first developed in 1948 by Claude Shannon as an attempt to 
understand the efficiency of information transmission through communication 
channels [297]. Shannon proposed that information can be quantified in term of the 
entropy [298], and the information that flows through channels can be measured using 
MI [274]. In particular, MI measures the reliability with which a system input (S) can 






                                               I(Z;S) = H(S) – H(S│Z), 
where H(S) denotes the entropy of S, and H(S|Z) denotes the conditional entropy of S 
given Z. It is worthwhile mentioning that MI is an appropriate measure of statistical 
association even in the case of a nonlinear relationship between input and output 
variables, a prevalent characteristic of signalling networks [274]. MI is often measured 
in Bits, where 1Bit of information intuitively means that the system can resolve 
unambiguously two different signal values [292].  
In the context of cell biology, MI between an environmental variable (e.g. 
extracellular levels of GnRH) and a signalling response (e.g. NFAT translocation to 
the nucleus) measures the uncertainty about the environment that is eliminated by 
signalling. Consequently, rather than MI focusing on identification of signalling 
intermediates in a pathway, it works on quantifying the amount of information that 
the pathway transfers. Figure 1.8 illustrates the principle with emphasis on how cell-
cell heterogeneity could impact information transfer (i.e. the reliability of hormone 
sensing in this example). Recently, a few research groups have applied this approach 
to quantify transferred information through signalling pathways. This provided us 
with more insights into cell signalling, and some of the key insights are outlined 
below.  
First a remarkable amount of available information is lost through signalling. A recent 
work provided the first quantification of information transfer via GnRHR revealed 
that although there was 3 Bits of information available, <1 Bit was transferred via 
GnRHR to ERK or NFAT [153]. Studies on different receptors and with different 
ligands and effectors in different cell types indicated that signalling pathways act as 





signalling networks [152, 153, 281, 296, 299]. The noise referred to here is the cell-
cell heterogeneity that results on a pronounced loss of information through signalling. 
The obvious indication from such a work is that despite the graded responses in 
population average over a broad range of stimulus, individual cells cannot distinguish 
between two different states of the environment. Thus, it is possible that the techniques 
used led to underestimate transferred information. Consequently, work on Chapter 5 
and Chapter 6 addresses the questions of where information is lost and the extent to 
which the methods used might impact information transfer. 
Second, equating the size of the response to information transfer is not acceptable in 
signalling cell studies. As shown in Figure 1.8, for response B, the transferred 
information would be higher for the large response than the small one. For response 
A, transferred information would be identical for both (large and small responses) 
[292]. Thus, where the average response and cell-cell variability scale right with one 
another, it might indicate that desensitisation has happened even though the reliability 
of the cells in sensing their environment has not changed. Notably, information cannot 
be gained via signalling and any increase in the size of the response via signalling 
pathways must be related to an increase in heterogeneity and cannot lead to an increase 
the reliability with which cells sense the stimulus 
Third, several studies have considered the role of negative feedback as a mechanism 
that can relieve (but not always) the limitation in losing such information. A study 
found that by reducing the basal activity, the negative feedback could enhance 
information transfer [287]. A recent study considered the effect of rapid and slow 
negative feedback on the quantity of information transfer. It showed that negative 





system output and can also protect information transfer by reducing cell-cell 
variability [152]. 
Fourth, sensing multiple pathways within a network was considered as a mechanism 
that cells do to mitigate loss. For example, in the case of activating a receptor that 
causes the activation of ERK and Akt pathways, the extreme scenarios would be either 
there is no correlation between ERK and Akt responses or a perfect correlation. in the 
former scenario, sensing both pathways will provide a substantial increase in 
transferred information and would be the opposite in the latter case. A similar 
observation was reported for the ERK-dependent and ERK-independent activation of 
CREB by NGF or PACAP [300], where sensing growth factors through multiple 
pathways did not increase transferred information. Instead, it protected the cells from 
loss of environment sensing on perturbation of individual signalling pathways. 
Finally, snapshot data might be underestimated transferred information. Consider a 
situation where cells are stimulated for example at 5 time points. The estimated MI 
value could be high at early time point (time 2) and reduce later (time 3). This clearly 
does not mean that the cells gain less information during time 2 than during time 3, 
instead it just shows that the later snapshot data underestimate the information gained 
over the entire stimulation period. In the same manner, the time 2 snapshot data could 
underestimate the information transferred over this period, suggesting that cells could 
gain information by sensing response trajectories over time as illustrated in Figure 1.9, 
and shown here [152]. This has been an important driver for the application of 





    
 
As shown the population average response is similar in A and B. However, the cell- 
cell variability is higher in A than B. This is illustrated in red dots (individual cells), 
and black lines on the y-axis (frequency distribution). The black dotted lines and 
arrows represent two concentrations of a stimulus. The frequency distributions in A 
overlap, indicating that there is an area of uncertainty where individual cell cannot 
distinguish between two equally probable states of the environment. The uncertainty 
is not seen in B. The quality of the signal that can be inferred from the response is 
higher in B than A. Consequently, MI value will be expected to be greater in B than 
A.  In the case where cells adapt to their environment as a result of negative feedback 
loops, a reduction in population-averaged response and variability between cells 
occurs (A→A′). However, the quality of sensing is not reduced. The opposite is true 
for B→B′, were the population averaged response is reduced but not the variability 
between cells. The quality of sensing reduced as well, as the frequency-distribution 
plots overlap. Thus, consideration of population averaged responses alone cannot be 
equated to information transfer (or in this case, the reliability of hormone sensing). 
The figure is reproduced from [292].  








The figure shows a heat map of population-averaged responses of ppERK for single 
cells with varied fast and low feedback (FB) at 3.5 and 0-4 (log10 scale), respectively. 
The simulations were run for 60 min. A predicted I(ppERK; S) for 10 min snapshot 
data is shown in A. MI was calculated taking response trajectories into account (shown 
in B). The calculated MI values reveal that maximum information transfer at 
intermediate feedback levels and information is increasing with trajectories (from 1.4 
Bits to 2.8 Bits). The cartoon in the left shows system simulated, with stimulus (S) 
that activates an upstream effector (E) which in turns catalyses the pERK. The fast FB 
loop represents ERK-dependent inhibition of E*/pERK. The slow FB loop represents 
pERK-driven phosphatase expression and causing dephosphorylation of pERK. The 
figure is reproduced from [153]. 
  






1.13. Cell lines 
 
In this work, different cells lines were used for the GnRHR signalling study. These 
are HeLa, MCF-7 and LβT2 cells. The HeLa cell line is the first immortalised human 
cell line established in culture [301]. It is a human epithelial cell line derived from 
cervical cancer cells that were obtained from Henrietta Lack in 1951. HeLa cells are 
widely used as a model for studying human cellular and molecular biology [301] and 
have been largely used for GnRHR signalling studies [152, 199, 256, 302]. However, 
this cell line has some disadvantages. The most significant one is that these cells can 
contaminate aggressively other cell cultures in a laboratory [303]. Thus, great care 
should be taken when working with this cell line. Another issue is that these cells do 
not have a normal karyotype as found in humans [303-305]. A normal cell contains 
46 chromosomes, but  the HeLa genome comprises of 76-80 chromosomes (due to the 
infection by human papillomavirus) and around 25 chromosomes are abnormal [301, 
304, 305].  
The second cell line is the MCF-7. These cells are breast cancer cells that were derived 
from a  woman with breast adenocarcinoma in the Michigan Cancer Foundation [306, 
307]. This cell line is largely popular due to its exquisite sensitivity to hormones 
through the expression of the ER, which makes it an ideal model for hormone response 
studies [308, 309]. Reports have shown that this cell line can be used to study PI3K, 
MAPK and to detect ERK and Akt phosphorylation [310, 311]. Furthermore, 
numerous groups have described GnRHR signalling in hormone-dependent cancer-
derived cell lines [258, 312]. MCF-7 cells are like HeLa cells, they are easily grown 
and can display a high degree of homogeneity [313]. However, although these cells 





karyotype containing 69 chromosomes [313, 314]. Both HeLa and MCF-7 cell lines 
do not express the endogenous GnRHR, but studies have shown that cells can 
heterogeneously express the receptor by transducing them with Ad mGnRHR [152, 
153, 258, 302, 315, 316]. In addition to that, these cell types acquire many of the 
properties of cancer cells. Despite that in vitro systems are isolated from the 
complexity of the endocrine environment; these models have significantly contributed 
to our knowledge. 
The third cell line is LßT2 cells. These are a mouse gonadotroph-derived cell line that 
was produced by targeted oncogenesis with Simian Virus 40 (SV40) T antigen in 
transgenic mice [197]. These cells display similar characteristic of mature 
gonadotrophs (i.e. express αGSU, the LHβ subunit and GnRHRs). Moreover, they can 
express FSHβ when cells treated with activin A [150]. Consequently, the LßT2 cell 
line is an important model for GnRHR-signalling pathways study [317]. Nevertheless, 
SV40 T antigen causes cell immortalisation [318] by interacting with a wide range of 
target proteins, like proteins phosphatase 2A and protein phosphatase 1. In most cells 
and tissue these two proteins account for >90% of Ser/ Thr phosphatase activity [319]. 
Moreover, the small SV40 cause the inhibition of protein phosphatase 2A [320], 
which is reported to affect ERK and MEK activities. This cell line has been largely 















The hypothalamic neuropeptide hormone (GnRH) is the primary regulator of 
mammalian reproductive function [20]. It is secreted in a pulsatile manner, and acts 
via GPCRs on gonadotrophs within the anterior pituitary [15]. Binding of GnRH to 
its cognate receptor causes the activation of PLC and consequent activation of a 
signalling network including two major pathways (i.e. the GnRHRs/Gq/PLC/Ca2+/ 
CaM/Cn/NFAT and GnRHRs/Gq/PLC/KC/ERK pathways) [209]. GnRHRs were 
cloned first in the early 90’s since then numerous studies have been conducted 
investigating its function in heterologous expression systems. In addition to 
gonadotrophs, GnRHRs have been found to be expressed in many cell types. The 
effects of GnRH are cell context-dependent. This implies that the GnRH signalling 
system can be different in different cell types, resulting in input-output relationships 
differences between these cells. These observations raise two questions. First, what is 
the optimal cellular model to study the mechanisms of GnRH action. Second, by 
comparing GnRH signalling in different cell types, would that provide us with 
additional insight into the mechanisms of signalling networks that mediate GnRH 
effect on cells.  
Single cell measures revealed marked variation from cell-cell in the responses to the 
same stimulus. This heterogeneity suggests that differences in network components 
from one cell to another result in different outcomes, just as they do for large cell 
populations with different cell types. Thus, the overall aim of the work here was to 
advance our understanding of GnRH signalling by exploring differences in responses 





In the first two chapters, a conventional approach for GnRH signalling was followed, 
comparing three different cell types with emphasis on response kinetics (Chapter 3) 
and the use of pharmacological inhibitors (Chapter 4). Then the emphasis was placed 
on cell-cell variability in responses with the use of the of information theoretic 
approach to quantify information transferred via GnRHRs in fixed cells (Chapter 5) 
and in live cells to explore the importance of stimulus and response dynamics (Chapter 
6). Specific aims of each of the results chapters and experimental approaches were as 
follows: 
The principle aims of the experiments described in Chapter 3 was to determine the 
effects of GnRH on the two main signalling pathways, as well as transcriptional 
readouts for both. This was achieved by automated fluorescence microscopy with an 
INCell to monitor the signalling in large numbers of fixed cells. Given the possibility 
of cell context-dependent signalling [22], the work was done in different cell lines. 
These are HeLa and MCF-7 cells (extra-pituitary cell lines) and LßT2 cells (pituitary-
derived cell line). An additional aim was to quantify ERK and NFAT1c-EFP activities 
in response to PDBu (PKC activator) and EGF. 
The work continued in Chapter 4 using the same cellular models and experimental 
readouts as used in Chapter 3. Here the aim was to use pharmacological inhibitors that 
target ERK and NFAT pathways for further delineation of the network architecture.  
The experiments described in Chapter 3 and Chapter 4 do not define information 
transfer via GnRHR, thus an information theoretic approach was applied in Chapter 
5. The statistical measure (MI) was used to quantify information transferred via 
GnRHRs to ERK and NFAT. An additional aim here was to quantify the information 





was compared in three cellular models using distinct readouts (transcriptional and 
non-transcriptional) for their activation.  
The aim of the experiments described in Chapter 6 was to determine whether cells 
gain additional information by sensing response dynamics, using live cell monitoring 
of Ca2+ responses and Ca2+-driven NFAT1c-EFP translocation in GnRH stimulated 
cells. Additional aims of the work described in Chapter 6 were to determine how much 
information is gained by sensing repeated GnRH pulses and by sensing GnRHR-



























 All products and reagents were purchased from Sigma Aldrich, UK, except those 
listed below. 
Product Company 
Matrigel basement membrane 
complex 10 ml 
BD Bioscience, Oxford, UK 
PDBu, AG1478, Ro31-8425, 
PD184352 
 
Calbiochem (Merck), Nottingham, UK 
Alexa Fluor® 546 Goat anti-
mouse IgG, highly cross-
adsorbed 
Alexa Fluor® 488 Goat anti-
mouse IgG, highly cross-
adsorbed 
Cell Signalling Technology (New England 
Biolabs), Hitchin, UK 
Plasticware 
Corning Life Sciences, distributed by Appleton 
Woods, Birmingham, UK, or Fisher Scientific, 
Loughborough UK 
HeLa cell line 
MCF-7 cell line 
European Collection of Cell Cultures, Salisbury, 
Wiltshire, UK 
LβT2 cell line 
Kindly provided by Prof. P.L. Mellon, University of 
California San Diego, San Diego, CA 
Hoechst 33258 GE Healthcare, Amersham, UK 
Fluo-4, AM, cell permeant 
 
Invitrogen Ltd., Paisley, UK 
Rhod-3 Calcium Imaging Kit 
FBS 








10% (v/v) FCS  
100 U/mL penicillin and 0.1 mg/mL streptomycin 
 
Gonadotrophin-Releasing Hormone 
Stored in sterilised ddH2O at -20ºC 
 
Serum Starvation Medium 
DMEM  
0.1 (v/v) FCS 
100 U/mL penicillin 0.1 mg/mL streptomycin 
 
Phosphate Buffered Saline  
5 x 0.5 g tablets dissolved in 1 litre ddH2O 
 
Phorbol 12, 13 dibutyrate   
Stored in DMSO at -20 ºC  
 
4% Paraformaldehyde  







Physiological Salt Solution 
20 mM HEPES  
137 mM NaCl 
5 mM KCl 
2 mM MgCl2 
1.8 mM CaCl2 
5.6 mM glucose 
1 mg/mL BSA 
0.5 mMNaH2PO4  
1 mMNaHCO3 
0.03 mM Phenol red  
(pH 7.4) 
  
Rhod-3 Loading Buffer 
100x PowerLoad concentrate 
100 mM Rhod-3 AM 








2.1. Experimental models 
As explained in Chapter 1, three different types of cells were used in this work; HeLa, 
MCF-7 and LβT2 cells. HeLa cells are a human cervical cancer-derived cell line that 
has been extensively used for GnRHR signalling studies [152, 199, 256, 302]. MCF-
7 cells are breast cancer cells derived from breast adenocarcinoma [258, 312]. LßT2 
cells are a mouse gonadotroph-derived cell line that was produced by targeted 
oncogenesis with SV40 T antigen in transgenic mice [197]. These cells can express 
αGSU, the LHβ subunit and GnRHRs [323].  
Since LbT2 cells are derived from transgenic mice they are genetically modified, and 
most experiments described here involved further genetic modification (i.e. viral 
transduction) of cells. The work was undertaken with approval of the University of 
Bristol's Biological and Genetic Modification Safety Committee (Project #4509) 
 
2.2. Cell culture 
All three cell lines were routinely maintained in Culture Medium consisting of 
Dulbecco’s Modified Eagle’s Media supplemented with 10% (v/v) fetal calf serum 
(FCS) 100 U/mL penicillin and 0.1 mg/mL streptomycin in T75 flask. Cells were 
maintained in a humidified atmosphere of 5% CO2 at 37°C. Cells were passaged upon 
reaching >70% confluence (approximately two to three times per week). Cells were 
subcultured by removal of medium, washing with 5 ml phosphate buffer saline (PBS) 
at room temperature, then incubating for around 3 min with 2 ml TE (0.25% trypsin, 
0.03% ethylenediaminetetraacetic acid (EDTA) in PBS) until cells detached. Cells 





(typically, 2.5 ml) were added into a T75 flask containing approximately 12 ml of 
fresh culture medium and supplemented as above. 
For some experiments, cells were cultured in 96-well plates. After trypsinisation as 
outlined above they were counted and suspended in an appropriate volume of culture 
medium so that they could be seeded in Costar black-walled 96-well culture plates at 
100 µl/well with 5000 HeLa or MCF-7 cell/well, or with 10.000 LβT2 cells/well.  
The LβT2 cells were routinely cultured as described above except that cultured plates 
were coated with Matrigel to improve cell attachment. Matrigel was stored in 200 µl 
aliquots at -20°C and for use, a single aliquot was thawed on ice and then added to 
DMEM (with no additions) at 4°C. 3 ml of the solution was used to coat each T75 
flask, and 30 µl was used to coat each well of a 96-well plate. The Matrigel was left 
at room temperature for 1 hr to solidify and then any residual liquid was removed by 
aspiration [315].  
 
2.3. Adenoviral transduction  
Several recombinant adenoviruses (Ad) were used to express proteins of interest in 
cells. These included Ad for expression of mouse GnRHR (Ad mGnRHR) and Ad for 
expression of an NFAT1c-emerald green fluorescent protein (EFP) (Ad NFAT1c-
EFP) which was used as a readout for GnRH-mediated activation of Ca2+/CaM/Cn 
pathway. Ad for expression of a reporter with Egr1 promoter driving expression 
zsGreen fluorophore (Ad Egr1-zsGreen) and another reporter in which NFAT 
response elements drive expression asRed fluorophore (Ad NFAT-RE-as Red). These 





Ad used were engineered as described here [140, 141, 180] and the stock solutions 
were stored with PBS at -80°C.  
Ad transduction was performed with cells cultured in 96-well plates as described 
under section 2.2. On the day after seeding into culture plates, the Culture Medium 
was replaced with DMEM containing 2% (v/v) FCS and the appropriate Ad (Ad 
mGnRHR, Ad NFAT1c-EFP, Ad Egr1-zsGreen or Ad NFAT-RE-asRed). These Ad 
were used at the range of 1 to 10 plaque-forming units per nanolitre (pfu/nl) except 
Ad mGnRHR, was used at 25 pfu/nl [22, 180, 324]. After 4-6 hr at 37°C Transduction 
Medium was removed and replaced with DMEM containing 0.1% (v/v) FCS (Serum 
Starvation Medium). Cells were then incubated overnight before stimulation. The 
removed Transduction Medium was immediately treated with Virkon to destroy any 
remaining Ad. 
 
2.4. Cell treatments for fixed cell imaging. 
For acute stimulations, 25µl of Serum Starvation Medium containing 5x concentrated 
stimulus was added to each well that contained 100 µl of the Serum Starvation 
Medium. Stimulations were at 37°C and were terminated by removal of this medium 
and addition of ice-cold 4% (w/v) paraformaldehyde (PFA) in phosphate-buffered 
saline (PBS). The stimuli and stimulation periods are outlined in the figure legends. 
For most experiments, cells were stimulated with varied concentrations of GnRH, 






2.5. Delineating network architecture with pharmacological inhibitors. 
The mechanism of GnRH, PDBu, and EGF action were explored with 
pharmacological agents to further characterise ERK and NFAT signalling in the three 
cell lines. The drugs that were used here are a) Cetrorelix, a GnRH antagonist [325], 
b) AG1478, an inhibitor of EGFR signalling that competitively blocks the ATP 
binding pocket of the EGFR [158, 326], c) Ro31-8425, a reversible and highly 
selective inhibitor of protein kinase C that blocks the ATP binding site [158] d) 
PD184352, that inhibits MEK1/2 [316], by binding a hydrophobic pocket and altering 
the Mg-ATP binding site of MEK1/2. This induces a conformational change in 
unphosphorylated MEK1/2 that prevents its activation [327], and e) Cyclosporine A 
(CsA) a potent immunosuppressant drug that inhibits calcineurin [111] by binding 
cyclophilin, and forming a complex that inhibits the phosphatase activity of 
calcineurin. The phosphatase calcineurin is required for the regulation of nuclear 
translocation and activation of NFAT transcription factors [111]. 
Cells were cultured as described above. Inhibitors were applied in a volume of 25 
µl/well for 30 min at 37°C. The antagonists were 4x concentrated in Serum Starvation 
Medium and were used at a concentration of 10-6 M for Cetrorelix, Ro31-8425, and 
CsA, and at a concentration of 10-7 M for AG1478 and PD184352. Cells were then 
stimulated with GnRH, PDBu or EGF in the continued presence of inhibitors in the 






2.6. Immunocytochemistry and fluorescence imaging with fixed cells  
2.6.1. Immunohistochemical quantification of total ERK and ppERK using a 
high content imaging platform  
Following culture and stimulation as outlined above, the stimulation medium was 
removed, and cells were fixed with ice-cold 4% (w/v) PFA in PBS for 5 min at 4°C. 
They were then permeabilized with ice-cold 100% methanol for 5 min at -20°C and 
then washed with PBS at room temperate. Cells were blocked with 5% normal goat 
serum (NGS) in PBS for 1-2 hr at room temperature. Cells were then incubated 
overnight at 4°C in PBS with primary antibody (30 µl/well). The primary antibody 
(1°Ab) used was monoclonal mouse antibody (1:200 dilution in PBS) recognizing 
ppERK or monoclonal rabbit antibody (1:300 dilution in PBS) recognizing total ERK. 
The 1°Ab was removed, and plates were washed 3x with 100 µl PBS at room 
temperature. Cells were then incubated with secondary antibody (2°Ab) for 90 min at 
room temperature. The 2°Ab used was green Alexa-488-conjugated goat anti-mouse 
(1:200 in PBS) or red Alexa-546-conjugated goat anti-rabbit (1:300 in PBS, 30 µl per 
well). Plates were then washed 3x with PBS and nuclei were stained with 4', 6-
Diamidino-2-Phenyindole, Dilactate (DAPI, 1:5000 in PBS) and incubated for 20 min 
at room temperature. Fluorescence images were then obtained and analysed as 
described below. If images are not obtained immediately, cells could be stored for 
several days at 4°C with 200 µl PBS/well to prevent drying of the cells, and plates 






2.6.2. Quantification of NFAT1c-EFP translocation using a high content imaging 
platform. 
Cells were treated as described above except that HeLa and MCF-7 cells were 
transduced with Ad NFAT1c-EFP and Ad mGnRHR, while LβT2 cells were 
transduced with Ad NFAT1c-EFP alone. After stimulation, they were fixed and 
stained with DAPI but were not processed for immunohistochemistry (IHC) as EFP 
fluorescence was used for quantification of nuclear and cytoplasmic NFAT1c-EFP. 
 
2.6.3. Monitoring Egr1-driven zsGreen and NFAT-RE driven asRed expression. 
Cells were treated as described earlier except that the HeLa and MCF-7 cells were 
transduced with Ad Egr1-zsGreen, Ad NFAT-RE-asRed and Ad mGnRHR, while 
LβT2 cells were transduced with Ad Egr1-zsGreen, Ad NFAT-RE-asRed. Cells were 
stimulated with GnRH as outlined in figure legends for a period of 4-6 hr at 37°C 
Cells were then fixed and stained with DAPI. However, cells were not processed for 
IHC as zsGreen, and asRed fluorescence were captured directly for quantification. 
 
2.7. Live cells imaging experiments.  
2.7.1. Imaging NFAT1c-EFP translocation in response to single and two 
pulses of GnRH in LßT2 cells. 
LβT2 cells were cultured and transduced with Ad NFATc1-EFP in 96-well plates as 
described under Section 2.2 and 2.3. On the day of imaging, the Culture Medium was 





composed of [20 mM HEPES (pH 7.4), 137 mM NaCl, 5 mM KCl, 2 mM MgCl2, 1.8 
mM CaCl2, 5.6 mM glucose, 1 mg/mL bovine serum albumin, 0.5 µM NaH2PO4 and 
1mMNaHCO3] and nuclei were stained with 400 nM Hoechst 33342 dye in PPS for 
30 min at 37°C. The Hoechst dye is membrane permeant so can be used for live cells, 
while DAPI is not and is therefore only used for fixed/permeabilized cells. Cells were 
then imaged at 37°C both before and during stimulation with GnRH.  
In the single pulse experiment, cells were imaged for an hour, and images were 
collected every 2 min for the first half hour then every 5 min for the next half hour. 
For the two pulses experiments, LβT2 cells received two pulses of GnRH. The first 
one lasted for 15 min, and images were collected every 2 min.  Next, the plate was 
taken out of the microscope stage to terminate the GnRH effect by extensive washing 
with PSS buffer (4x 100 µl/well). Then the plate was returned to the stage and cells 
were imaged for 130 min, before receiving the second pulse of GnRH which lasted 
for a further 30 min and images were collected every 2 min.  
In both experiments (single and repeated pulses), images were collected by moving 
from one well to the next then returning to the first well. Accordingly, multiple wells 
were imaged in parallel (12 well). Notably, the addition of the stimulus was done 
automatically by the machine. This allows for better temperature control and reduce 
delay in imaging. On the other hand, the use of 5% CO2 atmosphere is not possible, 








2.7.2. Live cell imaging of cytoplasmic [Ca2+] 
A fluorescent green dye (Fluo-4 AM) was used to quantify the intracellular Ca2+   
concentrations. Fluo-4 is an improved analogue of Fluo-3, where two chlorine 
substituents in Fluo-3 are replaced by fluorine in Fluo-4. This modification increases 
fluorescence excitation at 488 nm, so that higher signalling levels result. The Ca2+ 
indicator is hydrophilic and does not cross lipid membranes freely, so it is modified 
by addition of acetoxymethyl (AM) esters. During the incubation period the Fluo-
4AM enters cells, and then the endogenous esterase enzyme cleaves the AM 
hydrophobic component, causing the dye to be trapped inside the cell (Figure 2.1).  
Cells were cultured and plated as described earlier (Section 2.2). On the day of 
imaging, cells were incubated for 30 min at 37°C in PSS containing 5 mM Fluo-4 
AM, and 400 nM Hoechst. The cells were then washed three times with PSS to remove 
any additional indicator from the extracellular solution. Cells were then left in clean 
PSS for 10 min in the INCell Analyser 2200 at 37°C to recover prior to imaging. Cells 
were then auto injected with a stimulus. Images were collected from multiple wells in 
a single plate as described above for NFAT1c-EFP imaging. However, time intervals 
were shorter (images captured every 20 sec for 10 min) so only 3 wells were imaged 









The large circle represents the fluorescent dye core. The carboxylic groups are 
protected as AM esters which makes the dye neutral so that they can cross the cell 
membrane. Inside the cell, the AM groups are cleaved by esterases generating the 
charged and membrane impermeant Fluo-4 molecules that are trapped inside the cell. 
 
 
2.7.3. Live cell imaging of cytoplasmic [Ca2+] in combination with 
NFAT1c-EFP. 
Ad NFAT1c-EFP transduced LβT2 cells were incubated at 37°C for 60 min in loading 
buffer composed of 100x PowerLoad concentrate, 100 mM Rhod-3 AM and 2.5 mM 
probenecid. The PowerLoad concentrate is an optimized form of nonionic, pluronic 
surfactant polyols. It helps the Rhod-3 AM to be soluble in the PSS buffer. The water-
soluble probenecid increases dye retention by suppression efflux of fluorescent dyes 
via anion pumps that are found on the cell membrane. These components together 
maximize the loading of dye into cells and reduce background fluorescence [328, 329] 





After the incubation period, cells were washed 3x with PSS buffer, followed by a 
further 20 min incubation with Hoechst for nuclei staining. Cells were then left 10 min 
in INCell Analyzer 2200 to recover prior to imaging. The images were collected every 
30 sec for 30 min, then every 120 sec for 20 min.  
 
2.8. Image acquisition and image Analysis 
Digital images were acquired with INCell Analyser 1000 and 2200 high-content 
imaging platforms (GE Healthcare). High content imaging systems are increasingly 
used as cell-based assays for drug discovery as well as for interrogation of signalling 
pathways. This is largely because they can offer higher throughput and more rigorous 
quantification than other cell-based or microscopy-based assay systems. The ability 
to determine amount and localisation of signalling molecules in large numbers of 
individual cells is of particular importance for consideration of cell-cell heterogeneity, 
as described in Chapter 1. 
For the InCell 1000 experiments, images were captured using a 10x objective and a 
61002 trichroic mirror. Excitation and emission filters were 360 ± 40 nm and 460 ± 
40 nm for DAPI, 475 ± 20 nm and 535 ± 50 nm for Alexa 488, EFP, and zsGreen and 
535 ± 50 nm and 620 ± 60 nm for Alexa 546 and asRed. Three fields of view were 
imaged per well each 0.602 mm2. Exposure time for each fluorophore was determined 
individually to obtain clear images whilst keeping exposure times short (<1 sec).  
The INCell Analyser 2200 was used for the live cell imaging experiments described 
here. This system uses LEDs for excitations (as opposed to the Xenon lamp light 





and speed is increased with the INCell Analyser 2200. The blue channel was used to 
image Hoechst or DAPI with excitation filter of 590/18x, and emission filter of 452/48 
m. The FITC channel was used to image NFAT1c-EFP and or Fluo-4 AM with 
excitation and emission filters of 475/28x and 512/23 m, respectively. The Texas Red 
channel was used to image Rhod-3 with excitation and emission filters of 575/25x and 
620/30 m, respectively. 
INCell Analyser Investigator software (Workstation 3.7.1, GE Healthcare) was used 
to analyse the images. Multi-Target Analysis (an automated image analysis algorithm) 
was used to define areas of interest (i.e. perimeters of individual nuclei and cells). 
Where cells grow close to one another delineation of cell perimeters can be unreliable 
and for this reason, a “collar” was used (i.e. the cytoplasm was defined by adding a 3 
µm collar around the nucleus). However, LβT2 cells tend to grow in clusters, as shown 
in figure 2.2 and image analysis can fail to separate individual nuclei. Where 
individual nuclei are not accurately delineated, perimeters are drawn around large, 
elongated or irregularly shaped regions that represent multiple overlapping nuclei. In 
order to exclude these from the analysis additional filters were applied to exclude cells 
that have nuclear area >180 um2 and a nuclear roundness index >1.25, as illustrated 
in figure 2.2.  
 
2.9. Data presentation and routine statistical analysis  
For most experiments, full concentration-response curves were constructed at multiple 
time points. Each concentration was applied to duplicated or triplicate wells, so data 
were pooled from all replicated wells. Each experiment was routinely repeated three 





average responses, images were routinely collected for two to three fields of view per 
well. This provided thousands of individual cells for each treatment in each 
experiment and was used for frequency-distribution (FD) plots. 
Whole cells or nuclear fluorophore intensities are reported in arbitrary fluorescence 
units (AFU). The INCell workstation software generates an Excel spreadsheet (.xls 
file) that contains fluorescence intensity measures for each of the regions segmented 
and for each fluorophore. The file shows the measures for each well, for each field of 
view and for each cell. Graphs were plotted using GraphPad Prism [version 7]. Two-
way ANOVAs were used to examine if a specific drug is a significant source of 
variation. Then, separate One-way ANOVAs were applied to test for significant 
differences over time. Post-hoc tests were also used to test for differences between 
groups, as outlined in the figure legends.  
For the NFAT1c-EFP translocation assay, the distribution of the fluorophore was 
described either as a nuclear: cytoplasmic ratio (n:c) or as nuclear fraction (NF). 
Nuclear: cytoplasmic ratios are often used in work of this nature [140, 302] but can 
yield misleading results when fluorophore expression levels are low. For this reason, 
NFAT1c-EFP NF values are used for the data described in chapters 4 and 5. For live 
cell imaging of Fluo-4 and Rhod-3, cell-cell variability in fluorophore uptake will 
influence the single cell fluorescence measures. For this reason, responses were 
normalised to the fluorescence (background subtracted) in each individual cell before 
stimulation [330].  
Statistical analysis was performed using GraphPad Prism 7 (GraphPad Software Inc, 











Semi-automated software (Workstation 3.7.1) was used for cell segmentation as 
described under section 2.8. The cytoplasm perimeter (green) was defined by adding 
a 3 µm collar to the nucleus (blue). HeLa cells are well-separated making 
segmentation simple, but LβT2 cells grow in tightly packed groups. Thus, additional 
filters were applied. Cells with a nuclear area ≥180 um2 and nuclear form factor ≥ 1.25 
were excluded (for example, the cell marked 0 in red), whereas cells marked 1 in green 
were included. The images shown are from cropped image fields. Each field typically 



























2.10. Cell tracking  
For live cell imaging experiments, the Excel file generated by the INCell Analyzer 
software shows single cell measures. This file is imported into MatLab R2017a 
(MathWorks) to track the response of individual cells over time. The tracking 
algorithm matches the geometric centre of the nuclei between sequential images in the 
time stack (i.e. tracking is based on the x-y position of the nuclei identified by the 
image analysis algorithms). In preliminary experiments the use of alternative cell 
measures (nuclear area and nuclear stain intensity) were also considered for cell 
tracking but these offered no improvement over simply tracking using cell position 
(Appendix, tables 1 and 2). Cells are paired with a probability which depends 
exponentially on their Euclidean distance from one-another, and Markov chain Monte 
Carlo analysis was used to find the most likely matching configuration for each pair 
of images [153]. Responses of tracked cells were plotted and inspected to remove 
those for which the tracking had failed. In addition, outliers (approximately 5% of 
cells) were removed from the NFAT1c-EFP experiments. These were cells in which 
time 0 NFAT1c-NF values were <0.4 or >0.55 (see Appendix, Figure 1). 
For the dual pulse live cell imaging experiments, it was necessary to combine image 
stacks before tracking, as detailed in figure 2.3. The INCell analyser 2200 can add 
treatments automatically but cannot do the washing step between the two pulses. Thus, 
the plate was taken out of the stage before repeat stimulation to wash off a stimulus 
manually before returning it to the stage. Accordingly, two separate folders of digital 
images were generated, and these folders were combined using Notepad++ (Text 
editor, Microsoft) and MatLab R-2017a. Cell tracking was then precisely as described 








The INCell analyser 2200 can add treatments automatically but cannot do the washing 
step between the two pulses. Therefore, the plate was removed from the stage before 
repeat stimulation to wash off a stimulus manually. Accordingly, two separate folders 
of digital images were generated, and these folders were stitched together before MI 
calculation following the steps shown in the figure. The curve is representing the 
response of NFAT1c-EFP to GnRH. 
  





2.11. Single cell analysis and calculation of mutual information 
Mutual information (MI) was calculated between stimulus and the experimental 
measures using readouts as proxies for concentration levels based on fluorescence 
intensity. This was done at each time point and using single cell measures from 
complete concentration response curves. MI was estimated using the formula:  
I(Z;S) = H(Z) - H(Z|S) 
Where I: is the MI between a signal (S) and a response (Z), H(Z): is the unconditional 
entropy of the response, and H(Z|S): is the conditional entropy [298]. The Bayesian 
method which was proposed by Nemenman et al. [331] was used for entropy terms 
estimation, and for providing error bars of these estimations. The method is designed 
for discrete data, so that ERK and NFAT cell measures were discretized by binning 
them into 30 equally sized bins.  
For joint pathways MI estimation, data were collected (as described earlier) for 
nuclear ppERK and NFAT1c-EFP-NF in the same cells, or for Egr1-driven zsGreen 
and NFAT-RE driven asRed, also in the same cells. This provides an opportunity to 
calculate the MI between stimulus and each individual experimental measure, as well 
as the joint MI between the stimulus and the paired outputs (ppERK and NFAT1c-
EFP-NF or asRed and zsGreen) as previously shown, except that in this case, the 
response (Z) is interpreted as a two-dimensional vector.  
Similarly, for trajectory calculation, we use an “N” dimensional vector, where N is 
the number of sampling points. Alternatively, we calculated the MI between stimulus 





to two dimensions using multidimensional scaling (MDS) [292]. We do that to assess 
additional information gained by consideration of the response trajectories. 
For the two pulses experiments, the maximum value of NFAT1c-EFP-NF during each 
pulse was used to measure the responses (Z1 and Z2) to the first and second pulse. 
Information I(Z1; GnRH) was calculated, and the additional information from the 
response to the second pulse was calculated using the following formula: 
I(Z2;S|Z1) = I(Z1;GnRH)2 I(Z1;Z2) + I(Z1;Z2|GnRH),  
Here the I(Z1; Z2) is  MI between the individual cell responses in pulses 1 and 2. The 
I(Z1;Z2|GnRH) is the MI between the individual cell responses in pulses 1 and 2 






Chapter 3- Concentration dependencies and kinetics of ERK 







Gonadotrophin-releasing hormone mediates central control of reproduction. It does 
so, by acting through GPCRs on the anterior pituitary gland to stimulate the synthesis 
and secretion of gonadotrophins [180]. Type I mammalian GnRHRs are different from 
other GPCRs in that the receptors signal in an arrestin-independent manner and do not 
undergo rapid desensitisation [133, 302]. Binding of GnRH to its receptor causes a 
Gq-mediated activation of PLC with consequent elevation of cytoplasmic Ca2+ 
concentration and activation of PKC [24]. This Ca2+ causes a rapid increase in the 
exocytotic release of LH and FSH but also causes a calmodulin and calcineurin-
mediated activation of the Ca2+-dependent transcription factor NFAT [140, 163].  
GnRH also activates the Raf/MEK/ERK cascade [157, 165]. This is largely PKC-
mediated, and ERK has pronounced effects on gene expression, that are in part Egr1-
mediated [226]. Accordingly, nuclear translocation of an NFAT1c-EFP reporter or 
NFAT-RE-driven gene expression can be used as readouts for activation of the 
GnRHR/Gq/PLC/Ca2+/CaM/Cn/NFAT pathway, just as activating phosphorylation of 
ERK or Egr1-driven gene expression can be used as readouts for activation of the 
GnRHR/Gq/PLC/PKC/ERK pathway.   
The initial aim of the work described in this chapter was to determine the effects of 
GnRH on the two major signalling pathways outlined above, and this was achieved 
by automated fluorescence microscopy with an INCell 1000 or an INCell 2200. The 
GnRH effect on the downstream readouts for activation of ERK and NFAT was also 
explored. Given the possibility of cell context-dependent signalling [332] the work 
was done in three cellular models (HeLa, LβT2, and MCF-7 cells). Additional aim 





activator (PDBu). This is because both EGFR and PKC were reported to be implicated 
in GnRH signalling (see Chapter 1).  
 
3.2. Materials and methods 
Distinct stimuli were used to monitor their effects on ERK activation and to define 
dose-dependencies and response kinetics in different cell lines. This was done by 
indirect immunofluorescence, using primary antibodies directed to total ERK or 
ppERK and fluorophore-labelled secondary antibodies. Also, the nuclear translocation 
of NFAT1c-EFP was monitored by transducing cells with Ad NFAT1c-EFP. Images 
were obtained by automated fluorescence microscopy using a 10x objective. For all 
experiments, multiple fields were collected for each well, and two to four wells were 
run for each treatment, thus, the images show only a small proportion of the cells 
analysed (approximately 0.3%). 
 
3.3. Results  
3.3.1. GnRH Effects on ERK signalling in Ad mGnRHR transduced HeLa cells. 
Figure 3.1 shows representative images for DAPI (nuclear stain, blue channel), 
ppERK (active ERK, green channel) and total ERK (red channel) in control cells and 
in cells stimulated for 5 min with 10-7 M GnRH. As shown in figure 3.1A, GnRH 
caused a pronounced increase in ppERK stain intensity, particularly in the cell 
nucleus, but did not cause any obvious change in total ERK stain intensity. Analysing 





nuclear ppERK (ppERK-n) that was most pronounced at 5 min and reduced thereafter 
(Figure 3.1B). The ppERK-n was 295.01 ± 19.13 AFU in unstimulated cells and went 
up significantly to 459.01 ± 18.10 AFU with 10-6 M GnRH at 5 min.  
To better illustrate response kinetics, these data were re-plotted against time (Figure 
3.1D) and this revealed that GnRH effects were maximal at 5 min and had reduced to 
control (pre-stimulation) values by 60 min. Two-way ANOVAs of the data in figure 
3.1B revealed that GnRH concentration and time are both significant sources of 
variation (P<0.05, F (21,42) =14.29). Post-hoc tests comparing responses with GnRH 
to control measures with no GnRH revealed statistically significant responses 
(P<0.05) with 10-9-10-6 M GnRH at 5 and 15 min and with 10-8-10-6 M GnRH at 30 
min. However, two-way ANOVAs of the total ERK data in figure 3.1C revealed that 
neither GnRH concentration nor time is significant sources of variation (P>0.05). 
These data reveal that GnRH increases ppERK measures by increasing the proportion 















The cells were plated as described in Chapter 2. They were then stimulated for 5, 15, 
30 or 60 min with 0 or 10-12–10-6 M GnRH before being fixed and stained for ppERK, 
total ERK and with DAPI (nuclei). Digital images were acquired using an INCell 
1000. Panel A shows representative images of DAPI, ppERK and total ERK. The 
right-hand images show an example of the automated image segmentation used to 
define perimeters of the nuclei and cells (perimeters superimposed over GnRH treated 
cells) using automated image analysis algorithms. Scale bar, 30 μm. Image analysis 
algorithms were used to determine fluorophore intensity in areas of interest (nuclei 
and cytoplasm). Panel B shows ppERK-n in AFU. Panel C shows total ERK-n+c in 
AFU. Panel D shows the same data as B but re-plotted against time for each GnRH 
concentration (legend shows log M GnRH concentration). The figures show means ± 
SEMs for 3 replicate experiments (n=3) each of which was from an experiment with 
triplicate wells for each condition and three fields of view/well.   







The image analysis for the data in figure 3.1 provides measures of all three 
fluorophores in the nucleus and the cytoplasm. This could be expressed and presented 
in several different ways. For figure 3.2A ppERK-n was plotted, but the analysis also 
yields measures of cytoplasmic ppERK and whole cell (nuclear + cytoplasmic) 
ppERK, and these are compared in figure 3.2. For each measure, GnRH caused a clear 
concentration and time-dependent increase in ppERK although stain intensities were 
generally higher in the nucleus than in the cytoplasm (compare Figures 3.2B and 
3.2B). However, the responses were qualitatively similar, and the results of the 
statistical analysis were also similar. Two-way ANOVAs of the data in panel B 
revealed that GnRH concentration and time are both significant sources of variation 
(P<0.05, F (21,42) = 11.52). Post-hoc tests comparing responses with GnRH to 
control measures with no GnRH revealed statistically significant responses (P<0.05) 
with 10-9-10-6 M GnRH at 5 and 15 min and with 10-8–10-6 M GnRH at 30 min. The 
log EC50 (M) values were -9.60 ± 0.32, -9.06 ± 0.66, and -9.12 ± 0.92 at 5, 15 and 30 
min respectively.  
Two-way ANOVAs of the data in figure 3.2C revealed that GnRH concentration and 
time are both significant sources of variation (P<0.05, F (21,42) = 13.40). Post-hoc 
tests comparing responses with GnRH to control measures with no GnRH revealed 
statistically significant responses (P<0.05) with 10-9–10-6 M GnRH at 5 and 15 min 
and with 10-8 -10-6 M GnRH at 30 min. This suggests that the effects of GnRH do not 
appreciably differ between these cellular compartments. For subsequent experiments 
ppERK-n was used as the main experimental end-point, reasoning that this would be 
sensitive to both activation and nuclear translocation of ppERK and may be more 






The cells were cultured and processed as described above. Panel A shows ppERK-n 
stain intensity in AFU and is reproduced from figure 3.1 for comparison. Panel B and 
C show population averaged ppERK-c and ppERK-n+c in AFU respectively. The 
results show means ± SEMs, n=3, each with triplicate wells and three fields of 
view/well.   
 
 
3.3.2. PDBu effects on ERK signalling in Ad mGnRHR transduced Hela cells. 
Phorbol 12,13-dibutyrate (PDBu) activates conventional PKC (cPKC) by mimicking 
the actions of DAG. PKC regulates different signal transduction pathways including 
the ERK pathway [333]. Images in figure 3.3A revealed that PDBu caused a 
pronounced increase in ppERK stain intensity in the cell nucleus and had no effect in 
total ERK stain intensity.  
PDBu caused a clear concentration-dependent increase in ppERK-n levels. In 
unstimulated cells, the ppERK-n levels were 264.28 ± 11.91 AFU and went up 
remarkably to around 499.04 ± 2.41 AFU in cells stimulated with 10-6 M PDBu. Two-
way ANOVAs of the data in panel B revealed that PDBu concentration and time are 
both significant sources of variation (P<0.05, F (21,42) = 21.02). Post-hoc tests 
  
 
Figure 3.2. Comparison of 3 different measures for the effect of GnRH on ppERK 
in Ad mGnRHR transduced Hela cells.  















































comparing responses with PDBu to control measures revealed statistically significant 
responses (P<0.05) with 10-7-10-6 M PDBu at 5, 15, 30 min and (P<0.05) with 10-7-
10-6 M PDBu at 60 min. The data were re-plotted against time (Figure 6C). This 
revealed that PDBu effects were maximum at 5 min and reduced to control values by 
60 min. The log EC50 (M) values were -6.85 ± 0.25, -7.06 ± 0.11, -7.24 ± 0.25, and -
8.10 ± 0.17 at 5, 15, 30 and 60 min respectively.  
Total ERK levels were not changed by PDBu as shown in figure 3.3C, demonstrating 
that PDBu (like GnRH) increases ppERK measures by increasing the proportion of 
ERK that is dual phosphorylated, instead of increasing the total amount of ERK 
present. Two-way ANOVAs of the total ERK data revealed that neither PDBu 











Cells were cultured and treated as described in Chapter 2. Panel A shows 
representative images of DAPI, ppERK and total ERK stained cells cultured under 
control condition or stimulated 5 min with 10-7 M PDBu. The right-hand images show 
an example of the automated image segmentation used to define perimeters of the 
nuclei and cells (perimeters superimposed over PDBu treated cells). Scale bar, 30 μm. 
Panels B and C show population averaged ppERK-n and total ERK-n+c in AFU. Panel 
D shows the same data as A but re-plotted against time (legend shows log M PDBu 
concentration). The figures show means ± SEMs, n=3 each with triplicate wells for 
each condition and three fields of view/well.  
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3.3.3. EGF effects on ERK signalling in Ad mGnRHR transduced HeLa cells. 
Effects of EGF on ERK were also monitored in HeLa cells. Images in figure 3.4A 
showed that EGF triggered a marked increase in ppERK stain intensity in the cell 
nucleus but did not cause any obvious change in total ERK stain intensity. EGF caused 
a clear concentration-dependent increase in ppERK-n, peaking at 5 min, and reducing 
subsequently (Figure 3.4B). In control cells, the ppERK levels were 272.81 ± 7.02 
AFU, and this increased to around 557.72 ± 67.81 AFU with 10-8 M EGF.  
Two-way ANOVAs of the data in panel B revealed that EGF concentration and time 
are both significant sources of variation (P<0.05, F (21,42) = 17.36). Post-hoc tests 
comparing responses with EGF to control measures revealed statistically significant 
responses (P<0.05) with 10-10–10-7 M EGF at 5 and 15 min (P<0.05) and with 10-10 M 
EGF at 30 min. The EC50 values were -9.42 ± 1.03, -9.65 ± 1.21, -10.51 ± 3.01 and -
7.88 ± 1.21 at 5, 15, 30 and 60 min respectively. These data were re-plotted against 
time for better illustration of the response kinetics (Figure 3.4D) and demonstrated 
that EGF effects were maximal at 5 min and then declined over the time to near the 
basal levels (by 60 min).  
Two-way ANOVAs of the total ERK data in (Figure 3.4C) revealed that neither EGF 
concentration nor time are significant sources of variation (P>0.05), indicating that 
EGF increased the proportion of ERK that is dual phosphorylated, not the total amount 









Cells were cultured as described in Chapter 2. They were then stimulated with the 
indicated times and concentrations of EGF. Cells were fixed and stained for ppERK, 
total ERK, and nuclei. Representative images of DAPI, ppERK and total ERK stained 
cells cultured under control condition or stimulated with 10-7 M EGF for 5 min are 
shown in A. The right-hand images show an example of the automated image 
segmentation used to define perimeters of the nuclei and cells. Scale bar, 30 μm. 
Panels B and C show population averaged ppERK-n and total ERK-n+c in AFU. Panel 
D shows the same data as A but re-plotted against time. The figures show means ± 
SEMs, n=3 separate experiments each of which was performed in triplicate wells for 
each condition and with three fields of view/well.  
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3.3.4. GnRH Effects on ppERK and NFAT1c-EFP translocation in Ad mGnRHR 
transduced HeLa cells. 
The nuclear translocation of NFAT1c-EFP used here as a cellular readout for 
activation of the Ca2+/CaM/Cn pathway. HeLa cells were cultured and treated as 
described in Chapter 2. Nuclear translocation of the NFAT1c-EFP reporter was 
followed by calculating the ratio of the nucleus: cytoplasm (NFAT1c-EFP-n:c). 
Representative images for DAPI (blue channel), NFAT1c-EFP (green channel) and 
ppERK (red channel) in control cells and cells stimulated for 60 min with 10-7 M 
GnRH are shown in Figure 3.5A. The images demonstrate that NFAT1c-EFP was 
mostly cytoplasmic in unstimulated cells and translocated to the nucleus in GnRH 
stimulated cells. 
The data in Figure 3.5 demonstrates that GnRH caused a clear concentration-
dependent increase in ppERK-n stain intensity. In untreated cells, the ppERK-n was 
approximately 295.12 ± 19.13 AFU and increased to a maximum of 458.85 ± 19.10 
AFU at 5 min in cells stimulated with 10-6 M GnRH. Two-way ANOVAs of ppERK 
data (Figure 3.5B) revealed that GnRH concentration and time are both significant 
sources of variation (P<0.05, F (14,28) =6.21). Post-hoc tests comparing responses 
with GnRH to control measures with no GnRH revealed statistically significant 
responses (P<0.05) with 10-9–10-6 M GnRH at 5, 20 and 60 min. Re-plotting data 
against time (Figure 3.5C) showed that GnRH effects on ppERK-n levels were 
maximal at 5 min then gradually declined over the time. The log EC50 values were -
9.60 ± 0.33, -9 ± 0.71 and -8.10 ± 0.17 at 5, 20 and 60 min respectively.  
The NFAT1c-EFP translocation responses were measured in the same cells and these 





increase in NFAT1c-EFP translocation. The NFAT1c-EFP-n:c was 1.40 ± 0.13 under 
control condition and was increased to a maximum of 1.77 ± 0.24 by GnRH, with a 
log (EC50, M) values of -10.31± 1.12 at 5 min, -8.94 ± 0.41 at 20 min, and -9.35 ± 
0.45 at 60 min. Two-way ANOVAs revealed that GnRH concentration is a significant 
source of variation (P<0.05), whereas time is not (P>0.05, F (14, 28) =1.65). Post-hoc 
tests comparing responses with GnRH to control measures with no GnRH revealed 
statistically significant responses (P<0.05) with 10-8 –10-6 M GnRH at 5 and 20 min 
and with 10-8 –10-7 M GnRH at 60 min. To better illustrate response kinetics, these 
data were re-plotted against time (Figure 3.5E). GnRH effects were seen at 5 min and 












        
 
Cells were cultured and treated as described in Chapter 2. Representative images of 
DAPI, ppERK and NFAT1c-EFP cultured under control condition or stimulated with 
10-7 M GnRH for 60 min are shown in A. The right-hand images show an example of 
the automated image segmentation used to define perimeters of the nuclei and cells. 
Scale bar, 30 μm. Panels B and D show population average responses of ppERK-n in 
AFU and NFAT1c-EFP-n:c. Panels C and E the same data as B and D but re-plotted 
against time. The figures show means ±SEMs, n=3, with quadruplicate wells for each 
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Figure 3.5. GnRH effects of NFAT1c-EFP translocation in Ad mGnRHR 






3.3.5. Quantifying GnRH effects on Egr1 driven zsGreen and NFAT-RE driven 
asRed expression in Ad mGnRHR transduced HeLa cells. 
Figure 3.6A shows representative images of DAPI, Egr1-zsGreen (green channel) and 
NFAT-RE- asRed (red channel) in control cells and cells stimulated for 8 hr with  
10-7 M GnRH. GnRH increased the expression of both fluorophores (Egr1-zsGreen 
and NFAT-RE-asRed). GnRH caused a clear concentration-dependent increase in the 
Egr1-zsGreen-n+c that was 213.31 ± 0.31 AFU in control cells and went up to 
approximately 260.25 ± 17.88 AFU after being stimulated by 10-7 M GnRH. Two-way 
ANOVAs of the data in figure 3.6B revealed that GnRH concentration but not time is 
both significant sources of variation (P<0.05, F (14,42) =5.00). Post-hoc tests 
comparing responses with GnRH to control measures with no GnRH revealed 
statistically significant responses (P<0.05) with 10-8 –10-6M GnRH. These data were 
re-plotted against time showing that GnRH effects were maximal at 6 and 8 hr (Figure 
3.6C) and the log EC50 values were -8.16 ± 0.04 at 6 hr and -8.01 ± 0.12 at 8 hr.  
For NFAT-RE-asRed, as shown in figure 3.6D, GnRH caused a clear concentration-
dependent increase in the NFAT-RE-asRed-n+c. The expression of NFAT-RE-asRed-
n+c was around 199.81 ± 4.11 AFU in control cells and moved up during 8 hr to 
315.02 ± 24.50 with 10-7 M GnRH. Re-plotting against time (Figure 3.6E), the NFAT-
RE asRed-n+c levels were observed at 4 hr and peaked at 8 hr (end point of 
stimulation). Two-way ANOVAs showed that GnRH concentration (but not time) is 
a significant source of variation (P<0.05, F (14,24) =3.64). Post-hoc tests comparing 
responses with GnRH to control measures with no GnRH revealed statistically 
significant responses (P<0.01) with 10-8–10-6 M GnRH at 4, 6 and 8 hr. Studies in 





period. The log EC50 values were -8.61 ± 0.31, -7.30 ± 0.41, and -8.72 ± 0.56 at 4, 6, 















    
 
 
Cells were transduced with Ad Egr1-zsGreen, Ad NFAT-RE-asRed, and Ad 
mGnRHR, prior to serum starvation overnight. They were then stimulated for 4, 6 or 
8 hr with 0 or 10-12 -10-6 M GnRH. They were then fixed and stained with DAPI 
(nuclei). Digital images and analysis were used as described in Chapter 2. 
Representative images of DAPI, Egr1-zsGreen and NFAT-RE-asRed in cells cultured 
under control condition or stimulated 8 hr with 10-7 M GnRH are shown in A. The 
right-hand images show an example of the automated image segmentation used to 
define perimeters of the nuclei and cells. Scale bar 3 μm. Panels B and D show 
population averaged responses of Egr1-zsGreen-n+c and NFAT-RE-asRed-n+c in 
AFU. These data are re-plotted against time in panel C and E. The figures show means 
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Figure 3.6. Quantifying GnRH effects on Egr1 driven zsGreen and NFAT-RE 






3.3.6. GnRH effects on NFAT1c-EFP and ERK activation in LβT2 cells. 
LβT2 cells express endogenous GnRHRs, so they were transduced with Ad NFAT1c-
EFP alone then treated as described in Chapter 2. The NFAT1c-EFP translocation and 
ppERK levels were monitored in the same cells. Representative images for DAPI, 
NFAT1c-EFP, and ppERK in control cells and cells stimulated for 60 min with 10-7 
M GnRH are shown in figure 3.7A. These revealed that NFAT1c-EFP was largely 
cytoplasmic in unstimulated cells and translocated to the nucleus in response to 
GnRH.  
GnRH caused a clear concentration-dependent increase in NFAT1c-EFP 
translocation. The NFAT1c-EFP-n:c was approximately 0.73 ± 0.12 and increased by 
10-7 M GnRH to a maximum of 3.02 ± 0.62 at 60 min. For a better illustration of the 
kinetics, data were re-plotted against time (Figure 3.7C), and these show that GnRH 
effects on NFAT1c-EFP location were observed at 20 min and peaked at 60 min. Two-
way ANOVAs of the data in panel B revealed that GnRH concentration is a significant 
source of variation (P<0.05, F (7,14) =15.82). Post-hoc tests comparing responses 
with GnRH to control measures with no GnRH revealed statistically significant 
responses (P<0.05) with 10-9 –10-6 M GnRH at 5 and 20 min and with 10-8–10-6 M 
GnRH at 60 min. The log EC50 (M) values were similar with -10.01 ± 0.50 at 5 min, 
and -9.41 ± 0.15 at 20 and -9.10 ± 0.50 at 60 min.  
The ppERK was measured in the same cells and these shown in figure 3.7D. GnRH 
caused a clear concentration-dependent increase in ppERK-n stain intensity in 
stimulated cells (176.15 ± 1.72 AFU for control, 228.10 ± 12.02 AFU for 10-6 M 
GnRH). For better illustration, the response kinetics of these data were re-plotted 





were rapid within 5 min and were maintained at similar levels for 60 min. Two-way 
ANOVAs of ppERK data in figure 3.7D revealed that GnRH concentration and time 
are both significant sources of variation (P<0.05, F (14,28) =2.54). Post-hoc tests 
comparing responses with GnRH to control measures with no GnRH revealed 
statistically significant responses (P<0.05) with 10-9-10-6 M GnRH at 5 min and with 
10-8– 10-6 M GnRH at 20 and 60 min. The log EC50 (M) values were similar with -













            
         
 
Cells were treated for the indicated times and with the indicated concentrations of 
GnRH. They were then fixed and stained for ppERK and nuclei. Digital images and 
analysis were as described in Chapter 2. Representative image of DAPI, NFAT1c-
EFP and ppERK in cells cultured under control condition or stimulated 60 min with 
10-7 M GnRH are shown in A. Scale bar, 3 μm. Panel B shows NFAT1c-EFP-n:c. 
panel D shows ppERK-n stain intensity in AFU. Panels C and E represent the same 
data as B and D respectively but re-plotted against time. The figures show means 
±SEMs, n=3-4, each with quadruplicate wells for each condition and three fields of 
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Figure 3.7. Quantifying GnRH effects on NFAT1c-EFP location and the 






3.3.7. GnRH effects on Egr1 driven zsGreen and NFAT-RE driven asRed 
expression in LβT2 cells. 
LβT2 cells were transduced with Ad Egr1-zsGreen, and Ad NFAT-RE-asRed then 
treated as described in Chapter 2. The representative images in Figure 3.8A illustrates 
DAPI, Egr1-driven zsGreen, and NFAT-RE-driven asRed expression in control cells 
and cells stimulated for 8hr with 10-7 M GnRH. The stimulus led to an increase in 
Egr1-driven zsGreen expression in the nucleus and cytoplasm (Egr1-zsGreen-n+c) 
and NFAT-RE-driven asRED expression in the nucleus and cytoplasm (NFAT-RE-
asRed-n+c.  
As shown in figure 3.8A, GnRH caused a clear concentration-dependent increase in 
Egr1-zsGreen-n+c. This rose from 216.64 ± 0.80 AFU to 1049.35 ± 110.41 AFU after 
being stimulated by GnRH, and the effect was maximal at 8 hr with 10-6 M GnRH. 
The log EC50 (M) values were similar at all the indicated times (-7.72). These data 
were re-plotted against time (Figure 3.8C), revealing that GnRH effects were seen at 
4 hr and were maximal at 8 hr.  Two-way ANOVAs of the data in figure 3.8B showed 
that GnRH concentration and time are both significant sources of variation (P<0.05, 
F (14,28) =6.72). Post-hoc tests comparing responses with GnRH to control measures 
with no GnRH revealed statistically significant responses (P<0.05) with 10-8 –10-6 M 
GnRH.  
Effects of GnRH on NFAT-RE-driven asRed expression are shown in figure 3.8D. 
GnRH caused a clear concentration-dependent increase in NFAT-RE-asRed-n+c, 
which was most pronounced at 8 hr (from 140.71 ± 0.61 to 153.10 ± 4.10), with a log 
EC50 (M) value of -8.56 ± 0.32. To better illustrate response kinetics, data were re-





were like its effects on Egr1-zsGreen. The effect was seen at 4 hr and continued to 
rise until 8 hr, where the experiment was ended. However, the response on the former 
was lower than the latter (compare Figure 3.8C and Figure 3.8E). Two-way ANOVAs 
of NFAT-RE-asRed-n+c revealed that GnRH concentration and time are both 
significant sources of variation (P<0.05, F (14,28) =2.76). Post-hoc tests comparing 
responses with GnRH to control measures with no GnRH showed statistically 
significant responses (P<0.05) with 10-8 –10-6 M GnRH at 4 and 6 hr, and with 10-8 – 


















Cells were cultured and treated as described in Chapter 2. Representative images for 
DAPI, Egr1-zsGreen, and NFAT-RE-asRed for cells cultured under control condition 
or stimulated 8 hr with 10-7 M GnRH are shown in A. The right-hand images show an 
example of the automated image segmentation used to define perimeters of the nuclei 
and cells. Scale bar, 3 μm. Panels B and D show population average responses of 
Egr1-zsGreen-n+c and NFAT-RE-asRed-n+c in AFU. Panels C and E show the same 
data as B and D respectively but re-plotted against time. The figures show means ± 
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Figure 3.8. GnRH effects on Egr1 driven zsGreen and NFAT-RE driven asRed 






3.3.8. GnRH effects on NFAT and ERK activation in Ad mGnRHR transduced 
MCF-7 cells. 
Some studies have shown that breast cancer lines express the endogenous GnRHRs 
[325]. However, work in our lab has revealed no evidence for endogenous GnRHRs 
in MCF7 cells, although functional GnRHRs could be expressed in these cells by 
adenoviral transduction [325]. Thus, these cells were treated similarly to HeLa cells.   
Figure 3.9 shows that the effect of GnRH on NFAT1c-EFP translocation was rapid 
then remained sustained during the examined period (60 min). In control cells, the 
NFAT1c-n:c was 0.45 ± 0.01 and increased significantly to a maximum of 0.63 ± 0.01 
with 10-6 M GnRH. The effect of GnRH on NFAT1c-EFP-n:c was dose-dependent, 
and the maximum effect was seen at 60 min with 10-8 –10-6 M GnRH, with a log EC50 
(M) value of -9.18 ± 0.11. Two-way ANOVAs of the data in figure 3.9 revealed that 
only GnRH concentration is a significant source of variation (P<0.05, F (2,24) = 
452.00). Post-hoc tests comparing responses with GnRH to control measures with no 
GnRH revealed statistically significant responses (P<0.05) with 10-9–10-6 M GnRH at 
5, 20 and 60 min.  
For ERK dual phosphorylation, GnRH caused a clear concentration-dependent 
increase in ppERK-n. That was rapid and transient (peaking at 5 min and returning to 
basal conditions by 60 min). The level of ppERK-n increased significantly from 
935.65 ± 61.36 AFU to 1467.21 ± 132.12 AFU with 10-6 M. Two-way ANOVAs of 
ppERK data revealed that GnRH concentration and time are both significant sources 
of variation (P<0.05, F (14,56) =11.86). Post-hoc tests comparing responses with 
GnRH to control measures with no GnRH revealed statistically significant responses 





(M) values were –7.87 ± 0.31 at 5 min, –8.03 ± 0.01 at 20 min, and -10.65 ± 0.65 at 
60 min.  
      
            
 
Cells were treated as described in Chapter 2 and were stimulated for the indicated 
times and concentrations. Representative images of DAPI, NFAT1c-EFP, and ppERK 
in cells cultured under control condition or stimulated 5 min for ppERK and 60 min 
for NFAT1c-EFP with 10-7 M GnRH are shown in A. Scale bar, 3 μm. Panels B and 
D show population average responses of NFAT1c-EFP-NF and ppERK-n stain 
intensity. Panels C and E show the same data as B and D respectively but re-plotted 
against time.  The figures show means ±SEMs, n=4, each with quadruplicate wells for 
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Figure 3.9. GnRH effects on the activation of NFAT and ERK in Ad mGnRHR 






3.3.9. GnRH effects on Egr1 driven zsGreen and NFAT-RE driven asRed 
expression in Ad mGnRHR transduced MCF-7 cells. 
The effects of GnRH on Egr1 driven zsGreen and NFAT driven as Red expression 
were quantified in the same cells. The representative images in figure 3.10A, 
demonstrate DAPI, Egr1-zsGreen and NFAT-RE-asRed expression in control cells 
and cells stimulated for 8 hr with 10-7 M GnRH. GnRH caused a pronounced increase 
in NFAT-RE driven asRed expression in the whole cell but did not cause any obvious 
change in Egr1-driven zsGreen expression.  
GnRH caused a concentration-dependent increase in NFAT-RE-asRed-n+c, that was 
seen at 4 hr and was most pronounced at 8 hr (Figure 3.10D). The expression level of 
NFAT-RE-asRed was 318.28 ± 2.3 AFU under control condition and increased 
significantly to 340.44 ± 3.61 AFU after being stimulated with 10-7 M GnRH at 8 hr 
(Figure 3.10D). Two-way ANOVAs of the data in panel D revealed that GnRH 
concentration and time are a significant source of variation (P<0.05, F (14,56) =6.10). 
Post-hoc tests comparing responses with GnRH to control measures with no GnRH 
revealed statistically significant responses (P<0.01) with 10-8 –10-6 M GnRH at 6 and 
8 hr. The EC50 (M) values for NFAT-RE-asRed were -9.12 ± 0.44 at 4 hr, -9.12 ± 1.12 






       
  
 
Cells were cultured and treated as described in Chapter 2. Representative images for 
DAPI, Egr1 driven zsGreen expression, and NFAT-RE driven asRed expression for 
cells cultured under control condition or stimulated 8 hr with 10-7 M GnRH are shown 
in A. The right-hand images show an example of the automated image segmentation 
used to define perimeters of the nuclei and cells. Scale bar, 3 μm. Panels B and D 
show population average responses of Egr1-zsGreen-n+c and NFAT-RE-asRed-n+c 
in AFU. These data are re-plotted against time in panel C and E. The figures show 
means ± SEMs, n=4, each with quadruplicate wells for each condition and two fields 
of view/well.   
Figure 3.10. GnRH effects on Egr1 driven zsGreen and NFAT-RE driven asRed 





3.3.10. Comparing the effect of GnRH, PDBu, and EGF on ERK and 
NFAT1c-EFP activation in LβT2 cells. 
The effect of GnRH, PDBu, and EGF on ppERK activation and nuclear translocation 
of NFAT1c-EFP in LβT2 cells are compared and illustrated in figure 3.11. Stimulating 
the cells with 10-7 M GnRH or 10-6 M PDBu resulted in a sustained effect on the level 
of the ppERK-n, which was most pronounced at 30 min with GnRH and 15 min with 
PDBu, and the responses remained elevated during the observed period. In control 
cells, the ppERK-n level was 162.41 ± 1.62 AFU, and this was increased significantly 
to around 243.62 ± 19.27 AFU by GnRH (Figure 3.11A), and up to 206.71 ± 6.14 
AFU by PDBu (Figure 3.11B). In contrast, stimulation with 10-8 M EGF (Figure 
3.11C), induced a rapid and transient increase of the ppERK-n, which was 165.422 ± 
4.23 AFU and increased to 262.31 ± 5.31 AFU after being stimulated with EGF. The 
response peaked at 5 min then declined to the basal level by 60 min.  
Two-way ANOVAs of the ppERK data (Figure 3.11 A, B and C) revealed that 
concentration and time are both significant sources of variation (P<0.05, F 
(4,16)=14.76 (GnRH), F (4,16)=36.44 (PDBu) and F (4,16)=247.20 (EGF)). 
Bonferroni's multiple comparisons test (comparing the responses with GnRH or PDBu 
to control measures) showed that both stimuli are significant sources of variation 
(P<0.05) at all the indicated times. However, comparing the responses of ppERK-n 
with EGF to control measures showed that EGF is a statistically significant response 
(P<0.05) at 5 and 15 min but not for the 30 or 60 min.   
The NFAT1c-EFP translocation in response to the same stimuli was measured in 
parallel. As shown in figure 3.11D, GnRH caused a time-dependent increase in the 





response at 30 min. Notably, neither PDBu nor EGF had any effect on the nuclear 
translocation of NFAT-EFP in this cell line (Figure 3.11E and F). Two-way ANOVAs 
of the NFAT-EFP data in the data in panel D revealed that concentration and time are 
both significant sources of variation (P<0.05, and F (4,16) = 46,87 GnRH, F (4,16) = 
46.87). Comparing the responses with GnRH to control measures for each time by 
Bonferroni's multiple comparisons test revealed statistically significant responses 
(P<0.05) with 10-7 M GnRH at all the indicated times. However, neither concentration 




















Cells were plated as described in Chapter 2. They were then stimulated with 10-
7 M GnRH, 10-8 M PDBu or 10-8 M EGF, for the indicated times, before being 
fixed and stained for ppERK and nuclei. The cells were imaged using an 
automated fluorescence microscope. Data shown are the ppERK-n in AFU and 
NFAT1c-EFP-n:c. The results show the means ± SEMs, n=3-4, with triplicate 













































































































Figure 3.11. Comparison of the effect of GnRH, PDBu and EGF on the activation 





3.3.11. Comparing the effect of GnRH, PDBu, and EGF on ERK and 
NFAT1c-EFP in HeLa cells. 
As shown in figure 3.12A and C, GnRH and EGF had a transient effect on ppERK in 
HeLa cells that peaked at 5 min and returned to control values by 60 min. The response 
was substantially higher with EGF than with GnRH. In untreated cells, ppERK-n 
levels were 163.71 ± 2.14 AFU and increased to 209.18 ± 0.25 AFU and 232.56 ± 
6.45 AFU following stimulation with 10-7 M GnRH and 10-8 M EGF, respectively 
(Figure 3.12A and C). Stimulating cells with 10-6 M PDBu rapidly increased the level 
of ppERK-n from 162.33 ± 2.04 AFU to 233.23 ± 8.15 AFU by 5 min then gradually 
declined but did not return to basal conditions during the observed period (Figure 
3.12B).  
Two-way ANOVAs showed that both variables (concentration and time) are 
significant source of variation (P<0.05, and F (4,16) =44.46 (GnRH), F (4,24) 
=103.80 (PDBu) and F (4,24) =114.80 (EGF)). Post-hoc tests comparing responses 
with GnRH, PDBu or EGF to control measures for each time showed that GnRH and 
EGF concentration are statistically significant sources of variation (P<0.05) at 5, 15, 
30 min but not for the 60 min. However, PDBu effect is significant (P<0.05) at all the 
indicated times.  
The effect of these stimuli on NFAT1c-EFP translocation was measured in parallel 
(Figure 3.12 D, E and F). GnRH caused a time-dependent increase in NFAT1c-EFP-
n:c. In this cell line, a concentration of 10-7 M GnRH resulted in significant increase 
in NFAT1c-EFP-n:c (2.6-fold). The response was observed at 5 min, peaked at around 
15 min, and remained elevated during the observed period. Stimulating the cells with 





was most pronounced at 5 min and declined to the basal level by 60 min (Figure 
3.12F). However, no effect of PDBu on NFAT1c-EFP translocation was observed 
(Figure 3.12E).  
Two-way ANOVAs of the NFAT1c-EFP-n:c data in figure 3.12D, E and F, were 
performed and revealed that concentration (of GnRH and EGF but not for PDBu), and 
time are both significant sources of variation (P<0.05, F (4,16) =68.36 (GnRH) and F 
(4,24) =80.80 (EGF)). Post-hoc tests comparing responses with GnRH and EGF to 
control measures revealed statistically significant responses (P<0.05) of NFAT1c-
EFP with 10-7 M GnRH at all the indicated times, whereas with 10-8M EGF the 













Cells were cultured and treated as described in Chapter 2. Cells were then stimulated 
with GnRH PDBu, or EGF at the indicated time and concentrations, before being 
fixed, stained for ppERK and nuclei. Data shown are ppERK-n (in AFU) and 
NFAT1c-EFP-n:c. The figures show means ± SEMs, n=3-4, each from an experiment 






































































































Figure 3.12. Comparison of the effect of GnRH, PDBu and EGF on the activation 





3.3.12. Comparing the effect of GnRH, PDBu, and EGF on ERK and 
NFAT1c-EFP in MCF-7 cells 
Figure 3.13 illustrates the response of ppERK in MCF7 cells stimulated with GnRH, 
PDBu or EGF. Rapid and transient ERK phosphorylation was observed after 
stimulating cells with 10-7 M GnRH and 10-8 M EGF. The responses peaked at 5 min 
and returned to the control value by 60 min (Figure 3.13A and C). The ppERK-n level 
was considerably higher in cells treated with EGF than with GnRH. It was increased 
by 1.2- and 1.7-fold change following treatment with GnRH and EGF, respectively 
(Figure 3.13A and C). The ppERK response to PDBu (10-6 M) was more sustained. It 
peaked at 5 min and remained elevated throughout the time course (Figure 3.13B).  
Two-way ANOVAs for the ppERK data in the top panels (Figure 3.13A, B and C) 
revealed that time is a significant source of variation (P<0.05) in cells stimulated by 
GnRH, whereas concentration is not. However, in cells stimulated by PDBu or EGF, 
both variables are significant sources of variation (P<0.05, F (4,24) = 68.7.91 (GnRH) 
F (4,32) =23.15 (PDBu) F (4,32) =95.19 (EGF)). Post-hoc tests comparing responses 
with GnRH, PDBu and EGF to control measures showed that GnRH concentration 
(panel A) is statistically significant sources of variation (P<0.05) at 5, 15, 30 min but 
not for the 60 min, of the PDBu (in panel B) is statistically significant source of 
variation (P<0.01) at all the indicated times, whereas EGF concentration effect is 
statistically significant at only 5 and 15min.  
GnRH caused NFAT1c-EFP translocation in this cell line. The response peaked at 5 
min and remained steady throughout the observed period. The NFAT1c-EFP-n:c 





3.13D). However, no measurable effect of EGF or PDBu on NFAT1c-EFP nuclear 
translocation was observed here (Figure 3.13E and F).  
Two-way ANOVAs for the NFAT1c-EFP data (Figure 3.13D, E and F) showed that 
concentration and time are both significant sources of variation (P<0.05, F (4,24) 
=12.33) in cell treated with GnRH but not with PDBu or EGF. Post-hoc tests 
comparing responses with GnRH to control measures for each time revealed 















Cells were cultured and treated as described in Chapter 2. Data shown are the ppERK-
n (in AFU) and NFAT1c-EFP1c-n:c. The figures show means ± SEMs, n=4-5, each 






3.3.13. Comparing the effects of GnRH on ERK and NFAT1c-EFP and 
their transcriptions readouts in HeLa, LβT2 and MCF-7 cells. 
As shown in figure 3.14, two-way ANOVAs revealed that concentration and time are 
both significant sources of variation (P<0.05), and comparing the responses of ppERK 
with GnRH to control measures for each time showed that in LβT2 and HeLa cells the 
responses were significant different at all the indicated times (Figure 3.14A and B). 
However, in MCF-7 cells (Figure 3.14F), the GnRH effect was significant for the 5, 
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Figure 3.13. Comparison of the effect of GnRH, PDBu and EGF on the activation 





For the NFAT1c-EFP data (panels D, E, and F), two-way ANOVAs revealed that both 
variables are significant sources of variation in all three cell lines (P<0.05). Post-hoc 
tests comparing responses with GnRH to control measures for each time revealed that 
the GnRH effect on NFAT1c-EFP was statistically significant (P<0.05) with 10-7 M 
at all the time points and in the three cell lines examined here.  
Effect of GnRH on Egr1- and NFAT-RE driven expression of zsGreen and asRed 
respectively are also shown in figure 3.15. Two-way ANOVAs revealed that 
concentration and time are both significant sources of variation in all three cell lines 
(P<0.05). Comparing responses with and without GnRH for each time revealed that 
GnRH effect on Egr1-zsGreen-n+c was statistically significant with 10-7 M at 4, 6 and 
8 hr in both HeLa cells and LβT2 cells but not in MCF-7 cells (P<0.05). Two-way 
ANOVAs of the low panels (figure 13.14D, E and F) revealed that concentration and 
time are both significant sources of variation for HeLa cells (P<0.05, F (3,9) = 6.12, 
and only concentration is significant sources of variation for LβT2 with P<0.05). 
Comparing the responses of NFAT-RE-asRed with GnRH to control measures for 
each time showed that in LβT2 and HeLa cells the responses were significant at 4, 6, 
and 8hr (but not for the 2hr data). For MCF-7 cells data, GnRH had no effect on the 










Cells were cultured as described above and treated with 0 or 10-7 M GnRH for the 
indicated times. Cells were then fixed and stained for ppERK and cell nuclei (DAPI). 
Image acquisition and analysis were performed as described in Chapter 2. The data 
shown are the ppERK-n (in AFU) and NFAT1c-EFP-n:c. The results show the means 
± SEMs from 3 to 4 separate experiments (n=3-4), with triplicate wells and with three 

















Figure 3.14. Comparing the effect of GnRH on ppERK and NFAT1c-EFP in 
























Cells were cultured and treated as described in Chapter 2. Cells were then stimulated 
with 0 or 10-7 M GnRH for the indicated times. Cells were next fixed and stained for 
cell nuclei (DAPI). Image acquisition and analysis were performed as described in 
Chapter 2. The data shown are the NFAT-RE-asRed-n+c and Egr1-ZsGreen-n+c (in 
AFU). The results show the means ± SEMs, (n=3-4), with triplicate wells and with 
three fields of view/well.   
Figure 3.15. Comparing the effect of GnRH on Egr1 driven zsGreen and NFAT-
RE driven asRed expression in three different cell lines 
TTime (hrs) Time (hrs) 
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Type I mammalian GnRHRs are Gαq/11 coupled receptors. Their activation leads to 
the activation of both ERK and NFAT pathways [8, 25]. The aim of the experiments 
described in this chapter was to determine the effects of GnRH on the two pathways, 
and this was achieved by automated fluorescence microscopy. An additional aim was 
to monitor the responses of both ERK and NFAT1c-EFP to EGF and PKC activator. 
The work was performed in three different cell lines, LßT2 cells that express the 
endogenous GnRHRs, and HeLa and MCF-7 cells where both do not express GnRHR, 
therefore they had to be transduced with Ad mGnRHRs.  
The key findings are that similar effects of GnRH on ppERK were seen in the extra-
pituitary cell lines (HeLa and MCF-7 cells), the effect was rapid and transient 
(maximal at 5 min and returned to the control level by 60 min). In contrast, in the 
pituitary-derived cell line (LßT2 cells), the response was slower in onset and remained 
elevated throughout the observed period (Figure 3.13A-C). These findings are in 
accord with other studies that described the transient kinetics of ERK in both HeLa 
[316, 327] and MCF-7 cells [325]. A difference in these studies is that the cells were 
transfected either with Ad human GnRHR or Ad sheep GnRHR instead of Ad 
mGnRHR (which is used in this work to allow for direct comparison with the 
endogenous mGnRHRs of LβT2 cells). However, mammalian GnRHRs of humans, 
mice, horse, and sheep share more than 80% amino acid homology and have similar 
mechanisms for signalling [111].  
The difference in kinetics observed in these cell lines are not related to the differences 
in receptor affinity. The dose-response analysis showed similar potencies log EC50 





7 and LβT2 cells, which is in accord with previous studies in HeLa and MCF-7 cells 
[133, 316, 334]. The response of NFAT1c-EFP to GnRH was similar in the three cell 
lines. Though, the response in HeLa cells was greater than in the other two cell types, 
and the log EC50 (M) values was largely similar (-9 to -10, Figure 3.5, 3.7 and 3.9).  
The differences observed here between cell lines could be related to the way that cells 
were immortalised as explained in Chapter 1 (Section 1.13). The extra-pituitary cell 
lines are derived from carcinomas [335-337]. On the other hand, LßT2 cells were 
immortalised from large and small SV40 T antigen. SV40 T antigen causes cell 
immortalisation [318] by interacting with a wide range of target proteins, like proteins 
phosphatase 2A and protein phosphatase 1. In most cells and tissue these two proteins 
account >90% of Ser/ Thr phosphatase activity [319]. Moreover, the small SV40 cause 
the inhibition of proteins phosphatase 2A [320], which is reported to affect the ERK 
and MEK activities [338].  
Promoters of the genes encoding LHß, FSHß and αGSU have sites that can be 
regulated by both ERK and NFAT [123]. In order to investigate Ca2+/calcineurin/ 
calmodulin- and PLC/PKC/ERK-directed transcriptional activity directly, GnRH-
mediated activation of the Egr1 promoter and the NFAT-RE was examined in the three 
cell lines. GnRH increased the expression levels of the fluorescent proteins (zsGreen 
and asRed) that were used as readouts of Egr1 and NFAT-RE respectively. These 
responses had relatively similar kinetics in both HeLa and LβT2 cells. However, the 
expression levels of Egr1-zsGreen were greater than NFAT-RE-asRed in LβT2 
(Figure 3.6 and Figure 3.8). The potencies were comparable for each reporter with 
EC50 values of approximately 10-7. In the MCF-7 cell line, GnRH had little effect on 





expression (Figure 3.10). This low or absent expression might be related to that the 
stimulation period is not enough and signals can be observed if cells stimulated over 
8 hr. For example, the effect of GnRH on ERE driven luciferase reporter gene in LβT2 
was observed after a period of 18-24 hr [339].  
These variances in the expression levels of Egr1-zsGreen that were observed between 
the three cell types are likely related to the duration of the signalling to ERK that may 
affect the downstream process [341, 342]. The signal duration likely influences the 
transcription and activity of immediate early genes, such as c-Fos, and Egr1 [341]. 
Thus, the differences could be explained by that, the transient response of ERK in 
HeLa cells resulted in an increase in the Egr1-driven zsGreen expression, but ERK 
declined before the Egr-1zsGreen is accumulated further. On the other hand, the 
sustained ERK response that was seen in LβT2 cells could allow for more 
accumulation of Egr1-zsGreen [342]. However, different mechanisms could also be 
involved such as protection of ERK phosphorylation by specific interacting proteins 
or crosstalk with other signalling pathways [343]. Such differences emphasise the 
importance of examining different cell lines on signalling pathways studies.  
For further validation of the effect of GnRH, EGF and PDBu on the measurements, 
an extra step was conducted. As shown in Figure 3.11 to Figure 3.14, cells were 
subjected to a single dose of the stimulus and measured its effect on ppERK, NFAT-
1c-EFP and their transcriptions readouts at different time points. The main findings 
are that activation of ERK was shown to be stimulus dependent (transient by GnRH 
and EGF and sustained by PKC activator). Similarly, GnRH caused a sustained effect 
on the NFAT1c-EFP translocation, whereas EGF caused a transient response in only 





of the examined cell lines. These findings imply that EGF is functionally linked to the 
PLCγ pathway in HeLa cells and provides evidence for coupling between EGFR and 
PLCγ. On the other hand, EGF did not signal to NFAT in LβT2 and MCF-7 cell lines 
(Figure 3.11, 3.12 and 3.13). These differences are likely related to the variation in the 
activation mechanisms, scaffolding proteins and the balance of kinases and 
phosphatase in the cells. These factors play a crucial role in shaping responses [36]. 
The transient response that are resulted by EGF it could be related to the dynamics of 
its receptor [39]. A more likely explanation is that EGFR undergoes rapid cell-
dependent agonist-induced internalisation upon stimulation by EGF, terminating ERK 
activation [39]. However, mammalian GnRHRs do not undergo rapid homologous 
receptor desensitisation [302, 344]. Notably, regarding the expression of Egr1-
zsGreen and NFAT-RE-asRed in MCF-7 cells, an opposite result was obtained 
(Compare Figure 1.10 C and E with Figure 1.14 C and F), GnRH caused the 
expression of NFAT-RE-asRed and no effect on Egr-1zsGreen (Figure 1.10), whereas 
GnRH had no effect on both measurements (Figure 1.14). The main reason is 
unknown and thus, various inhibitors were used in next chapter for further 
investigations of the signalling pathways in these cell lines 
To sum up, ERK activation kinetics were found to be stimulus specific, while PDBu 
caused sustained ERK activation, EGF caused transient activation. GnRH effects were 
dependent upon cell context, with GnRH causing transient responses in the HeLa and 
MCF-7 cells and a sustained response in LβT2 cells. Regarding NFAT1c-EFP the 
response was sustained with GnRH in all three cell types. In spite of the fact that PKC 
is thought to mediate elevation of cytoplasmic Ca2+ in pituitary cells [345], PDBu did 
not signal to NFAT in any of the examined cell lines. EGF effects were also context-





Egr1- driven zsGreen expression, and NFAT-RE- driven asRed expression in both 
LßT2 and HeLa cells. However, the effect on Egr1-zsGreen was greater in LßT2 than 
in HeLa cells. In contrast, in MCF-7 cells, GnRH had little effect on NFAT-RE-asRed 
and no effect on Egr1-zsGreen was observed in this cell line (summarised in Table 
3.1). These differences presumably reflect differences in the identity or concentration 
of signalling components in the three cellular models explored. Therefore, the 
experiments described in the following chapter were planned to use pharmacological 


















Measurement HeLa cells LβT2 cells MCF-7 cells 
ERK Transient Sustained Transient 
NFAT1c-EFP Sustained Sustained Sustained 
Egr1-zsGreen Sustained Sustained No effect 
NFAT-RE-asRed Sustained Sustained Sustained 
 
Table 3.1. Summary of the GnRH effect on ERK, NFAT1c-EFP, Egr1-zsGreen 
and NFAT-RE-asRed in three cell lines.  
Stimulating cells with GnRH caused transient ERK activation in HeLa and MCF-7 
cells and sustained effect in LβT2 cells. However, its effect on NFAT1c-EFP 
translocation was found to be sustained in all three cell types. GnRH-caused Egr1- 
driven zsGreen expression, and NFAT-RE- driven asRed expression in LßT2 and 
HeLa cells, but the effect was greater on Egr1-zsGreen in LßT2 than in HeLa cells. In 
contrast, the effect of GnRH in MCF-7 cells shown to be relatively low on NFAT-RE-














4.1.  Background 
The substantial role of GnRH in the reproductive system has made it a major target 
for the treatment of infertility and sex steroid hormone-dependent diseases [346, 347]. 
GnRH interacts with its cognate receptor in the plasma membrane and utilises various 
signalling mechanisms for the activation of ERK and NFAT [6, 133, 158]. The fine 
control of ERK or NFAT signalling is involved in the regulation of numerous genes 
that implicated in the LHß, FSHß, and αGSU expression [348-350]. GnRHRs are also 
expressed in extra-pituitary sites such as steroid hormone-dependent cancer cells 
including prostate, ovary, and mammary [76]. In these sites, GnRH has been shown 
to have a direct effect in cell proliferation and a novel role in controlling tumor 
progression [199, 351, 352].  
The previous chapter (Chapter 3) described the use of a high content imaging approach 
to interrogate intracellular signalling in HeLa, MCF-7, and LβT2 cell lines, with 
immunofluorescence used to monitor ppERK and fluorescent reporters used to 
monitor effector activation and effector-driven transcription. The data reveal 
activation of the Ca2+/CaM/Cn/NFAT and Raf/MEK/ERK cascades by GnRH, but 
also reveal marked context-dependence of signalling. Such differences imply that 
there are differences in network topology between these models and are consistent 
with the large body of evidence showing that GnRH signalling is dependent on cellular 
context [131, 133, 332]. The differences in ppERK response kinetics could 
conceivably reflect differences in strength of negative feedback pathways known to 
shape ERK responses in other systems [353-355] or differences in reliance on EGF-





This chapter documents a series of experiments using the same cellular models and 
experimental readouts as used for Chapter 3, but with additional use of 
pharmacological inhibitors to further delineate the network architecture for ERK and 


















4.2.  Materials and methods 
Pharmacological inhibitors were used to further probe the signalling networks in 
LβT2, HeLa, and MCF-7 cell lines. The inhibitors used here are a) Cetrorelix, is a 
synthetic decapeptide that competes specifically with GnRH for binding receptors on 
the anterior pituitary cells. Thus, it prevents the action of GnRH in releasing LH and 
FSH [356], b) AG1478, an inhibitor of EGFR signalling that competitively blocks the 
ATP binding pocket of the EGFR [357] c) Ro31-8425, a reversible and highly 
selective inhibitor of protein kinase C that blocks the ATP binding site [358], d) 
PD184352, a MEK1/2 inhibitor that is a highly selective non-competitive inhibitor. It 
does that preventing the activation of MAPKK1 by Raf or MEK kinase with an IC50 
of 2-7µM [359], and e) cyclosporine A (CsA) a potent immunosuppressant drug that 
inhibits calcineurin by binding cyclophilin, and forming a complex that inhibits the 
phosphatase activity of calcineurin [360, 361]. These molecules were applied for a 30 
min pre-treatment, then cells were stimulated with the concentrations and for the times 
outlined under the figures.  
 
4.3.  Results 
4.3.1 Effect of pharmacological inhibition on GnRH signalling in LβT2 cells.  
Cells were subjected to the above inhibitors prior to stimulation with 10-7 M GnRH 
(Figure 4.1). As shown, pre-treatment of the cells with the indicated inhibitors caused 
variable reductions in GnRH signalling to ERK, NFAT1c-EFP, Egr1-zsGreen, and 





Two-way ANOVAs of the data in each panel of figure 4.1 revealed that stimulus, 
inhibitor and stimulus-inhibitor interactions were significant sources of variation 
(P<0.05). Post-hoc tests revealed that GnRH caused a significant increase in ppERK-
n (from 153.12 ± 2.10 to 223.11 ± 4.25 AFU) and that this effect was significantly 
inhibited by PD184352, RO31-8425 and Cetrorelix, but not by AG1478 or CsA 
(Figure 4.1A). Similarly, GnRH caused a significant increase in Egr1-zsGreen (from 
205.10 ± 1.21 to 808.11 ± 4.00 AFU) and this effect was inhibited by PD184352 and 
Cetrorelix but not by AG1478 or CsA (Figure 4.1B). Notably, although R031-8425 
caused a 30% reduction in the GnRH effect on Egr1-zsGreen this effect was not 
significant (P>0.05). It also caused a 70% reduction in ppERK-n response but that was 
statistically significant (P<0.05). 
Of the data in panel C and D, post-hoc tests revealed that GnRH caused a significant 
increase in NFAT1c-EFP-n:c (from 0.84 ± 0.03 to 1.22 ± 0.11 AFU) and that this 
effect was significantly inhibited by Cetrorelix and CsA but not by PD184353, RO31-
8425, or AG1478 (Figure 4.1C). Similar effect was seen in NFAT-RE-asRed (Figure 
4.1D). GnRH caused a significant increase in NFAT-RE-asRed (from 137 ± 1AFU to 
156 ± 0.85 AFU) and this effect was completely abrogated by Cetrorelix and CsA but 
not by the other treatments. Notably, CsA inhibited totally the GnRH effect on 
NFAT1c-EFP translocation (100% reduction) and had a similar inhibition effect on 








LβT2 cells were cultured and treated as described in Chapter 2. Then the indicated 
inhibitors were applied for 30 min prior to stimulation for 5 min (in A and D) or 6 hr 
(in B and E) with 0 or 10-7 M GnRH. The cells were then fixed and stained for ppERK 
and nuclei. The figures show means ±SEMs, n=3, each with triplicate wells for each 
condition and three fields of view/well. The black columns represent the unstimulated 
group where the cells were subjected only to the inhibitors, except for the control 
group (Ctrl) without inhibitor. The grey columns represent cells subjected to the 
inhibitors prior to GnRH stimulation. The star (*) shows significant inhibition of 
GnRH signalling (P<0.05) in cells subjected to inhibitors (grey columns) comparing 
to Ctrl (the first grey column). The F (5,20) = 62.93 (A), The F (5,20) = 188.30 (B), 
F (5,20) = 33.28 (C), F (5,20) = 99.77 (D). The dotted lines represent the background 
values for each measurement.   






4.3.2 Effect of pharmacological inhibition on PDBu signalling in LβT2 cells. 
Two-way ANOVAs of the data in panel A and panel B in figure 4.2 revealed that 
stimulus, inhibitor and stimulus-inhibitor interactions were significant sources of 
variation. Post-hoc tests showed that PDBu caused a significant increase in ppERK-n 
(from 152.12 ± 2.10 AFU to 201.05 ± 0.57 AFU). This effect was significantly 
inhibited by PD184352 and RO31-8425, but not by the other drugs. In the same way, 
PDBu caused a significant increase in Egr1-zsGreen (from 205.21 ± 1.10 AFU to 
808.13 ± 4.44 AFU) and this effect was inhibited by PD184352 (~70% reduction), 
and RO31-8425 (~80% reduction) but not by AG1478, Cetrorelix or CsA (Figure 
4.2D).  
Of the data in panel C and D, separate two-way ANOVAs revealed that neither 
stimulus nor inhibitor is significant sources of variation. PDBu had no effect on 
NFAT1c-EFP translocation or on the NFAT-RE-asRed expression in this cell line 








Cells were cultured and treated as described in Chapter 2. Then the indicated inhibitors 
were applied for 30 min prior to stimulation for 5 min (in A and C) or 6 hr (in B and 
D) with 0 or 10-6 M PDBu. The cells were then fixed and stained for ppERK and 
nuclei. Digital images and analysis were acquired as detailed under section 2.8. The 
figures show means ±SEMs, n=3, each with triplicate wells for each condition and 
three fields of view/well. The black columns represent the unstimulated group where 
the cells were subjected only to the inhibitors, except for the control group (Ctrl) 
without inhibitor. The grey columns represent cells subjected to the inhibitors prior to 
GnRH stimulation. The star (*) shows significant inhibition of GnRH signalling 
(P<0.05) in cells subjected to inhibitors (grey columns) comparing to Ctrl (the first 
grey column). The F (5,20) = 173.7 (A), F (5,20) = 119.60 (B). The dotted lines 
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4.3.3 Effect of pharmacological inhibition on EGF signalling in LβT2 cells. 
LβT2 cells were subjected to different inhibitors (outlined in figure 4.3) prior to 
stimulation with 10-8M EGF. As shown, pre-treatment of the cells with the indicated 
inhibitors caused variable reductions in EGF signalling to ERK, NFAT1c-EFP, 
Egr1zsGreen, and NFAT-RE-asRed.   
Two-way ANOVAs of the data in panels A and B revealed that stimulus, inhibitor and 
stimulus-inhibitor interactions were significant sources of variation. Post-hoc tests 
showed that EGF caused a significant increase in ppERK-n (from 152 ± 2 AFU to 270 
± 5 AFU) and that effect was significantly inhibited by PD184352 and AG1478 (60% 
reduction), but not by RO31-8425, Cetrorelix or CsA (Figure 4.3A). Similarly, EGF 
caused a significant increase in Egr1-zsGreen-n+c (from 205.21 ± 1.01 to 238.02 ± 
0.03 AFU) and this effect was abrogated by PD184352 and AG1478 (Figure 4.3B). 
Both Cetrorelix and R031-8425 caused a 30% reduction in the EGF effect on Egr1-
zsGreen, although this effect was small, statistically was. significant (P<0.05). 
Two-way ANOVAs of the data in panel C and D revealed that stimulus, inhibitors, 
and stimulus-inhibitor interaction were not significant sources of variation. As shown 
in figure 4.3, there was no measurable effect of EGF on the NFAT1c-EFP 
translocation or NFAT-RE-asRed, suggesting that the agonist is not signalling to 







Cells were cultured and treated as described in Chapter 2. Then the indicated inhibitors 
were applied for 30 min prior to stimulation for 5 min (in A and C) or 6 hr (in B and 
D) with 0 or 10-8M EGF. They were then fixed and stained for ppERK and nuclei. The 
figures show means ±SEMs, n=3, each with triplicate wells for each condition and 
three fields of view/well. The black columns represent the unstimulated group where 
the cells were subjected only to the inhibitors, except for the control group (Ctrl) 
without inhibitor. The grey columns represent cells subjected to the inhibitors prior to 
GnRH stimulation. The star (*) shows significant inhibition of GnRH signalling 
(P<0.05) in cells subjected to inhibitors (grey columns) comparing to Ctrl (the first 
grey column). The F (5,20) = 18.25 (A), F (5,20) = 45.84 (B). The dotted lines 
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4.3.4 Pharmacological inhibition of GnRH signalling in Ad mGnRHR 
transduced HeLa cells. 
The mechanism of GnRH signalling to ERK and NFAT was also examined in this cell 
line. As shown in figure 4.4, separate two-way ANOVAs of the data in panels A and 
B revealed that stimulus, inhibitor and stimulus-inhibitor interactions were significant 
sources of variation. Post-hoc tests revealed that GnRH caused a significant increase 
in ppERK-n from 157.03 ± 0.67 AFU to 241.12 ± 1.20 AFU, and that this effect was 
significantly inhibited by Cetrorelix. Although GnRH resulted in a significant increase 
in ppERK-n in cells treated with PD184352 (178.45 ± 7.50 AFU) and in cells treated 
with RO31-8425 (196.40 ± 1.60 AFU), the increase was decreased compared to 
control cells by 70% and 50%, respectively (P<0.05). Similar GnRH effect was seen 
on EGr1-zsGreen (Figure 4.1D). GnRH caused a significant increase in Egr1-zsGreen 
(from 208.65 ± 4.10 AFU to 234.03 ± 7.14 AFU) and this effect was completely 
abrogated by PD184352, RO31-8425, and Cetrorelix but not by the other treatments.  
Of the data in panel C, Two-way ANOVAs revealed that stimulus, inhibitor and 
stimulus-inhibitor interactions were significant sources of variation. Post-hoc tests 
revealed that GnRH caused a significant increase in NFAT1c-EFP-n:c translocation 
(from 0.84 ± 0.03 to 1.22 ± 0.05) and that this effect was significantly inhibited by 
Cetrorelix and CsA (100% reduction). Likewise, GnRH caused a significant increase 
in NFAT-RE-asRed-n+c, from 139.24 ± 2.15 AFU to 173.10 ± 4.06 AFU, and this 








LβT2 cells were cultured and treated as described in Chapter 2. Then the indicated 
inhibitors were applied for 30 min prior to stimulation for 5 min (in A and D) or 6 hr 
(in B and E) with 0 or 10-7M GnRH. The cells were then fixed and stained for ppERK 
and nuclei. The figures show means ±SEMs, n=3, each with triplicate wells for each 
condition and three fields of view/well. The black columns represent the unstimulated 
group where the cells were subjected only to the inhibitors, except for the control 
group (Ctrl) without inhibitor. The grey columns represent cells subjected to the 
inhibitors prior to GnRH stimulation. The star (*) shows significant inhibition of 
GnRH signalling (P<0.05) in cells subjected to inhibitors (grey columns) comparing 
to Ctrl (the first grey column). The F (5,20) = 44.68 (A), F (5,20) = 7.43 (B), F (5,20) 
= 147.30 (C), F (5,20) = 23.70 (D). The dotted lines represent the background values 
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Figure 4.4. Pharmacological inhibition of GnRH signalling in Ad mGnRHR 






4.3.5 Pharmacological inhibition of PDBu signalling in Ad mGnRHR 
transduced HeLa Cells 
As shown in figure 4.5, pre-treatment of the cells with the indicated inhibitors caused 
variable reductions in PDBu signalling to ERK, Egr1-zsGreen, and NFAT-RE-asRed. 
Separate two-way ANOVAs of the data in panels A and B revealed that stimulus, 
inhibitor and stimulus-inhibitor interactions were significant sources of variation. 
Post-hoc tests demonstrated that PDBu caused a significant increase in ppERK-n 
(from 137 ± 0.5 to 240 ± 1.2 AFU) and that this effect was significantly reduced by 
PD184352 and RO31-8425, but not by AG1478, Cetrorelix or CsA (Figure 4.5A). In 
PD184352-treated and RO31-8425-treated cells, although PDBu caused a significant 
increase in ppERK-n, the increase was statistically decreased compared to control 
cells (70% reduction, P<0.05). Similarly, PDBu caused a significant increase in Egr1-
zsGreen (from 207 ± 2.8 to 360 ± 13 AFU) and this effect was inhibited by PD184352 
and R031-8425 (Figure 4.5B). The PKC inhibitor is abrogated the effect of PDBu -
mediated Egr1-zsGreen expression (220 ± 8 AFU, ~95% reduction). In PD184352-
treated cells, although PDBu resulted in a significant increase in Egr1-zsGreen 
expression, the increase was statistically decreased compared to control cells (257 ± 
4 AFU, 65% reduction).   
Of the data in panel C and D, Two-way ANOVAs revealed that neither stimulus nor 
inhibitor were significant sources of variation. PDBu had no effect on NFAT1c-EFP 
translocation. Two-way ANOVAs of the data in panel D revealed that only stimulus 
was a significant source of variation. PDBu caused a significant increase in NFAT-





on the expression level of NFAT-RE-asRed was observed in cells treated with 




Cells were cultured as described in Chapter 2. Then the indicated inhibitors were 
applied for 30 min prior to stimulation for 5 min (in A and D) or 6 hr (in B and E) 
with 0 or 10-6 M PDBu, they were then fixed and stained for ppERK and nuclei. The 
figures show means ±SEMs, n=3-4, each with triplicate wells for each condition and 
three fields of view/well. The black columns represent the unstimulated group where 
the cells were subjected only to the inhibitors, except for the control group (Ctrl) 
without inhibitor. The grey columns represent cells subjected to the inhibitors prior to 
GnRH stimulation. The star (*) shows significant inhibition of GnRH signalling 
(P<0.05) in cells subjected to inhibitors (grey columns) comparing to Ctrl (the first 
grey column). The F (5,30) = 45.00 (A), F (5,20) = 11.21 (B), F (5,30) = 13.40 (D). 
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Figure 4.5. Pharmacological inhibition of PDBu signalling in Ad mGnRHR 





4.3.6 Pharmacological inhibition of EGF signalling in Ad mGnRHR transduced 
HeLa cells.  
HeLa cells were subjected to different inhibitors (outlined in figure 4.6) prior to 
stimulation with 10-8 M EGF. Pre-treatment of the cells with the indicated inhibitors 
caused variable reductions in EGF signalling to ERK and NFAT1c-EFP.  
As shown in figure 4.6, two-way ANOVAs of the data in panel A revealed that 
stimulus, inhibitor and stimulus-inhibitor interactions are significant sources of 
variation. Post-hoc tests revealed that EGF caused a significant increase in ppERK-n 
(from 156.74 ± 0.56 to 244.02 ± 4.10). Comparing the effect of EGF in the control 
group to the treated one revealed that EGF signalled significantly under all tested 
condition. A partial reduction by ~25% was observed in AG1478-treated cells, 
however, this effect was not significant (P>0.05). In contrast, EGF had no significant 
effect on Egr1-driven zsGreen expression in HeLa cells (P>0.05).   
Two-way ANOVAs of the data in panel C revealed that stimulus, inhibitors, and 
stimulus-inhibitor interaction were significant sources of variation. As shown in figure 
4.6C, post-hoc tests revealed that EGF caused a significant increase in NFAT1c-EFP-
n:c (from 1.12 ± 0.06 to 2.00 ± 0.12), and this effect was significantly inhibited by 
AG1478 and CsA (100% reduction) but not by PD184352, RO31-8425 or Cetrorelix 









HeLa cells were cultured and treated as described in Chapter 2. Then the indicated 
inhibitors were applied for 30 min prior to stimulation for 5 min (in A and D) or 6 hr 
(in B and E) with 0 or 10-8 M EGF. Cells were then fixed and stained for ppERK and 
nuclei. The figures show means ±SEMs, n=3, each with triplicate wells for each 
condition and three fields of view/well. The black columns represent the unstimulated 
group where the cells were subjected only to the inhibitors, except for the control 
group (Ctrl) without inhibitor. The grey columns represent cells subjected to the 
inhibitors prior to GnRH stimulation. The star (*) shows significant inhibition of 
GnRH signalling (P<0.05) in cells subjected to inhibitors (grey columns) comparing 
to Ctrl (the first grey column). The F (5,30) = 7.61 (A), F (5,30) = 77.78 (C). The 

























3 0 0 C o n t r o l
































C o n t r o l











































C o n t r o l









































C o n t r o l


















Figure 4.6. Pharmacological inhibition of EGF signalling in Ad mGnRHR 





4.3.7 Pharmacological inhibition of GnRH signalling in Ad mGnRHR 
transduced MCF-7 cells. 
Separate two-way ANOVAs of the data in figure 4.7, panels A and C revealed that 
stimulus, inhibitor and stimulus-inhibitor interaction were a significant source of 
variation. Post-hoc tests revealed that EGF caused a significant increase in ppERK-n 
(from 157.41 ± 3.23 to 193.12 ± 10.42). This effect was significantly reduced by 
PD184352 and Cetrorelix but not by RO31-8425, AG1478, or CsA (Figure 4.7A). 
R031-8425 caused a 30% reduction in the GnRH effect on Egr1-zsGreen but this 
effect did not reach statistical significance (P>0.05). Likewise, post-hoc test showed 
a marked increase in NFAT1c-EFP-n:c by GnRH (from 1.12 ± 0.13 to 1.61 ± 0.21). 
This effect was significantly reduced by both Cetrorelix and CsA (100% reduction).  
Of the data in panels B and D, separate two-way ANOVAs revealed that neither 
stimulus nor inhibitor were a significant source of variation. GnRH had no effect on 








Cells were cultured as described earlier. The cells were stimulated with 0 or 10-7 M 
GnRH for 5min (A and B) or 6 hr (C and D), they were then fixed and stained for 
ppERK and nuclei. Digital images and analysis were acquired (detailed under section 
2.8). The figures show means ±SEMs, n=3, each with triplicate wells for each 
condition and three fields of view/well. The black columns represent the unstimulated 
group cells where the cells were subjected only to the inhibitors, except (Ctrl). The 
grey columns represent cells subjected to the inhibitors prior to GnRH stimulation. 
The star (*) shows significant inhibition of GnRH signalling (P<0.05) in cells 
subjected to inhibitors (grey columns) comparing to Ctrl (the first grey column). The 
F (5,30) = 17.50 (A), F (5,30) = 6.10 (C). The dotted lines represent the background 
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Figure 4.7. Pharmacological inhibition of GnRH signalling in Ad mGnRHR 





4.3.8 Pharmacological inhibition of PDBu signalling in MCF-7 cells 
As shown in figure 4.8, pre-treatment of the cells with the indicated inhibitors caused 
variable reductions in PDBu signalling to ERK, NFAT1c-EFP, Egr1zsGreen, and 
NFAT-RE-asRed. Separate two-way ANOVAs of the data in panel A and B revealed 
stimulus, inhibitor and stimulus-inhibitor interactions were significant sources of 
variation. Post-hoc tests revealed that PDBu caused a significant increase in ppERK-
n (from 157.40 ± 3.23 to 219.46 ± 12.63 AFU) and that this effect was significantly 
inhibited by PD184352 and RO31-8425, but not by AG1478, Cetrorelix or CsA 
(Figure 4.8A). Similarly, PDBu caused a significant increase in Egr1-zsGreen (from 
208.21 ± 1.2 4to 240.31 ± 5.15 AFU), and this effect was inhibited by PD184352 and 
R031-8425 (Figure 4.8B).  
On the other hand, separate two-way ANOVAs of the data in panel C and D revealed 
that neither stimulus nor inhibitor were significant sources of variation. As shown, 
PDBu had no effect on NFAT1c-EFP translocation, and no measurable effect on the 









Cells were cultured as described earlier. The cells were stimulated with 0 or 10-6 M 
PDBu for 5min (A and B) or 6 hr (C and D), they were then fixed and stained for 
ppERK and nuclei. Digital images and analysis were acquired (detailed under section 
2.8). The figures show means ±SEMs, n=3,5, each with triplicate wells for each 
condition and three fields of view/well. The black columns represent the unstimulated 
group cells where the cells subjected only to the inhibitors, except (Ctrl). The grey 
columns represent cells subjected to the inhibitors prior to GnRH stimulation. The star 
(*) shows significant inhibition of GnRH signalling (P<0.05) in cells subjected to 
inhibitors (grey columns) comparing to Ctrl (the first grey column). The F (5,30) = 
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4.3.9 Pharmacological inhibition of EGF signalling in MCF-7 cells.  
Two-way ANOVAs show that stimulus, inhibitors, and stimulus-inhibitor interaction 
were significant sources of variation (Figure 4.9). Post-hoc test showed that EGF 
caused a significant increase in ppERK. The ppERK-n level increased from 157.40 ± 
3.23 AFU to 253.31 ± 20.10 AFU. Comparing the effect of EGF in the control group 
to the treated one revealed that the effect of EGF-mediated ERK signalling was 
significantly inhibited by PD18435 and AG1478 but not by RO31-8425, RO31-8425, 
Cetrorelix, or CsA. Notably, although in PD184352-treated and AG1478-treated cells 
EGF resulted in a significant increase in ppERK-n, the increase was statistically 
decrease compared to control cells. The ppERK-n was 199.34 ± 14.01 AFU (60% 
reduction) by MEK inhibitor, and 182.02 ± 11.27 AFU by EGFR inhibitor (70% 
reduction). In contrast, no measurable effect of EGF on the other measurements (Egr1-
zsGreen, NAFT1c-EFP, NFAT-RE-asRed) was observed in this cell line (Figure 4.9B, 
C and D).   
The effects of these inhibitors on ERK and NFAT activities and their transcriptional 
readouts (Egr1-zsGreen and NFAT-RE-asRed) in the three cellular models are 








Cells were cultured as described in chapter 2. The cells were stimulated with 0 or  
10-8 M PDBu for 5min (A and B) or 6 hr (C and D), they were then fixed and stained 
for ppERK and nuclei. Digital images and analysis were acquired as detailed under 
section 2.8. The figures show means ±SEMs, n=3, each with triplicate wells for each 
condition and three fields of view/well. The black columns represent the unstimulated 
group cells where the cells subjected only to the inhibitors, except (Ctrl). The grey 
columns represent cells subjected to the inhibitors prior to EGF stimulation. The star 
(*) shows significant inhibition of GnRH signalling (P<0.05) in cells subjected to 
inhibitors (grey columns) comparing to Ctrl (the first grey column). The F (5,30) = 
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Coloured boxes show proteins identified as mediators by sensitivity to inhibitors (i.e. >50% inhibition in ppERK and/or Egr1-zsGreen 
assays, or in NFAT1c-EFP and NFAT-RE-asRed assays). The numbers from 1-5 represent the drugs that inhibit 1-EGFR (AG1478), 2-
GnRHR (Cetrorelix), 3-PKC (RO318425), 4-MEK (PD184352) and 5-AC (Cyclosporine A). The green numbers show the ~% reduction 
of ERK or NFAT activity in cells subjected to inhibitors. The black numbers show % reduction of the Egr1-zsGreen or NFAT-RE-asRed 
expression in cells subjected to inhibitors. No measurable effect of EGF on NFAT-RE-asRed in the three cell lines was observed. Thus, 
the transcriptional response is excluded here. For the MCF-7 cell line, ANOVAs reveal no significant effect of EGF or GnRH on Egr1-
zsGreen responses and the GnRH effect on the NFAT1c-EFP response was very small. Accordingly, the inhibitor- sensitivity and % 
inhibition data are based solely on ppERK and NFAT1c-EFB- n:c readouts. The percentage numbers (approximate numbers) were 
calculated by working out the difference in expression level between Ctrl (grey column, Figure 4.1-4.9) and treated groups, where cells 
subjected to inhibitors prior to stimulation with GnRH, EGF or PDBu (grey columns, Figure 4.1-4.9). Then divided the number by the 































Figure 4.10. A schematic diagram of signalling pathway in LßT2, HeLa, and MCF-7 cells  






4.4.  Discussion 
The hypothalamic neuropeptide GnRH-I acts on GPCRs on the anterior pituitary 
gonadotrophs. It causes a PKC-mediated activation of ERK and Ca2+-mediated 
activation of NFAT, both of which mediate GnRH effects on gonadotrophin 
expression [2, 24, 123, 140]. GnRHR signalling has been shown to be dependent on 
cell context but that the reasons for this are unknown. This dependence was clearly 
seen in Chapter 3, where the kinetics of responses to GnRH differed in LβT2, HeLa 
and MCF-7 cells. Thus, the aim of this chapter was to further delineate network 
architecture in three cell lines using pharmacological inhibitors. 
The effects of GnRHR agonists were previously demonstrated to be mimicked by 
GnRHR antagonists in hormone dependent cancer cells [351, 362-366], and this 
suggested that there might be no dichotomy between GnRHR agonists and antagonists 
in these cells. An explanation was that GnRHR ligands were acting through other 
receptor types, such as type II GnRHRs in hormone-dependent cancer cells [351]. 
However, the data here argue against this idea. This is because cetrorelix had no 
measurable effect a lone on any of the experimental readouts or in any of the cell types 
examined. The GnRHRs antagonists always blocked GnRH effects in all cell types. 
GnRH is the endogenous ligand for type I mammalian GnRHR and cetrorelix is a type 
I GnRHR antagonist. Thus, the data obtained here all indicate that GnRH is acting via 
type I GnRHR (endogenous or exogenous) in the three examined cell lines.  
In primary pituitary cell cultures, the GnRHR acts mainly via Gαq/11, driving the 
activation of ERK and NFAT pathways [145]. However, there is also evidence 





types (see Chapter 1, section 1.5.2) [362]. On the other hand, it was argued that 
GnRHRs do not act via Gαq/11 in breast cancer cells [256]. Work here using NFAT 
translocation and NFAT-RE-driven asRed expression (as downstream readouts for 
Ca2+ mobilisation) and using ERK activation (as a downstream readout for PKC 
activation) revealed that GnRH activates these pathways in both HeLa and LβT2 cells. 
In MCF-7 cell line although GnRH activated ERK and NFAT pathways, its effect on 
the downstream transcriptional readouts of both ERK and NFAT was not significant. 
The results indicated that GnRH activates Gαq/11 in all of them.  
The use of CsA (Cn inhibitor) inhibited significantly GnRH effects on NFAT but not 
on ppERK in all three cell types (Figure 4.1, 4.4 and 4.7). These observations indicate 
that the two reporters of NFAT activation can both be used as a readout for Ca2+ 
elevation that drives the activation of CaM/Cn/NFAT pathway. In a similar way, the 
MEK inhibitor inhibited the effects of both GnRH and PDBu on ppERK. It also 
prevented their effects on Egr1-zsGreen responses in all three cell types, which 
implies that GnRH causes a PKC-mediated activation of ERK in these cells and that 
the Egr1-zsGreen is a reliable readout for ERK activation. However, the MEK 
inhibitor did not prevent GnRH effects on NFAT1c-EFP or NFAT-RE-asRed. In some 
systems PKC activation can modulate the function of Ca2+ ion channel increasing 
cytoplasmic Ca2+ concentration but this did not occur, as PDBu failed to activate either 
NFAT readout in all three cell lines [345]. 
Gonadotrophin releasing hormone is reported to cause a PKC-mediated 
transactivation of EGFR ligands and an EGFR-mediated activation of ERK in some 
cells [332, 367]. In fact, EGF was shown to stimulate ppERK in LβT2, HeLa and 





ppERK was inhibited by RO-318425 (Figure 4.1, Figure 4.4 and Figure 4.7), which 
is consistent with the above observation. However, these results here do not examine 
the involvement of EGFR in ERK activation by GnRH. The AG1478 (EGFR 
inhibitor) inhibited the effects of EGF on the responses of ppERK and/or Egr1-
zsGreen responses in all three cell types, showing both efficacy and specificity. 
AG1478 also, had no effect on PDBu or GnRH mediated ppERK activation in any of 
the cell types. Consequently, PKC activation seems not to cause sufficient EGFR 
activation for ERK activation in any of the examined cells here. GnRH causes a PKC-
mediated ERK activation but EGFR-independent activation of ERK in LβT2 cells and 
HeLa cells.  
The experimental results that are obtained from EGF-stimulated HeLa cells (Figure 
4.6) revealed some interesting observations. EGF-mediated ppERK was not 
significantly inhibited by PKC inhibitor or MEK inhibitor, but the stimulus failed to 
increase Egr1-zsGreen expression in these cells. The underline reason behind this 
effect is unknown, but it contrasts with the effect of these inhibitors on PDBu (Figure 
4.5), demonstrating efficacy of the inhibiters in these cells. However, the lack of the 
expression of Egr1-zsGreen might be related to the transient response of ppERK to 
EGF in these cells [341, 342]. In other words, if a sustained response is required for 
Egr1-zsGreen activation, this would explain the absence of transcriptional response to 
EGF here, it would also raise the possibility that inhibitors could also be more 
effective when a more sustained ppERK activation occurs. Another surprising 
observation is that EGF caused a marked increase in NFAT1c-EFP translocation in 
these cells. The effect was inhibited by AG1478, that might reflect PLCγ -mediated 
Ca2+ mobilisation by EGFR. The effect was only seen in HeLa cells extending the 





observation was that GnRH and EGF both increased ppERK levels but failed to 
increase Egr1-zsGreen responses in MCF7 cells. Given that these cells are cancer 
cells, it could be a consequence of a protein found in these cells acts as corepressor 
binding and activating a specific repressor, which in turn binds to the promotor 
preventing the initiation of transcription of that gene [368]. In general, these 
observations could be a related to the way that cells were immortalised as described 
in Chapter 3. Overall, we can conclude that HeLa and MCF-7 cells might well be 
unsuited to further work on transcription regulation by GnRH, because GnRH did not 
measurable increase the expression of either transcriptional reporter in these cells.   
To sum-up, in the three cell lines, GnRH-mediated ERK and NFAT signalling are 
GnRHR-dependent. PDBu-mediated ERK signalling is dependent on MEK and PKC, 
but no sign of signal to NFAT following PKC activator. EGF caused NFAT 
translocation in HeLa cells, but not in the other two cell lines. The context-dependence 
of GnRH signalling that was seen in Chapter 3 in comparison of response kinetics, 
can be extended to differential sensitivity to inhibitors (summarised in figure 4.10), 
but no evidence was seen here for GnRH acting via EGFR transactivation in any of 
the examined cell types. However, despite the % reduction in response that was given 
by an inhibitor, it does not tell us anything about the relative importance of any given 
effector or pathway for GnRH signalling. Therefore, in the following chapters a 
statistical measure derived from information theory is used as alternative approach to 













Most work on cell signalling mechanisms is based on the measurement of average 
responses from large cell populations, despite cell-cell variation. This variability is 
critical for cells behaviour, as each cell has to sense the environment for appropriate 
decisions [275, 282, 285, 300]. Information theoretic approaches that take cell-cell 
variability into account are increasingly being used in cell biology to study the effect 
of this heterogeneity on transferred information through signalling pathways [153]. 
Here, information can be quantified as the uncertainty about the environment that is 
removed by signalling, and one way of doing this is to calculate MI between system 
inputs and outputs [292]. 
In Chapter 4, the use of pharmacological inhibitors helped to map the network 
architecture of ERK and NFAT in the three cellular models (HeLa, LβT2 and MCF-7 
cells), but the percentage reduction given by the inhibitors (summarised in Figure 
4.10), did not tell us how much information transferred through each pathway. 
Accordingly, the focus was placed here on the use of the information theoretic 
approach as a tool that might provide biologist with better insight into the route 
carrying most information, so that can be targeted for therapeutic manipulation.  
The aim of this chapter was using MI to quantify information transfer via GnRHRs to 
ERK or NFAT, using two distinct readouts (transcriptional and non-transcriptional) 
for their activation. The work here was done based on the following hypotheses: First, 
the amount of information transfer might be specific to the cellular model, and to test 
this hypothesis, different cell types were used (LßT2, HeLa and MCF-7 cells). Second, 
GnRHRs activate a bifurcating signalling system, and cells might gain additional 





hypothesis, joint MI between GnRH concentration and responses measured in the 
same cells were calculated. Third, the conditions of the chosen assay might lead to 






5.2. Materials and methods 
For MI measurement, at first, full concentration-response curves were constructed in 
three cell lines and at 3 time points. Images were collected from 2-3 fields of view per 
well and the individual cells measures were used to calculate MI between GnRH 
concentration and the experimental readouts at each time point. The images used for 
this analysis are from experiments already described in Chapter 3 and for which 
population averaged responses have been reported in figures 3.5, 3.6, 3.7, 3,8, 3,9 and 
3.10. In these experiments ppERK and NFAT1c-EFP measures were determined in 
the same cells, enabling measurement not only of I(ppERK; GnRH) and I(NFAT1c-
EFP; GnRH) but also of joint MI (as described in Chapter 2).  
In a similar way, cells expressing the Egr1-zsGreen and NFAT-RE-asRed (imaging 
readouts for ERK-driven and NFAT-driven transcription, respectively) were used for 
calculation of I(Egr1-zsGreen; GnRH) and I(NFAT-RE-asRed; GnRH), as well as 
joint MI. The high content imaging platform used provides the same experimental 
measures for each individual cell (approximately 100 to 600 cells per well for HeLa 
and MCF-7 cells and up to 1500 cells per well for LβT2 cells) and this enables 
calculation of frequency-distribution (FD) plots. Notably, an MI of 1 is obtained when 
2 different states of the environment can be unambiguously distinguished, and this 








5.3.1. Measurement of GnRHR-mediated information transfer to ERK or 
NFAT1c-EFP in Ad mGnRHR transduced HeLa cells. 
HeLa cells transduced with Ad NFAT1c-EFP and Ad mGnRHRs were stimulated with 
varied concentrations of GnRH for 5, 20 or 60 min before staining for nuclei and 
ppERK. The cells were then imaged for calculation of the nuclear fraction (NF) of 
NFAT1c-EFP as well as nuclear ppERK stain intensity (ppERK-n). This chapter 
describes re-analysis of the experiments shown in Chapter 3 and the population 
averaged data are repeated here for simplicity. As shown  in figure 5.1A, GnRH 
caused a concentration and time-dependent increase in ppERK that was rapid and 
transient (i.e. maximal at 5 min but reduced by 60 min) as well as a concentration and 
time-dependent increase in nuclear translocation of NFAT1c-EFP (Figure 5.1B) that 
was slower in onset (maximum at 20 min) and was more sustained (comparable at 20 
and 60 min).  
Binning individual cells according to the log of the ppERK-n (Figure 5.1D) showed 
cell-cell variation in the ppERK levels. GnRH increased the population averaged 
ppERK levels by shifting the FD plots rightward. There was no evidence for such 
distinct cell populations, as cells showed a graded response, rather than an all-or-
nothing response. In a similar way, individual cells in figure 5.1E were binned 
according to the NF of the NFAT1c-EFP, and these revealed pronounced cell-cell 
variation, a rightward shift of FD plots on stimulation by GnRH. The pronounced 
overlaps between the FD plots for stimulated and unstimulated cells suggest that MI 
values will be low. As shown in Figure 5.1C, I(ppERK; GnRH) values were maximal 





I(NFAT1c-EFP-NF; GnRH) values were 0.16 ± 0.03 Bits at 5 min and increased to 
0.30 ± 0.04 Bits by 60 min (Figure 5.1C).  
In the above data, MI values were always less than 1 Bit despite system inputs of 3 
Bits (i.e. 23 different GnRH concentrations) implying that most information is lost 
through signalling networks. However, it is possible that information loss is mitigated 
by the joint sensing of multiple pathways within the network. The Joint MI values 
were comparable at all time points with 0.52 ± 0.01 Bits at 5 min, 0.44 ± 0.08 Bits at 
20 min and 0.30 ± 0.04 Bits at 60 min and were always greater than MI values for 
either response alone. Thus, additional information was gained by joint sensing, but 











   
 
Cells were cultured and treated as described in Chapter 2. They were then stimulated 
for 5, 20 or 60 min with 0 or 10-12 – 10-6 M GnRH before being fixed and stained 
(nuclei and ppERK) and used for digital image acquisition and analysis. Panels A and 
B show population averaged ppERK-n in AFU, and NFAT1c-EFP-NF values (mean 
± SEM, n=3) and are repeated from figure 3.5 for simplicity. Single cell data from 
complete concentration-response curves were then used to calculate the MI between 
GnRH and ppERK-n or NFAT1c-EFP-NF as well as the joint MI for GnRH sensing 
by both pathways (Panel C). Representative FD plots are shown for cells stimulated 5 
min (D) or 60 min (E) with the indicated concentrations of GnRH.  
  

















































































Figure 5.1. Measurement of GnRHR-mediated information transfer to ERK or 





5.3.2. Measurement of GnRHR-mediated information transfer to Egr1-zsGreen 
or NFAT-RE-asRed in Ad mGnRHR transduced HeLa cells  
HeLa cells were transduced with Ad mGnRHR, Ad Egr1-zsGreen and Ad NFAT-RE-
asRed. The cells were then stimulated with different concentration of GnRH for 4, 6, 
and 8 hr, before being imaged and analysed as described in Chapter 2. As shown in 
figure 5.2A and B, GnRH caused concentration and time-dependent increases in Egr1 
driven zsGreen expression and NFAT-RE driven asRed expression. The expression 
levels were relatively similar in both (seen at 4 hr and peaked at 8 hr).  
Binning individual cells according to the log of the Egr1-zsGreen-n+c showed 
pronounced variation between cells in the Egr1-zsGreen levels. GnRH increased the 
population averaged Egr1-zsGreen levels by shifting the FD plots rightward. There 
was no evidence for distinct cell population as the data showed graded responses 
rather than an all-or-nothing response (Figure 5.2D). In the same way, binning 
individual cells according to the log of the NFAT-RE-asRed-n+c revealed pronounced 
cell-cell variation, a rightward shift on stimulation by GnRH and no evidence for 
distinct GnRH responsive and GnRH non-responsive cell populations (Figure 5.2E).   
The pronounced overlaps between the FD plots for stimulated and unstimulated cells 
suggest that MI values will be low. As shown in figure 5.2C, the I(Egr1-zsGreen-n+c; 
GnRH) values was 0.19 ± 0.02 Bits at 4 hr, increased slightly to 0.24 ± 0.03 Bits at 6 
hr and remined sustained for the next two hr. The I(NFAT-RE-asRed; GnRH) values 
were gradually increased over the time. The MI values were 0.14 ± 0.02 Bits at 4 hr, 
0.22 ± 0.3 Bits at 6 hr and 0.26 ± 0.05 Bits at 8hr. However, the joint MI values were 
higher than MI values for each response alone (0.30 ± 0.03 Bits at 4hr increased to 





As shown, the MI values were always <1 Bit despite system inputs of 3 Bits. However, 
since the Egr1-zsGreen and NFAT-RE-asRed were measured in the same cells, 
sensing both pathways were possible. The Joint MI values were comparable at all time 
points (0.34 ± 0.03 Bits at 4 and 6 hr and 0.40 ± 0.07 Bits at 8 hr) and were always 


















Cells were cultured as described in Chapter 2 and stimulated with GnRH for the 
indicated times and with the indicated concentrations. The cells were then fixed and 
stained (nuclei) and used for digital image acquisition and analysis. A and B show 
population average Egr1-zsGreen-n+c and NFAT-RE-asRed-n+c values in AFU 
(means ± SEMs, n=3-4), and are repeated from figure 3.5 Chapter 3 for simplicity. 
Single cell data from complete concentration-response curves were then used to 
calculate the MI between GnRH and Egr1-zsGreen-n+c or NFAT-RE-asRed-n+c, as 
well as the joint MI for GnRH sensing by both pathways, and these are shown in panel 
C. Representative FD plots are shown in D and E for cells stimulated 8 hr with the 
indicated concentrations of GnRH.  
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Figure 5.2. Measurement of GnRHR-mediated information transfer to Egr-





5.3.3. Measurement of GnRHR-mediated information transfer to ERK or 
NFAT1c-EFP in LßT2 cells. 
LßT2 cells transduced with Ad NFAT1c-EFP were stimulated with varied 
concentrations of GnRH for 5, 20 or 60 min before staining for nuclei and ppERK. 
The cells were then imaged for calculation of the NFAT1c-EFP-NF, as well as nuclear 
ppERK stain intensity. As shown in figure 5.3A, GnRH caused a concentration and 
time-dependent increase in ppERK-n, that was rapid and sustained (maximal at 5 min 
and maintained at a similar level for 60). GnRH also caused concentration and time-
dependent increase in the nuclear translocation of NFAT1c-EFP-NF, which was 
slower in onset and was maximum at 60 min (Figure 5.1B). 
Binning individual cells according to the log of the ppERK-n stain intensity revealed 
pronounced cell-cell variation in the ppERK levels. GnRH increased the population 
averaged ppERK levels by shifting the FD plots rightward. No evidence was found 
for GnRH responsive and GnRH non-responsive cell populations, as a graded 
response rather than an all-or-nothing response was seen (Figure 5.3D). Likewise, 
binning individual cells according to the NF of the NFAT1c-EFP revealed pronounced 
cell-cell variation and a rightward shift on stimulation by GnRH. No evidence was 
found for such distinct cell populations (Figure 5.3E).  
The pronounced overlaps between the FD plots for stimulated and unstimulated cells 
suggest that MI values will be low.  As shown in figure 5.3C, the I(ppERK; GnRH) 
values were comparable at all time points (0.41 ± 0.03 Bits at 5, 20 and 60 min). The 
I(NFAT1c-EFP-NF; GnRH) values were 0.20 ± 0.1 Bits at 5 min (lower than ppERK 
at the same time) and increased to 0.52 ± 0.03 Bits by 60 (Figure 5.3C). The Joint MI 










LßT2 Cells were cultured and treated as described in Chapter 2. They were then 
stimulated for 5, 20 or 60 min with 0 or 10-12 – 10-6 M GnRH before being fixed and 
stained (nuclei and ppERK) and used for digital image acquisition and analysis. A and 
B show population averaged ppERK-n in AFU, and NFAT1c-EFP-NF values (mean 
± SEM, n=3) and are repeated from figure 3.7 for simplicity. Single cell data from 
complete concentration-response curves were then used to calculate the MI between 
GnRH and ppERK-n or NFAT1c-EFP-NF, as well as the joint MI for GnRH sensing 
by both pathways (Panel C). Representative FD are shown in panel D and E for cells 
stimulated 60 min with the indicated concentrations of GnRH. 
  
Figure 5.3. Measurement of GnRHR-mediated information transfer to ERK or 





5.3.4. Measurement of GnRHR-mediated information transfer to Egr1-zsGreen 
or NFAT-RE-asRed in LßT2 cells  
LβT2 cells transduced with Ad Egr1-zsGreen and Ad NFAT-RE-asRed were 
stimulated with varied concentrations of GnRH for 4, 6 and 8 hr before staining for 
nuclei. The cells were then imaged and analysed as describe in Chapter 2. As shown 
in figure 5.4A and B, GnRH caused concentration and time-dependent increases in 
Egr1 driven zsGreen and NFAT-RE driven as Red expression. The responses of both 
readouts were slow in onset and peaked at 8 hr.  
Binning individual cells according to the log of the Egr1-zsGreen-n+c stain intensity 
revealed pronounced cell-cell variation in the Egr1-zsGreen levels, and that GnRH 
increased the population averaged Egr1-zsGreen levels by shifting the FD plots 
rightward (Figure 5.4D). Similarly, binning individual cells according to the log of the 
NFAT-RE-asRed-n+c revealed pronounced cell-cell variation, a rightward shift on 
stimulation by GnRH (Figure 5.4E). No evidence was found for GnRH responsive 
and GnRH non-responsive cell populations, as the data showed graded responses 
rather than an all-or-nothing response (Figure 5.4D and E).   
Figure 5.4C shows that the I(Egr1-zsGreen; GnRH) values were similar at all time 
points (~0.8 Bits). However, although the I(NFAT-RE-asRed; GnRH) values were 
gradually increased over the time, the MI values were considerably lower than I(Egr1-
zsGreen; GnRH). The I(NFAT-RE-asRed; GnRH) values were 0.20 ± 0.03 Bits at 4 
hr and increased to 0.35 ± 0.06 Bits by 8 hr. The joint MI values were higher than MI 
values for each response alone (0.90 ± 0.05 Bits at 4 hr increased to 1.00 ± 0.02 Bits 








Cells were cultured as described in Chapter 2 and stimulated with GnRH for the 
indicated times and concentrations. Cells were then fixed and stained (nuclei) and used 
for digital image acquisition and analysis. A and B show population average Egr1-
zsGreen-n+c and NFAT-RE-asRed-n+c values in AFU (means ± SEMs, n=3-4), and 
are repeated from Figure 3.8 for simplicity. Single-cell data from complete 
concentration-response curves were then used to calculate the MI between GnRH and 
Egr1-zsGreen-n+c or NFAT-RE-asRed-n+c, as well as the joint MI for GnRH sensing 
by both pathways. These values are shown in panel C. Single cell data were also used 
to generate FD plots by binning log-transformed Egr1-zsGreen and NFAT-RE-asRed 
values. Representative FD are shown in D and E for cells stimulated 8hr with the 
indicated concentrations of GnRH. 
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Figure 5.4. Measurement of GnRHR-mediated information transfer to Egr1-





5.3.5. Measurement of GnRHR-mediated information transfer to ERK and 
NFAT1c-EFP in Ad mGnRHR transduced MCF-7 cells 
MCF-7 cells transduced with Ad mGnRHR, Ad NFAT1c-EFP were stimulated with 
varied concentrations of GnRH at 5, 20 or 60 min, then fixed and stained for nuclei 
and ppERK. The cells were then imaged for calculation of the nuclear fraction of 
NFAT1c-EFP as well as nuclear ppERK stain intensity. As shown in figure 5.5A, 
GnRH caused a concentration and time-dependent increases ppERK-n that was rapid 
and transient (the maximal effect was at 5 min and returned to the basal condition by 
60 min). Also, GnRH caused a concentration and time-dependent increase in the 
nuclear translocation of NFAT1c-EFP. The GnRH effect on NFAT1c-EFP 
translocation was rapid (like the ppERK response at the same time) but remained 
sustained during the examined period (60 min).   
Binning individual cells according to the log of the ppERK-n stain intensity revealed 
pronounced cell-cell variation in the ppERK levels and that GnRH increased the 
population averaged ppERK levels by shifting the FD plots rightward (Figure 5.5D). 
No evidence was seen for GnRH responsive and GnRH non-responsive cell 
populations (the responses were graded). For the NFAT1c-EFP-NF data in Figure 
5.5.C, the individual cells revealed pronounced cell-cell variation, a rightward shift 
on stimulation by GnRH and no evidence for GnRH responsive and GnRH non-
responsive cell populations (Figure 5.5E).  
The I(ppERK; GnRH) values were maximal at 5 min  with 0.10 ± 0.03 Bits and 
reduced to 0.05 ± 0.01 Bits by 60 min. The I(NFAT1c-EFP-NF; GnRH) values were 










Cells were cultured and treated as described in Chapter 2. They were then stimulated 
for 5, 20 or 60 min with 0 or 10-12 – 10-6 M GnRH before being fixed and stained 
(nuclei and ppERK) and used for digital image acquisition and analysis. A and B show 
population averaged ppERK-n in AFU, and NFAT1c-EFP-NF values (mean ± SEM, 
n=3) and are repeated from Figure 3.9 for simplicity. Single cell data from complete 
concentration-response curves were then used to calculate the MI between GnRH and 
ppERK-n or NFAT1c-EFP-NF, as well as the joint MI for GnRH sensing by both 
pathways (Panel C). Representative FD plots are shown for cells stimulated 5 min (D) 
or 60 min (E) with the indicated concentrations of GnRH.  
  
Figure 5.5. Measurement of GnRHR-mediated information transfer to ERK or 





5.3.6. Measurement of GnRHR-mediated information transfer to Egr1-zsGreen 
or NFAT-RE-asRed in MCF-7 cells  
MCF-7 cells transduced with Ad Egr1-zsGreen and Ad NFAT-RE-asRed in addition 
to Ad mGnRHR were stimulated with varied concentrations of GnRH for 4, 6 and 8 
hr before staining for nuclei. The cells were then imaged and analysed as describe in 
Chapter 2. As shown in figure 5.5A, GnRH had no effect on Egr1 driven zsGreen 
expression. Whereas, GnRH caused a concentration and time dependent increase 
NFAT-RE-driven asRed expression. Although the effect was relatively small, it was 
statistically significant (P<0.05) as detailed in Chapter 3.  
Since GnRH had no measurable effect on the expression level of Egr1-zsGreen, 
binning individual cells according to the log of the Egr1-zsGreen-n+c stain intensity 
revealed no cell-cell variation (no response to GnRH concentrations, Figure 5.6 D). 
Thus, MI values were considerably small (~ 0.02 Bits). In a similar way, binning 
individual cells (in Figure 5.5D) according to the log of the NFAT-RE-asRed-n+c 
revealed that the effects of GnRH on NFAT-RE-asRed were considerably low. The 
overlap between the FD plots remained (Figure 5.6E). Accordingly, MI values were 
expected to be small. As shown in figure 5.6C, the I(NFAT-RE-asRed; GnRH) values 
were maximum ~0.03 Bits at 8 hr.  
However, considering the possibility of mitigating the lost information by sensing 
multiple pathways within the network, and since Egr1-zsGreen and NFAT-RE-asRed 
responses were measured in the same cells, joint MI values were calculated for this 
data set, and these were higher than MI values for each response alone (0.12 ± 0.01 








Cells were cultured as described in Chapter 2 and stimulated with GnRH for the 
indicated times and at the indicated concentrations. The cells were then fixed and 
stained (nuclei) and used for digital image acquisition and analysis. A and B show 
population average Egr1-zsGreen-n+c and NFAT-RE-asRed-n+c values in AFU, 
(means ± SEMs, n=3-4), and are repeated from Figure 3.9 for simplicity. Single-cell 
data from complete concentration-response curves were then used to calculate the MI 
between GnRH and Egr1-zsGreen-n+c or NFAT-RE-asRed-n+c, as well as the joint 
MI for GnRH sensing by both pathways (panel C). Single cell data were also used to 
generate FD plots by binning log-transformed Egr1-zsGreen and NFAT-RE-asRed 
values. Representative FD plots are shown in D and E for cells stimulated 8hr with 
the indicated concentrations of GnRH. 
  
-1 2 -1 1 -1 0 -9 -8 -7 -6
1 1 0 0
1 1 5 0
1 2 0 0
1 2 5 0
1 3 0 0
0
4  h r
6  h r
8  h r
























4  h r
6  h r
8  h r

























4  h r
6  h r









































8  h r G n R H  L o g M

















8  h r
Figure 5.6. Measurement of GnRHR-mediated information transfer to Egr1-





5.3.7. Optimizing procedures for an ERK activation assay using MI 
measurements  
The statistical measure (MI) is used to estimate information transfer via GnRHR to 
ERK or NFAT (for example). Information could be lost through the cascade. Also, a 
technical source could contribute to a loss of information by using inappropriate 
choice of technology. Thus, the protocol used for ERK staining was optimised to 
maximised estimate MI. LßT2 cells were cultured as described in Chapter 2. On the 
following day, cells were stimulated with 0 or 10-7 M GnRH. They were then fixed 
and stained for ppERK with varied dilutions of 1°Ab and 2°Ab. The 1°Ab used was 
monoclonal mouse antibody, diluted in PBS at 1:200, 1:400, 1:800, 1:1600 or 1:3200. 
Cells were then incubated with 2°Ab green Alexa-488-conjugated goat anti-mouse 
diluted in PBS at 1:200, 1:400 or 1:800. Images were acquired with INCell 1000 
Analyser at the acquisition time of 1000 millisecond (msec).  
As shown in figure 5.7, reducing the 1°Ab and 2°Ab dilutions increased the ppERK 
levels over a broad range of GnRH concentrations. For example, in cells stimulated 
by GnRH and stained with 1°Ab at the dilution of 1:200, the ppERK levels were 
increased from ~200 AFU to ~ 300 AFU, and 500 AFU with 2°Ab diluted at 1:800, 
1:400 and 1:200 respectively. However, the single cell data used for the calculation of 
MI showed that the estimated MI values did not differ under all tested conditions (0.6 
to 0.7 Bits). Routinely, we are working in these ranges. For all other experiments 
reported in this thesis, ppERK was stained with 1°Ab at the dilution of 1:400 or 1:800 






5.3.8. Optimizing the acquisition time for an ERK activation assay using MI 
measurements 
The exposure time is one of the parameters that need to be considered carefully when 
acquiring a digital image. As the length of the exposure time affects pixel intensity 
and image brightness, it will ultimately affect the signal to noise ratio. In other words, 
if acquisition time is too short it will not be possible to resolve images from 
background noise, and if it is too long, the detectors could theoretically become 
saturated. Thus, the acquisition time for an ERK activation assay was optimised as 
well. LβT2 cells were cultured as usual, stimulated with 0 or 10-7 M GnRH, fixed and 
stained for ppERK with varied dilutions of 1°Ab (1:200, 1:400, 1:800, 1:1600 or 
1:3200). Then cells were incubated with 2°Ab at 1:200. The cells were then imaged 
using INCell 1000 Analyser at the acquisition time of 1, 3, 10, 30, 100, 300, 1000, 
3000 and 10000 msec.  
As shown in figure 5.8 A-D, no signal was acquired with cells imaged at the exposure 
time of 3, 10, 30 msec. The obtained values were increased by increasing the exposure 
time (Figure 5.8 E-I). The single cell data measures used for the calculation of MI 
showed that the MI values were maximum in cells imaged at the exposure time of 
100, 300, 1000 and 3000 msec, and lower values were obtained when cells imaged at 
the acquisition time 10000 msec (Figure 5.8J). 
Overall, the obtained results shown in figure 5.7 and 5.8 indicate that the choices of 
assay’s conditions do not underestimate our MI values, as we are routinely staining 
cells for ppERK with 1°Ab diluted at 1:400 or 1:800, and with 2°Ab diluted at 1:200, 
and images were acquiring at 1000 msec. In another experiments, images were 





The estimated MI for ppERK or NFAT1c-EFP translocation responses were not 
reduced, although MI values were lower with a 4X objective. Also, in another 
experiments (Craig McArdle personal communication) imaging more fields of view 
to increase the cell numbers did not increase MI values with these assays. Taken 
together these observations we can conclude that MI values are not underestimated by 









LßT2 cells were cultured and stimulated with 0 or 10-7 M GnRH. Cells were then fixed 
and stained for ppERK with varied dilution of 1°Ab and 2°Ab (as shown in the 
figures). Cells were then imaged with 10x objective and at 1000 msec. A-D show 
population average ppERK-n in AFU, (means ± SEMs, n=3). The single cell data 
measures were used for the calculation of MI (shown in E).  
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LßT2 cells were cultured as described in Chapter 2. Cells were stimulated with 0 or 
10-11 -10-7 M GnRH, they were then fixed and stained for ppERK with the indicated 
dilutions. Cells were then imaged with the 10x objective at varied acquisition time (1 
to 10000 msec). A-I show population average ppERK-n in AFU with the indicated 
exposure times (means ± SEMs, n=3). The single cell data measures were used for the 
calculation of MI (J).  
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Figure 5.8. Optimizing the acquisition time for an ERK activation assay using 






Mutual information (MI) that takes cell-cell variability into account [292] is widely 
applied in cell biology [153]. It can measure the quality of the inference of the signal 
from the response [274]. The previous chapter (Chapter 4) used methods that were 
useful in mapping the signalling pathways but did not tell us how much information 
is transferred through any of the examined pathways. Thus, here MI was used to 
estimate information transfer via GnRHR to ERK or NFAT and their transcriptional 
readouts using the same cellular models that were used in Chapter 4.  
The key findings are summarized in figure 5.9, as shown more information about 
GnRH concentration is transferred to the transcriptome via ERK than via NFAT in 
LßT2 cells, but the opposite is true for both HeLa and MCF-7 cells. For both effectors 
and effectors driven transcriptions, it was found that a significant amount of 
information was lost through signalling (i.e. 3 Bits of information was available, and 
<1 Bit was transferred).  
Even though GnRHR signalling is cell context dependent, the data obtained here 
revealed a loss of information irrespective of the cellular model used (Figure 5.9). 
Another possibility is that the low MI might be related to the additional variability that 
introduced by Ad mGnRHR transduction for receptor expression in HeLa cells.  
However, the data obtained from LβT2 cells that endogenously express GnRHR argue 
against this possibility. As shown in figure 5.9 the measured information transfer 
between GnRHR and all experimental readouts was comparable for both endogenous 
GnRHRs (LβT2 cells) and heterologously expressed GnRHR (HeLa and MCF-7 





In both heterologous GnRHR expression systems HeLa and MCF-7 cells we routinely 
transduced with Ad mGnRHRs at 25 pfu/nl providing around 70.000 sites/per cell for 
receptor expression [152]. The GnRHRs number was previously estimated from 
radioligand binding by transducing HeLa cells with Ad mGnRHR at varied titters 
(0.8–25 pfu/nl) [22, 180, 324], and found to be in the range of 20.000 to 75.000 
sites/per cell. The variation between cells in expressing the receptors could be related 
to the cell-cell heterogeneity [22, 180, 324]. Gonadotrope-derived cell lines and 
mouse gonadotrophs express around 25–75 × 103 GnRHR [22, 180, 324]. Thus, do 
the number of receptors influence sensing information? Previous work studied the 
relationship between receptor number and transferred information to ppERK by 
transducing HeLa cells with varied titters of Ad mGnRHR [152]. This revealed that 
I(ppERK; GnRH) can be increased by increasing GnRHR number [152]. The MI 
values were increased from ~0.4 Bits to ~0.6 Bits in the range of 20-75 x 103 GnRHRs 
per cell, and no further increase beyond that [152]. The same study also recorded a 
loss of information between ppERK and PDBu (PKC activator) [152], suggesting that 
factors other than GnRHRs number influence information transfer in this pathways.  
GnRHR engage a bifurcating signalling system where activation of PLC mediates the 
activation of Ca2+ effectors (like NFAT) as well as PKCs and their effectors (like 
ERK) (11). Thus, sensing multiple pathways within networks could be an alternative 
possibility for mitigating information loss (11). This was addressed by measuring 
ppERK and NFAT translocation responses or Egr1-zsGreen and NFAT-RE-asRed in 
the same cells. The data revealed that estimated MI values can be increased by sensing 
multiple pathways within GnRHR signalling network. A study on growth factor 
stimulated signalling showed the important role of concomitant activation of pathways 





transferred information via another was retained) [300]. However, in respect of 
information transfer, it is important to know that this robustness does not equate to 
biological redundancy. The emphasis on the amount of information transfer via 
signalling networks not on cell decision. Consider a case where a stimulus elicits 
single cell ERK and NFAT responses that are perfectly correlated with one another 
but mediate activation of different effectors. In that case, ablation of ERK or NFAT 
would not affect the information that cell was provided about hormone concentration 
in its environment, it would affect their responses to the stimulus. Thus, the robustness 
in information transfer that results from concomitant activation tells us nothing about 
the transferred information downstream of ERK or NFAT [153]. 
Interestingly, the MI values for each response alone and join MI values showed 
different time dependencies in the three cellular models. For instance, in HeLa cells, 
I(ppERK; GnRH) decreased from 0.48 to 0.17 Bits from 5 to 60 min, whereas 
I(NFAT-NF; GnRH) showed a small increase (from 0.16 to 0.2 Bits), and joint MI 
dropped from 0.5 to 0.2 Bit, during the same period. A similar time course pattern was 
observed in MCF-7 cells. On the contrary, in LßT2 cells, the I(NFAT1c-EFP; GnRH) 
values increased from 0.2 to 0.5 Bits from 5 to 60 min, whereas I(ppERK; GnRH) 
remained unaltered. This is another demonstration of cell context-dependent 
signalling.  
Notably, in some cell types (HeLa cell for example, Figure 5.1), the estimated MI 
value was high at 10 min and reduced by 60 min. This clearly does not mean that the 
cells gain less information from a 60 min GnRH stimulation than from a 10 min one, 
instead it just shows that the 60 min snapshot data underestimate the information 





data could underestimate the information transferred over this period. Another 
interesting observation is that in LβT2 cells the I(Egr1-zsGreen; GnRH) value was 
higher than I(ppERK; GnRH) value. If the information is lost as it goes through the 
cascade, it would be expected that the information transferred to the Egr1-zsGreen 
(the downstream of ERK) would be lower than information transferred to ERK. 
However, this is not the case (Figure 5.3 and Figure 5.4). The higher Egr1-zsGreen 
value is consistent with the idea that the snapshots underestimate information transfer 
via GnRHR to ERK. Another possible explanation is that the measured MI value to 
GnRHR signalling to ppERK is the minimum possible value that can be obtained 
during the 60 min and the value could be higher. While Egr1-zsGreen readout is 
accumulated gradually over time (8 hr) giving us a better estimate of transferred 
information. This means that the amount of measured information could differ by 
using different experimental readouts. Therefore, our experimental procedures 
(assays) were optimized to minimize the lost information that could be due to the used 
technique. So, the transferred information via signalling can be maximized in order to 
improve MI estimation. The work was done by using different readouts, varied 
antibodies dilution and different exposure times (Figure 5.7 and Figure 5.8) and 
objectives (data are not shown). The obtained results revealed that the choices of 
assay’s conditions that we routinely work with do not underestimate our MI values 
Further, to mitigate the loss in information through signalling, few studies suggested 
negative feedback as a mechanism that can protect against information loss. For 
example, a study by Chong et al., 2011 showed that the information transferred 
between tumour necrosis factor (TNF) and nuclear factor-kB (NF-κB) was enhanced 
by negative feedback that reduced noise [299]. Another study demonstrated that by 





through protein kinase signalling systems [298]. A recent study of ERK signalling 
considering the effect of rapid and slow negative feedback on increasing or reducing 
information transfer in the ERK pathway [152]. The study revealed that negative 
feedback can reduce information transfer by reducing the dynamic range for the 
system output and can also protect information transfer by reducing cell-cell 
variability [152].  
Few studies have reported a mark loss of information through other receptors and 
signalling pathways including NF-κB and pituitary adenylate cyclase-activating 
peptide (PACAP) [198, 199]. The work here is investigating signalling mechanism in 
different cell types. It was shown, in the first two chapters, that these cells can signal 
to ERK and/or NFAT via other receptors than GnRHR. For example, the activation of 
TKRs by EGF caused the activation of both ERK and NFAT pathways in LβT2 cells 
and ERK pathway in HeLa and MCF-7 cells. A recent study measured transferred 
information via EGF to ERK in HeLa cells provided with 3 Bits and revealed that ~0.2 
Bits of information was transferred to ERK over 5 min [298]. Comparing this value 
with the obtained values here via GnRHR (0.5 Bits, Figure 5.1) make it interesting to 
explore the reliability of these cells in sensing their environment via other receptors.  
In summary, using single-cell measures to quantify transferred information to ERK or 
NFAT via GnRHRs showed that signalling is inefficient (<1 Bit of information 
transferred to ERK or NFAT). Most information was lost through signalling as system 
inputs were 3 Bits for most experiments. Although, cells gained additional information 
by simultaneous sensing of ERK and NFAT pathways, the increase was small. Similar 
data were obtained in the three cell types, revealing similar information transfer via 





estimated MI value was high at early time point and reduced thereafter, indicating that 
snapshot data might underestimate the information gained over the entire stimulation 
period, and cell could gain information over time. Thus, this possibility is explored in 





        HeLa cells         LβT2 cells      MCF-7 cells 
            
The figures show that providing the system with 3 Bits of information, less than 1 Bit was transferred. For example, around 0.5 Bits of 
information transfer to ERK in HeLa and LβT2 cells and just 0.1 Bit in MCF-7 cells. However, in MCF-7 the estimated MI values to the 
transcriptional readouts were much lower than MI values obtained in the other cellular models. These observations extend the idea of 
cell-context-dependent GnRH signalling to the amount of information transferred via the GnRHR. 
 













Single cell measures reveal high cell-cell variability, and information theoretical 
approaches can be used to explore the influence of such heterogeneity on information 
transfer. The previous chapter (Chapter 5) explored the transmitted information via 
GRHRs to ERK and NFAT and their transcriptions readouts in three cellular models 
(HeLa, MCF-7 and LβT2 cells). The data obtained revealed loss of information 
through signalling networks irrespective of the cell type or response measured (Figure 
5.9). One Bit of information can resolve two different signal values, but at single time-
points, MI values were always <1Bit, despite 3 Bits system inputs. Sensing multiple 
pathways as a mechanism that cells might do to mitigate such any loss was explored 
as well. This revealed that cells indeed gained additional information by sensing joint 
pathways, but the increase was always modest <1Bit. This implies that the available 
information might be underestimated by using snapshot data, and sensing response 
dynamics could be an alternative possibility to increase information.  
In this chapter, this possibility was explored by live cell imaging of NFAT1c-EFP 
translocation responses in GnRH stimulated LβT2 cells. MI was also calculated taking 
response trajectory into account. Also, since, nuclear translocation of NFAT is 
mediated by elevation of cytoplasmic Ca2+, similar experiments were undertaken 
using Ca2+ responses measured with Ca2+ sensor dyes (Fluo-4 or Rhod-3). As GnRH 
is secreted in a pulsatile manner, the amount of additional information gained by 






6.2. Materials and methods 
LβT2 cells were cultured and imaged as detailed in Chapter 2. Briefly, for a single 
pulse of GnRH experiment, LβT2 cells were maintained at 37oC on the imaging stage 
of the INCell 2200 and GnRH was added automatically from a compound plate. This 
enabled cell images to be acquired before and after stimulation without having to 
remove the culture plate from the INCell.  
For dual pulse of GnRH experiments, the first pulse was as above and was terminated 
by removing the plate from the stage and washing the stimulus before the plate was 
returned to the INCell for the second stimulus. For data analysis, the image stacks 
obtained for the first and second imaging period were stitched together manually using 
Notepad++ (Text editor, Microsoft). InCell Analyzer was then used for image analysis 
to determine fluorophore intensities in regions of interest. The nuclear perimeter was 
determined from the Hoechst stain and the x-y position of the centre of each nucleus 
was used to track individual cells over time. This was achieved using a MatLab 
algorithm (Kindly provided by Dr. Margaritis Voliotis). Time-courses of responses 
were plotted for each individual tracked cell and were inspected to aid removal of 
incorrectly tracked cells and outliers as described in Chapter 2. 
 
6.3. Results 
6.3.1. Live cell NFAT1c-EFP imaging in LβT2 cells 
Ad NFAT1c-EFP transduced LßT2 cells were stimulated with a single pulse of 0 or 
10-11-10-7 M GnRH in PSS buffer. The cells were then imaged for 50 min. The 





showed no response to GnRH (grey shade traces) whereas in >80% GnRH caused a 
sustained response in the nuclear fraction (NF) of NFAT1c-EFP (Figure 6.1B).  
Population averaged data (pooled from all tracked cells) revealed that GnRH causes a 
concentration and time-dependent increase in nuclear translocation of NFAT1c-EFP 
in LβT2 cells (Figure 6.1E). Maximum responses were obtained with 10-9 M 10-8 M 
and 10-7 M GnRH and by 20-30 min. They were then sustained to 50 min (the last 
time-point measured).  
Binning individual cells according to the NF of the NFAT1c-EFP (Figure 6.1F) 
revealed pronounced cell-cell variation and that GnRH increased the population 
averaged NFAT1c-EFP levels by shifting the FD plots rightward. There was no 
evidence for such distinct cell populations, as cells showed a graded response, rather 
than an all-or-nothing response.  
The pronounced overlaps between the FD plots for stimulated and unstimulated cells 
immediately suggest that MI values will be low.  As shown in figure 6.1 G, calculated 
MI values for each time points followed a very similar time-course to the NFAT1c-
EFP-NF translocation responses, increasing to a maximum of 0.38 ± 0.01 Bits by 20-
30 min and remaining at this level until 50 min. MI was also calculated taking response 
trajectories of individual cells into account using 10, 30 and 50 min, and this was 0.54 
± 0.01 Bits. Calculation of MI values at a wide range of time points (Figure 6.1D) 
reveals that we have not underestimated MI by simply choosing the wrong time-point 
for analysis. However, the increase in MI seen when trajectory is considered 
demonstrates that the snapshot data do indeed underestimate information transfer via 








LβT2 cells were culture and treated as described in Chapter 2. Cells were imaged at 
37°C both before and during continuous stimulation with varied concentrations of 
GnRH as shown. Images were acquired at the indicated times, and automated image 
analysis algorithm was used to calculate the NFAT1c-EFP-NF. A MatLab tracking 
algorithm was used to follow individual cell responses over time. The cells that had a 
failed tracking or had at time 0 NFAT1c-EFP-NF values of <0.4 or >0.55 were 
removed (around 2% defined as outliers). Representative single cells responses are 
shown for control cells (A) for cells stimulated from time 0 with 10-10 M GnRH (B) 
with 10-9 M GnRH (C) and with 10-7 M GnRH (D). Population average responses for 
all tracked cells are shown as the means ± SEMs, from 3 separate experiments (n=3), 
with duplicate wells (E). The total number of cells tracked for each GnRH 
concentration was between 70 and 320. Single cell data were used to generate FD 
plots. Representative FD plots shown for cells stimulated 20 min (F) with the indicated 
concentrations of GnRH. The I(NFAT-NF; GnRH) values for all tracked cells at each 
time point are shown in panel G. Also, panel G shows the MI between GnRH and the 
translocation response when single cell response trajectories are considered (10, 30 
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6.3.2. Sensing dynamics and live cell Fluo-4 imaging in LβT2 cells. 
In the next series of experiments, the Ca2+ sensitive fluorescent dye Fluo-4 was used 
for live cell imaging of GnRH effects on the cytoplasmic Ca2+ concentration in LβT2 
cells. As shown in figure 6.2A, in control cells, cytoplasmic Ca2+ concentrations 
(indicated by Fluo-4 fluorescence) were relatively stable over time, although clear 
oscillations were seen in a small proportion (<20%) of cells imaged (Figure 6.2A).  
10-7 M GnRH caused a rapid increase in Ca2+ (Figure 6.2B). These responses varied 
markedly from cell to cell although most cells responded to this concentration of 
GnRH (>90%). The maximum responses were typically achieved within 30 sec of 
stimulation with a gradual reduction toward plateau levels after 4-10 min. 
Interestingly, some cells showed a clear delay between GnRH addition and Ca2+ 
elevation (light blue shade traces in Figure 6.2D), an effect that was also seen in cells 
stimulated with lower GnRH concentrations (Figure 6.2B and C). At lower GnRH 
concentrations, the single cell data revealed a tendency for lower maximal responses 
(Figure 6.2B and C).  
The population averaged data (Figure 6.2E) revealed that the maximum GnRH effect 
and response kinetics were both dependent upon GnRH concentration. Notably, the 
highest concentration of GnRH caused the most transient response (i.e. maximum 
response: plateau response ratio was greater with 10-7 M than with 10-9 M GnRH and 
the time taken to achieve the maximum response was less with 10-7 M GnRH than 
with 10-9 M GnRH (Figure 6.3C and D).  
Binning individual cells according to the log of the nuclear Fluo-4 stain intensity 
(Figure 6.2F) revealed pronounced cell-cell variation in the Fluo-4 levels and that 





rightward. No evidence was found for GnRH responsive and GnRH non-responsive 
cell populations, as a graded response rather than an all-or-nothing response was 
shown. The overlaps between the FD plots for stimulated and unstimulated cells 
immediately suggest that MI values will be low. As shown in figure 6.2G, MI values 
were calculated for each time points and these followed a very similar time-course to 
the population averaged Fluo-4 responses. The MI values increased to a maximum of 
0.74 ± 0.01 Bits within 30 sec of stimulation, then reduced gradually to 0.58 ± 0.1 
after 2 min and remained at this level for 10 min (the last time-point measured).  
It is important to note that the data in figure 6.2G are normalised to the individual cell 
Fluo-4 level before stimulus addition in order to correct for cell-cell variation in Fluo-
4 loading. MI values were calculated for both the raw data (Fluo-4 fluorescence in 
AFU) and the normalised data. For raw data, the MI values were 0.60 ± 0.05 Bits 
within 30 sec of stimulation then gradually decreased to 0.35 ± 0.04 within 10 min. 
The values obtained were a little higher with the normalised data, indicating that this 
technical source of variation causes MI values to be underestimated with the raw data. 
With the normalized data the maximum MI value was 0.74 ± 0.10 Bits at 30 sec, but 
when trajectory was considered using 140, 160 and 300 sec responses, the MI value 
was increased to 1.01 ± 0.04 Bits.  
Thus, maximum estimates for information transfer via GnRHR are greater with the 
Ca2+ sensor (Figure 6.2H) than with the NFAT1c-EFP translocation reporter (Figure 
6.1.G) and, although MI values are increased by consideration of response trajectory 
for both readouts, the majority of information available still appears to be lost through 










Cells were cultured and treated as described in Chapter 2. Images were collected every 
20 sec, and a Matlab tracking algorithm was used to follow individual cell responses 
over time. The cells that had a fail tracking were removed (around 2% of cells, defined 
as outliers). Panel A shows representative images of Hoechst, nuclear Fluo-4 stained 
cells cultured under control condition or stimulated for 1 min with 10-7 M GnRH (3). 
Representative single cells responses are shown for control cells (B) for cells 
stimulated from time 0 with 10-10 M GnRH (C), with 10-9 M GnRH (D) and for  
10-7 M GnRH (E). Population average responses for all tracked cells are shown as the 
means ± SEMs, n=3 (F). The total number of cells tracked for each GnRH 
concentration was between 130 and 320 cells. Representative FD plots are shown for 
cells stimulated 1 min (G) with the indicated concentrations of GnRH. The I(Ca2+; 
GnRH) values for all tracked cells at each time point were calculated for both the raw 
data (Fluo-4 fluorescence in AFU, closed circles) and the normalised data (open 
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6.3.3. Live cell Fluo-4 imaging in HeLa cells 
GnRH effect on the cytoplasmic Ca2+ concentration was also measured in HeLa cells 
as an alternative model. The cells were cultured and treated as LβT2 cells were treated 
with the exception that HeLa cells were transduced with Ad mGnRHRs for the 
expression of heterogenous receptors. As shown in figure 6.3B, in control cells, 
cytoplasmic Ca2+ concentrations were relatively stable over time. However, a small 
transient response was observed following fluid addition (PSS alone without GnRH). 
As shown in figure 6.3, GnRH induced a rapid increase in Ca2+. The maximum 
responses achieved with 10-7 M GnRH and within 30 sec of stimulation, followed by 
a gradual reduction toward plateau levels after 4-10 min (Figure 6.3E). Although most 
cells responded to this concentration of GnRH (>90%), the responses were varied 
from cell to cell. Some cells exhibited a low response to the stimulus (grey shade 
traces), whereas other cells showed a spike response to GnRH (dark orange shade 
traces), and around 10% showed clear oscillations. At lower GnRH concentrations, 
the single cell data revealed a tendency for lower maximal responses (Figure 6.3D).  
The population averaged responses (Figure 6.3F) were consistent with the single cell 
responses. The maximum GnRH effect and response kinetics were both dependent 
upon GnRH concentration. The maximum response: plateau response ratio was 
greater with 10-7 M than with 10-9 M GnRH and the time taken to achieve the 
maximum response was less with 10-7 M GnRH than with 10-9 M GnRH. Like the 
single cell observation, a transient response was observed in control cells (Figure 6.3F, 
open circle) following the addition of fluid (PSS alone), which might be an effect of 





Binning individual cells according to the log of the nuclear Fluo-4 stain intensity 
revealed pronounced cell-cell variation in the Fluo-4 levels. GnRH increased the 
population averaged Fluo-4 levels by shifting the FD plots rightward. No evidence 
was seen for GnRH responsive and GnRH non-responsive cell populations, as a 
graded response rather than an all-or-nothing response occurred (Figure 6.3G).  
The pronounced overlaps between the FD plots for stimulated and unstimulated cells 
suggest that MI values will be low. This is shown in figure 6.3H. MI values were 
calculated for single-time-point data and these followed a quite similar time pattern to 
the population averaged Fluo-4 responses. The MI values were maximum of 0.56 ± 
0.03 Bits at 24 sec, followed by a small reduction of 0.49 ± 0.03 Bits within 1 min 
then again increased gradually to 0.66 ± 0.01 after 3 min where it remained sustained 
for 10 min (the last time-point measured). MI values were calculated for both the raw 
data (Fluo-4 fluorescence in AFU, closed circles) and the normalised data (open 
circles) and found to be higher in the latter (Figure 6.3H), suggesting that this technical 
source of variation causes underestimation of MI values in the raw data. The 
maximum MI value obtained in normalised data was 0.56 ± 0.03 Bits at 24 sec, but 
when trajectory was considered (using 140, 160 and 300 sec responses) the MI value 
was increased to 1.01 ± 0.05 Bits. However, despite the increase in MI values by 
consideration of response trajectory, still most of the information available appears to 






           
         
 
 
Cells were treated as described in Chapter 2. Images were acquired every 20 sec, and 
a Matlab tracking algorithm was used to follow individual cell responses over time. 
The cells that had a fail tracking were removed (around 5% of cells defined as 
outliers). Panel A shows representative images of Hoechst, nuclear Fluo-4 stained 
cells cultured under control condition or stimulated for 24 sec with 10-7 M GnRH. 
Representative single cells responses are shown for control cells (B), for cells 
stimulated from time 0 with 10-10 M GnRH (C), with 10-9 M GnRH (D) and with  
10-7 M GnRH (E). Population average responses for all tracked cells are shown as the 
means ± SEMs, n=4 (F). The total number of cells tracked for each GnRH 
concentration was between 150 and 300 cells. Representative FD plots are shown for 
cells stimulated 24 sec (G) with the indicated concentrations of GnRH. Panel H shows 
the I(Ca2+; GnRH) values for all tracked cells at each time point calculated for both 
the raw data (Fluo-4 fluorescence in AFU, closed circles) and the normalised data 
(open circles).  
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6.3.4. Joint sensing of Ca2+ and NFAT signalling 
Transferred information might be increase by joint sensing of Ca2+ and NFAT 
translocation responses, so this possibility was explored. However, Fluo-4 and 
NFAT1c-EFP cannot be imaged in the same cells. This is because of that the excitation 
of both Fluo-4 and EFP are similar (see Chapter 2), which will cause the emission 
spectra to overlap. Accordingly, an alternative Ca2+ sensitive fluorophore, Rhod-3, 
was used. Rhod-3 is a red-shifted calcium indicator providing a means to avoid bypass 
the overlap. 
Imaging the response of both NFAT and Rhod-3 (Figure 6.4) in the same cells 
revealed that cytoplasmic Ca2+ concentrations were relatively stable over time in 
control cells. A rapid increase in Ca2+ in cells stimulated by10-7 M GnRH was 
observed, with a maximum response achieved within 1 min of stimulation, followed 
by a gradual reduction toward plateau levels after 4-10 min. A delay between GnRH 
addition and Ca2+ elevation was seen in cells stimulated by 10-9 M GnRH (Figure 
6.4B), At lower GnRH concentrations, the single cell data revealed a tendency for 
lower maximal responses. 
Consistent with single cell responses, the population averaged data showed that the 
maximal GnRH effect and response kinetics were both dependent upon GnRH 
concentration. The maximum response: plateau response ratio was greater with  
10-7M than with 10-9M GnRH (Figure 6.4B and C). MI values calculated for each time 
point followed a very similar time-course to the Rhdo-3 responses (a maximum of 
~0.7 Bits within 30 sec of stimulation then a gradual reduction to control values over 





For NFAT1c-EFP translocation, the single cell responses in figure 6.4 demonstrate 
that small proportion of cells (<20%) showed no response to GnRH (grey shade 
traces), and more than 80% of cells showed a sustained response (green shade traces. 
Population averaged data revealed that GnRH causes a concentration and time-
dependent increase in NFAT1c-EFP- NF translocation. Maximum response was 
obtained with 10-9 M, 10-8 M, and 10-7M GnRH and by 10-20 min. They were then 
sustained to 25 min (the last time-point measured).  MI values calculated for each time 
point followed a very similar time-course to the NFAT1c-EFP-NF translocation 
responses (a maximum of ~0.4 Bits by 10 min and remaining at this level until 25 
min). No much additional information was gained by sensing joint pathways, the MI 








Cells were cultured as described in Chapter 2. Cells were imaged at 37°C both before 
and during continuous stimulation with varied concentrations of GnRH as shown in 
the figures. Images were collected every 45 sec, and a MatLab tracking algorithm was 
used to follow individual cell responses over time. The cells that had a failed tracking 
were removed (around 3% of cells, defined as outliers). Representative single cells 
responses of Rhod-3 or NFAT1c-EFP are shown for control cells (A and D) for cells 
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Cells were cultured as described in Chapter 2. Cells were imaged at 37°C both before 
and during continuous stimulation with varied concentrations of GnRH as shown in 
the figures. Images were collected every 45 sec, and a Matlab tracking algorithm was 
used to follow individual cell responses over time. Representative single cells 
responses of Rhod-3 or NFAT1c-EFP are shown in Figure 6.4. Population average 
responses for all tracked cells are shown here as means ± SEMs, n=4. Panel A and B 
show population average responses for Rhod-3, and NFAT-1c-EFP-NF respectively. 
Panel C shows the MI values for all tracked cells at each time point. The maximum 
MI values were ~0.4 Bits for NFAT1c-EFP-NF, ~ 0.9 Bits for Ca2+ and these values 
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Figure 6.5. Imaging Rhod-3 and NFAT1c-EFP in the same cells: population 





6.3.5. Sensing repeated pulses 
GnRH is secreted in a pulsatile manner which is critical for normal reproductive 
function [23]. Signalling also continues after GnRH pulses are terminated and this 
raises two related questions. First how much information transfer occurs after the 
GnRH pulse. Second, how much additional information is gained by sensing a second 
pulse of GnRH. Here these questions were addressed by live cell imaging of NFAT1c-
EFP expressing in LβT2 cells with two pulses of GnRH and using the tracked cells to 
calculate MI values.  
The response of the individual cells to GnRH was remarkably variable as shown in 
figure 6.5. Small proportion of cells (<10%) showed no response to GnRH, some cells 
showed a clear delay between GnRH addition and NFAT1c-EFP translocation. 
However, most of the cells responded to GnRH. The maximum response was seen 
with the highest concentration of GnRH (10-7 M and 10-8 M) which was achieved 
within 10-15 min of GnRH stimulation for each pulse (Figure 6.5B and C). Consistent 
with the single cell observations above, the population averaged data revealed that the 
maximum GnRH effect and response kinetics were both dependent upon GnRH 
concentration. The maximum response was seen with higher GnRH concentrations 
(10-7 M and 10-8 M). 
MI values were calculated for the responses to GnRH in the 1st and 2nd pulse, and these 
shown in figure 6.5E. The MI values were 0.38 ± 0.02 Bits for the 1st pulse and 0.23 
± 0.03 Bits for the 2nd pulse. The MI value between the 1st pulse and 2nd pulse 
responses was calculated, and this increased to ~0.46 Bits. The additional information 
that cells could gain by sensing the 2nd pulse was also calculated, and this revealed 





considered using all time points (MDS as described in Chapter 2), the MI value was 




Ad NFAT1c-EFP transduced cells were stimulated with GnRH as shown for 15 min 
(first grey bar). The cells were then washed 3x over 5 min with PPS, and then imaged 
for a further two hours before repeat stimulation (second grey bar) for 30 min using 
the same concentrations. Images were acquired at the indicated times, and a Matlab 
tracking algorithm was used to follow individual cell responses over time. The cells 
that had a failed tracking or had at time 0 NFAT-NF values of <0.4 or >0.55 were 
removed (around 5% of cells defined as outliers). Panel A, B and C are shown 
representative single cell responses (control and cells stimulated with 10-9 M GnRH 
or 10-7 M GnRH). Population average responses for all tracked cells are shown as the 
means ± SEMs, n=4, with data from duplicate wells. The total number of cells tracked 
for each GnRH concentration was between 80 and 200. The MI values were calculated 
and for the first pulse were 0.45 Bits and 0.23 Bits for the second pulse. Little 
information additional was gained by sensing both pulses (~0.1 Bits). These values 
were increased to ~0.6 Bits with trajectory consideration. 
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6.3.6. Varying a time between two pulses 
Cell-cell variability in cellular responses could reflect differences in the expression of 
key signalling effectors. In a recent model of the GnRH signalling pathway [153], the 
expression level of two effectors (GnRHRs and calmodulin) could fluctuate across 
different time-scales (fluctuation half-times from 10 min- representing unstable 
effectors- to 10.000 min representing stable effector). The results revealed that 
additional information could be gained from sensing a second pulse in the former 
scenario and little or no information in the latter one. A prediction from these 
simulations is that increasing the time between two pulses could increase information 
gained from sensing the second pulse. Here this hypothesis was investigated by 
loading LβT2 cells with Fluo-4 (as calcium indicator). Cells were then received two 
pulses of GnRH, with varying times between pulses (10, 20, 60 and 90 min). The first 
one lasted for 7 min with 20 sec intervals for imaging and was terminated by removing 
the plate from the stage and washing the stimulus with PSS buffer (4x 100µl over 3 
min). The plate was then returned to the INCell for the second stimulus. Cells were 
then imaged for 10, 20, 60 or 90 min, before receiving the second pulse of GnRH and 
again imaged for 7 min with 20 sec intervals.  
The population averaged data revealed that the maximum GnRH effect and response 
kinetics were both dependent upon GnRH concentration. GnRH caused a rapid 
increase in Ca2+ (Figure 6.2A). The maximum responses were typically achieved 
within 1 min of stimulation for each pulse. The responses to 1st pulse and 2nd pulse of 
GnRH were typical. The highest concentrations of GnRH caused the most transient 
response (10-8 M and 10-7 M). A tendency for lower maximal responses was seen at 





response was less with 10-8 M and 10-7 M GnRH than with 10-9 M GnRH (Figure 6.3C 
and D). 
MI values were calculated for 1st and 2nd pulse of GnRH, and these are shown in Figure 
6.7. For each case, the MI values were ~0.7 Bits for the 1st pulse and ~0.6 Bits for the 
2nd pulse, and little information was gained by sensing the 2nd pulse (~0.1Bit). Note 
that, were stimulated with 0 or 10-10-10-7 M GnRH, providing 2.2 Bits of information 
as the system input. The information transferred between pulses where also calculated 
and these were comparable under all test condition (Figure 6.7). Two-way ANOVAs 
of the MI values between pulses revealed that varying the time between pulses are not 
significant sources of variation (P>0.05). Very little information was gained by 
sensing the second pulse and the amount of information gained was not dependent on 
the pulse interval, implying that the sources of variation in this model are relatively 
stable over the time-course of the experiments. Also, MI was calculated taking the 
entire trajectory into account, and this increased the MI values to approximately 1Bit 














to 1st pulse 
GnRH and 
the response 





10 min  1.03 ± 0.18 0.70 ± 0.07 0.68 ± 0.04  0.13 ± 0.04 1.10 ± 0.01 
20 min 0.92 ± 0.02 0.61 ± 0.04 0.57 ± 0.05 0.12 ± 0.03 1.02 ± 0.1 
60 min 0.92 ± 0.13 0.61 ± 0.01 0.64 ± 0.08 0.20 ± 0.12 1.10 ± 0.1 
90 min  0.78 ± 0.01 0.63 ± 0.06 0.51 ± 0.04 0.06 ± 0.02 0.97 ± 0.1 
 
 
LβT2 cells were incubated with Fluo-4 for 30 min at 37°C then washed 3x with PSS 
prior to stimulation with 0 or 10-10-10-7 M GnRH for 7 min (1st grey bar). The cells 
were then washed 4x over 3 min with PPS, and then imaged for a further 10 min (A), 
20 min (B) 60 min (C) or 90 min (D) before repeat stimulation (2nd grey bar) for 7 min 
using the same concentration as used with the first pulse. Panels A-D show the 
population average responses for all tracked cells. The results show the means ± 
SEMs, n=3. A MatLab tracking algorithm was used to follow individual cell responses 
over the time and the total number of cells tracked was between 100- 340 cells. MI 
values in response to 1st, 2nd pulse and between pulses with different inter-pulse 
intervals are calculated and are shown in the table. The inset text box shows MI values 
between GnRH concentration and the maximum response for the 1st and 2nd pulses. It 
also shows the additional information gained by sensing both pulses, the MI between 
pulses, and I(Fluo-4; GnRH) when the entire response trajectory is taken into 
consideration.  
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In the previous experiments, it was noted that the population averaged Fluo-4 
responses were lower in the 2nd pulse than the 1st, particularly with the higher inter-
pulse intervals. This could conceivably reflect down-regulation of GnRHR caused by 
the 1st GnRH pulse, but this seems unlikely as agonist induced internalisation of type 
I mammalian GnRH is slow and recovery would be expected to occur between the 
pulses. It could also be related to leakage of Fluo-4 from the cells, or chemical 
modifications of the Fluo-4 that impair chemical sensing, occurring over time. In order 
to distinguish between these possibilities, related experiments were undertaken in 
which cells were treated with10-7 M GnRH (group C) or without GnRH (group B) in 
the 1st pulse, then washed and incubated for another 90 min before stimulation with 0 
or 10-7 M GnRH. As shown (Figure 6.8), the response of cells to the 2nd pulse of GnRH 
was similar in both groups. Accordingly, there was a time-dependent reduction in 











LßT2 cells were treated as described in figure 6.7. Group A represents control, cells 
in group B were injected with PSS only and cells in group C were received 10-7M 
GnRH (1st grey bar). Cells were imaged for 7 min, then GnRH effect was terminated 
by washing cells 4x over 3 min with PPS. Cells were then imaged for 90 min before 
both groups (B and C) receiving a second pulse of GnRH (2nd grey bar). The figure 
shows the population average responses for all tracked cells. The results show the 
means ± SEMs, n=3. The normalised Fluo-4 value of the 2nd pulse was calculated 
using the AUCs and these values were comparable 1.38 ± 0.29 (B) and 1.745 ± 0.59 
(C). The t-test of the second pulse reveals no significant differences in response to 





6.3.7. GnRHR-independent Ca2+ mobilisation  
The maximal MI values reported in this chapter are approximately 1 Bit (irrespective 
of the experimental end-point and whether response trajectory is taken into 
consideration). The implication is that a marked loss of information through signalling 
occurs early in the GnRHR signalling cascade, perhaps at the level of GnRHR 
coupling to its G-protein, or G-protein activation of PLC. If so, we might expect higher 
MI values with a GnRHR-independent stimulus for Ca2+ mobilisation so, in the final 
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loaded LβT2 cells were stimulated with 0 or 10-5-10-7 M ionomycin, providing 2.45 
Bits of information as the system input.  
As shown in figure 6.8, in control cells receiving no ionomycin, cytoplasmic Ca2+ 
concentrations were relatively stable over time. Clear oscillations were observed in a 
small proportion (<20%) of cells imaged (Figure 6.8A). 10-5 M ionomycin caused a 
rapid increase in Ca2+ (Figure 6.8D). These responses varied markedly from cell to 
cell although almost all cells responded to this concentration of ionomycin (>90%). 
The maximum responses were typically achieved within 30 sec of stimulation with a 
gradual reduction toward plateau levels after 3-10 min. At lower ionomycin 
concentrations, the single cell data revealed a tendency for lower maximal responses 
and delays between ionomycin addition and Ca2+ elevation (Figure 6.8B). 
Consistent with the single cell observations above, the population averaged data 
revealed that the maximum ionomycin effect and response kinetics were both 
dependent upon ionomycin concentration. Notably, the maximum response: plateau 
response ratio was greater with 10-5 M ionomycin than with 10-6 M ionomycin and the 
time taken to achieve the maximum response was less with former than with latter.  
Binning individual cells according to the log of the nuclear Fluo-4 stain intensity 
revealed pronounced cell to cell variation in the Fluo-4 levels. Ionomycin increased 
the population averaged Fluo-4 levels by shifting the FD plots rightward. No evidence 
was obtained for ionomycin responsive and non-responsive cell populations, as a 
graded response rather than an all-or-nothing response was seen (Figure 6.8G). The 
pronounced overlaps between the FD plots for stimulated and unstimulated cells 
suggest that MI values will be low. This is shown in figure 6.8H. MI values were 





the Fluo-4 responses. They increased to a maximum of 1.3 ± 0.06 Bits at 24 sec and 
then reducing gradually. MI was also calculated taking response trajectories of 
individual cells into account using 140, 160, 300 sec, and this was increased to 1.5 ± 
0.03 Bits. The MI values are greater in cells stimulated with ionomycin than with 






           
         
 
Cells were cultured and treated as described in Chapter 2. Images were collected every 
20 sec, and a Matlab tracking algorithm was used to follow individual cell responses 
over time. The cells that had a failed tracking were removed (around 2% of cells, 
defined as outliers). Panel A shows representative images of Hoechst, nuclear stain 
and Fluo-4 stained cells cultured under control condition or stimulated with 10-5 M 
ionomycin for 24 sec. Representative single cells responses are shown for control cells 
(B) for cells stimulated from time 0 with 10-7 M ionomycin (C), with 10-6M ionomycin 
(D) and with 10-5M ionomycin (D). Population average responses for all tracked cells 
are shown as the means ± SEMs, n=4 (E). The total number of cells tracked for each 
GnRH concentration was between 130 and 320 cells. The I(Ca2+; ionomycin) values 
for all tracked cells at each time point are calculated shown in D. It also (D) shows MI 
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Single cell measures of the amount and/or activity of signalling protein reveal high 
cell-cell variability. Information theory-derived statistical approaches can be used to 
explore the influence of such heterogeneity on information transfer [274, 283, 296, 
298]. The signalling experiments in the previous chapter showed that the MI values 
used to measure information transfer via GnRHRs were always <1 Bit regardless of 
the experimental measure, and cell type studied. This indicates that GnRHRs engage 
noisy communication channels with most of the information lost through signalling. 
However, the obtained data were by imaging fixed cells, and such snapshot data might 
underestimate information transfer. The effects of GnRH are usually dependent on 
temporal aspects of the stimulus, such as stimulus duration with constant stimulation, 
or pulse characteristics with intermittent stimulation. Thus, an obvious possibility is 
that cells gain additional information by sensing over time.  
This chapter aimed to determine if additional information is gained by sensing 
response trajectories over time. This was achieved by live cell monitoring of Ca2+ 
responses and Ca2+-driven NFAT1c-EFP translocation in cells stimulated by GnRH. 
In addition, and as GnRH is secreted in pulses, the second aim was exploring if 
additional information is gained by repeated GnRH pulses. Sensing ionomycin was 
also considered.  
The main findings were that GnRH caused concentration and time-dependent 
increases in NFAT1c-EFP-NF in live LβT2 cells (Figure 6.1). It also caused a similar 
effect in Ca2+ in both LβT2 and HeLa cells (Figure 6.2 and Figure 6.3). The calculated 
MI at each time point for both measurements were relatively low (<0.4 Bits for 





for GnRH effects on MI were largely similar with time-course for the population 
averaged to the NFAT1c-EFP and Fluo-4 responses. This observation indicates that 
the dynamic range is the main factor of the observed MI values and implies that cell-
cell variability does not simply scale with any of these population averaged responses.  
The obtained results here also revealed that information was underestimated by having 
snapshot data. For each of these experiments, MI values were calculated taking 
response trajectories in individual tracked cells into account and this increased MI 
values from 0.38 Bits to 0.54 Bits for the NFAT1c-EFP translocation response in 
LβT2 cells, from 0.74 Bits to 1Bit for Ca2+ responses in LβT2 cells and from 0.56 Bits 
to 1Bit for Ca2+ response in HeLa cells. Here, the key observation is that for each cell 
type and/or experimental readout, additional information is gained by sensing over 
time. However, still most available information is lost through signalling, even when 
trajectories are considered (as system inputs were 2.45 Bits). 
These data extend (and in part contribute to) a recent study in which GnRH effects on 
NFAT1c-EFP translocation was studied in Ad GnRHRs transduced HeLa cells [153]. 
That work revealed a similar effect of GnRH on NFAT1c-EFP. The response was 
sustained and marked cell-cell variability was observed. The MI values were higher 
with I(NFAT1c-EFP; GnRH) approximately 0.6 Bits in HeLa cells, as compared to 
0.39 Bits in LβT2 cells. Interestingly some differences were observed, and these are 
that a) responses were more rapid in HeLa cells than in LβT2 cells and b) that 
consideration of trajectory increased MI estimates for LβT2 (from 0.38 Bits to 0.54 
Bits) but not for HeLa cells [153].  
The response of Ca2+ to GnRH has been extensively characterised in different cell 





[Ca2+]i [371]. Oscillatory responses were described in male mice, and transient 
responses at both lower and higher concentrations were recorded from acute pituitary 
slices in vitro [369]. A similar study, in mouse gonadotrophs described the responses 
in individual cells and revealed that responses are varied in duration, magnitude, and 
frequency of oscillation [370]. Here in this work, a small proportion of oscillatory 
pattern was seen under the control condition (< 20%) in both LβT2 and HeLa cells. In 
both cell types, the highest concentrations of GnRH caused biphasic (spike-plateau) 
responses, while at lower GnRH concentrations more gradual elevation was observed. 
The time taken to achieve the maximum response was longer than the time taken with 
highest GnRH concentrations.  
MI was calculated, and obtained results revealed that the I(Fluo-4; GnRH) values were 
~0.8 Bits in LβT2 cells and ~0.6 Bits in HeLa cells. These increased to a maximum 
of ~1Bit with trajectory consideration. This is the first study to quantify information 
transfer via GnRHRs using Ca2+-sensitive dyes, and it reveals that information appears 
to be lost early in the GnRH signalling network (i.e. prior Ca2+ mobilisation). 
Noteworthy, although single cell responses in both cell lines were relatively similar, 
some differences where observed. These are that in HeLa cells (Figure 6.3), a small 
and transient response occurred in the control group after fluid addition (PSS buffer 
without GnRH), such a response did not observe in the endogenous expression system 
(LßT2 cell line, Figure 6.2). When MI values were calculated, different time 
dependencies between HeLa and LßT2 cells was clearly observed. (Compare Figure 
6.2 H and Figure 6.3 H). In HeLa cells, the MI values peaked to 0.54 Bits within 30 
sec of GnRH addition, then dropped to ~0.4 Bits a minute later, before peaking again 





For LßT2 cells, MI value was ~ 0.8 Bit 30 sec of GnRH stimulation, reduced to 0.6 
Bit over 2 minutes and remained unaltered during the examined period. Likewise, 
when trajectory was considered using different time points (see appendix, table 3). MI 
values were relatively higher when late time points consider in HeLa cells, and the 
opposite was for LβT2 cells. These differences could reflect the differences in 
mechanical stimulation on cytoplasmic Ca2+ concentration in these cell lines.  
The observed difference in time-courses for GnRH effects on I(NFAT1c-EFP-NF; 
GnRH) and I(Ca2+; GnRH) are best illustrated by the experiments in which NFAT1c-
EFP translocation and Rhod-3 were imaged in the same cells (Figure 6.4 and Figure 
6.5), with I(NFAT-EFP-NF; GnRH) increasing gradually to a maximum of 0.4 Bits at 
10-20 min and I(Ca2+; GnRH) peaking to ~0.9 Bits within 1 min. Similar differences 
were observed for the population averaged responses that were rapid and transient for 
Rhod-3 as compared to the slower and more sustained NFAT1c-EFP translocation 
response (Figure 6.5). For these experiments joint MI was also calculated, reasoning 
that if the NFAT translocation response was modulated by GnRH effects other than 
Ca2+ elevation, there might be a poor correlation between the two responses and a 
substantial increase in MI by consideration of both. However, the maximum joint 
sensing MI value was very similar to that for Ca2+alone arguing against this 
possibility. Joint MI exceeded that for either response alone at later time-points 
implying that the correlation between the NFAT and Ca2+ responses reduces at later 
time-points.  
GnRH caused a concentration and time-dependent increase in NFAT1c-EFP-NF in 
LβT2 cells. The effect was reversed when the stimulus was washed off and repeated 





pulse and little additional information was gained by sensing the second pulse (0.08 
Bit). Similar results were obtained in previous work done in HeLa cells [153].The 
additional information from sensing the 2nd pulse suggests a good correlation between 
individual cell responses in 1st and 2nd pulse. This was confirmed in the previous study 
by showing the response in one pulse could be predicted from the response in the other 
(MI 1 Bit) [153]. An important difference between this and the earlier study is that the 
use of the INCell 2200 here enabled automated stimulus addition so that a pre-
stimulation control could be established. Also, washing the 1st from HeLa cells caused 
a major increase in NFAT1c-EFP-NF that is presumably an artifact caused by 
mechanical stimulation and was much less prevalent in the LβT2 data shown here. 
Remarkably, the MI value calculated from NFAT1c-EFP-NF after the 1st GnRH pulse 
and during the pulse was comparable. This is in line with the idea that GnRH 
signalling continues between GnRH pulses and that such inter-pulse signalling 
contributes to downstream responses during GnRH pulses. This would require that the 
stimulus can be sensed from the inter-pulse signal, precisely as shown here. 
A similar two pulse protocol was used to examine the amount of additional 
information that could be gained by a 2nd GnRH pulse using Fluo-4 as the signalling 
readout. The main difference is that the interval between pulses was varied to explore 
the amount of additional information gained by a 2nd GnRH pulse. The responses of 
Ca2+ are more rapid in onset compared to NFAT1c-EFP translocation responses so 
that the duration of the 1st pulse can be decreased, and rapidly reversed. Thus, the 
interval between pulses can be reduced and varied. The expected concentration-
dependent and time-dependent increases in Ca2+ during the 1st and 2nd pulse with 
GnRH was seen. Unexpectedly, a smaller response to the 2nd pulse of GnRH was seen 





However, the reduction does not reflect desensitisation to GnRH as a similar response 
was observed in cells treated with PSS alone without GnRH and imaged for further 
90 min before stimulation with GnRH (Figure 6.8). A possible explanation is that 
during the extended incubations period a proportion of the Ca2+ sensor is lost from the 
cells. It may also be that the sensor is altered chemically that reduced its Ca2+ 
sensitivity. Nevertheless, as MI values are not affected by transformations of the 
output or input, theoretically, this should not impact the calculated MI values. As 
shown in Figure 6.7, MI values calculated for 1st pulse and 2nd pulse were comparable 
regardless of the time interval between them (~0.7 Bits and ~0.6 Bits for 1st pulse and 
2nd pulse respectively). It was previously predicted that cells would gain additional 
information as the interval between the pulses increased [153]. Yet, this is not the case 
here as the additional MI values were low (0.06-0.2 Bits) irrespective of the pulse 
interval (10-90 min). Therefore, both NFAT1c-EFP translocation data and Ca2+ 
imaging data argue against the possibility of repeated pulses could increase the 
reliability of GnRH sensing. 
The fact that signalling pathways act as noisy communication systems with much 
information lost through signalling is increasingly recognised, but the sites at which 
information is lost is very poorly defined. As shown, I(Ca2+; GnRH) values were 
typically <1 Bit implying that most information is lost prior Ca2+ mobilisation. Thus, 
in the final experiments, ionomycin (a Ca2+ ionophore) was used. It enhances Ca2+ 
influx by stimulating store-regulated cation entry [372]. As expected, ionomycin 
caused concentration and time-dependent increases in Ca2+ (like GnRH, Figure 6.8). 
However, the I(Ca2+; ionomycin) value was maximum at 1.25 Bits within 30 sec of 





Interestingly, the MI value with this GnRHR-independent stimulus is greater than any 
MI value reported here for GnRH signalling. This suggests that the GnRHR and its 
upstream effectors are a signalling node at which significant information loss occurs. 
Similarly, the fact that I(Ca2+; GnRH) values exceed I(NFAT-NF; GnRH) values and 
that these in turn exceed I(NFAT-RE values) in both the HeLa and LβT2 cell models, 
implies that information is lost at each step through the signalling cascade (Figure 5.1 
and Figure 5.3). The recorded loss of information could be a result of engaging the 
stimulus with IP3R on endoplasmic reticulum for calcium mobilisation. A study by 
Lestas et all., in 2010, showed that there is a correlation between the number of 
components that mediates a specific target and the efficiencies of signalling networks. 
More generally, increasing the number of mediators would provide more opportunities 
for the noise to suppress information transmission through the networks [373]. 
Sensing other receptors was also considered in this study. Oxytocin receptors have 
been implicated in regulation of gonadotrophin expression. Oxytocin stimulates 
gonadotrophin secretion from pituitary cell cultures and increases the Ca2+ 
concentration [374, 375]. However, when LßT2 cells were loaded with Fluo-4 and 
stimulated with 10-6 M-10-10 M oxytocin, no response was seen (data not shown). This 
could be because this cell line does not express the endogenous oxytocin receptors. In 
fact, a study has revealed that although oxytocin receptors are present in the anterior 
pituitary, its expression appears to occur on lactotroph cells rather than gonadotroph 
cells [376]. On the other hand, another research showed the oxytocin increased the 
cytosolic Ca2+ concentration in αT3-1 cell line (a murine gonadotroph-derived cell 





As mentioned above, the sources of cell-cell variation that effect information transfer 
are very poorly defined. A recent publication described a model of GnRH signalling 
to NFAT (a mixed mechanistic and probabilistic model) [153]. In that model the 
expression level of two effectors (GnRHR and CaM) were fluctuated across different 
time-scales to introduce heterogeneity. The main conclusion was that if the introduced 
variations are relatively constant over time, the response in the 2nd pulse can be 
predicted from that in the 1st pulse, and thus cells can gain little or no information by 
sensing both. On the other hand, if the effector concentrations vary rapidly the 
response of the 2nd pulse cannot be inferred from the 1st pulse (or vice versa). 
Consequently, a marked increase in information will be gained from sensing both 
pulses [153]. The published HeLa cell NFTAT1c-EFP translocation data were in 
accord with the former possibility (little information gain from sensing the 2nd pulse). 
This is also true for the LβT2 cell NFAT1c-EFP translocation data described here. 
Thus, although the main reason for the heterogeneity in the NFAT1c-EFP 
translocation response is not clear, it appears not to be dependent on any component 
of a network that varies markedly in the time-frame of these experiments 
(approximately 2 hr). Interestingly, here the responses of Ca2+ are rapid in onset and 
offset, and rapid oscillatory responses are seen in some cells [140, 369, 370]. These 
indicate that the relevant network components could be less stable. Therefore, we 
expected that by increasing the interval between the pulses, the estimated MI from 
sensing both pulses might increase. Nevertheless, this was not the case, as we can see 
in Figure 6.8, the additional MI values were low irrespective of the pulse interval (10, 
20, 60 and 90 min).  
Overall, the reasons behind the variability in single cell Ca2+ responses still unknown. 





that are relatively stable over time, such as variations in concentration of component 











7.1. Background and scope of the study 
Since the isolation of GnRH from the hypothalamus four decades ago, landmark 
studies have been conducted identifying its structure [12, 19, 61, 112], secretion and 
regulation [377, 378]. In addition to that, the structure of GnRHRs and their 
mechanisms of action have been extensively characterised [76, 120, 190, 240, 256]. 
Notably, the mammalian type I GnRHRs lack COOH-terminal tails that are found in 
other GPCRs and contribute to their rapid desensitisation [190]. Signalling pathways 
are initiated following the activation of receptors by GnRH [152, 153]. The interaction 
of these pathways within the networks create complex systems, allowing for high 
coordination of cellular responses. However, it has been reported experimentally 
[379] and theoretically [380] that cellular systems are heterogeneous. GnRH is 
secreted in a pulsatile manner, and in vivo studies demonstrated that individual 
gonadotrophin genes respond differentially to GnRH pulses [317, 381, 382]. 
Therefore, the intracellular signalling network should decode the received information 
to ensure an appropriate physiological response of the gonadotroph cell. 
Several studies have revealed that GnRH effects are cell context-dependent, 
suggesting different signalling mechanisms in different cell types. Therefore, the 
overall aim of the work here was to advance our understanding of GnRH signalling 
by exploring differences in responses between different cell types as well as between 
individual cells of a given cell type. First, the work focused on identifying the optimal 
cellular model for studying the mechanisms of GnRH action. This was done using a 
conventional approach to compare GnRH signalling in three cell types HeLa and 
MCF-7 cells (extra-pituitary cell lines) and LβT2 cells (a gonadotroph-derived cell 





extended beyond just describing structure of biological networks to using a 
mathematical approach that allowed us to examine the reliability of signalling 
networks in transferring information about the extracellular environment to the cells. 
Recently, this approach was used to quantify transferred information via different 
signalling pathways [152, 153, 298-300, 383]. These combined methodologies have 
advanced our understanding of signalling mechanisms. The main findings for each 
results chapter are summarised below. 
The first two chapters studied the cell context-dependence of GnRHR signalling to 
the ERK and NFAT pathways in the three cell types. Measures were collected from 
the population average, and the emphasis was on the response kinetics in Chapter 3, 
and the sensitivity of ERK and NFAT pathways to pharmacological inhibition in 
Chapter 4. Chapter 3 begun by monitoring the effect of GnRH on ERK and NFAT 
signalling pathways that was achieved using a high content imaging system (an INCell 
1000 or an INCell 2200). Another aim was to characterise the responses of both ERK 
and NFAT to EGF and a PKC activator as EGF receptors and PKC are both implicated 
in GnRH signalling. The main findings were that a) ERK activation is stimulus-
specific (sustained activation by PDBu and transient activation by EGF), and b) that 
GnRH effects on ppERK were cell context-dependent (transient in extra-pituitary cell 
lines and sustained in the pituitary-derived cell line, Figure 3.11, Figure 3.12, and 
Figure 3.13). GnRH-mediated Egr1-driven zsGreen expression (a readout for ERK 
driven gene expression), and NFAT-RE- driven asRed expression (a readout for 
NFAT-driven gene expression) were found to be comparable in both LßT2 and HeLa 
cells. However, in MCF-7 cells, the effect of GnRH on NFAT-RE- driven asRed 
expression was relatively weak, and no effect was seen on Egr1-zsGreen expression 





confirmed that GnRHR signalling is indeed dependent on the cellular context and 
emphasised the importance of examining different cell lines in signalling pathway 
studies. It also helped to optimize the protocols for examining ERK and NFAT 
signalling, that were further examined in the next chapter with the additional use of 
pharmacological inhibitors. 
Chapter 4 aimed to use distinct pharmacological inhibitors in order to further 
delineation of the network architecture of ERK and NFAT. The experimental results 
revealed that GnRH acts via type I GnRHRs in all three cellular models examined 
because cetrorelix prevented GnRH signalling to ERK and NFAT (Figure 4.1, Figure 
4.4 and Figure 4.7). Endogenous GnRHR expression is reported in some hormone-
dependent cancer cells [351, 384-387] but not in MCF-7 cells [199]. It has been 
thought that context-dependence of GnRH effects in hormone-dependent cancer cells 
can reflect activation of endogenous type II GnRHR [388-390]. Yet, when cetrorelix 
was applied in MCF-7 cells transduced with Ad mGnRHR for functional GnRHR, the 
antagonist blocked GnRH effect on ERK or NFAT revealing that GnRH is acting via 
the type I GnRHR. GnRH-mediated ERK activation was PKC and MEK dependent 
and EGFR independent in all three cell lines. Moreover, GnRH caused Ca2+ dependent 
activation of NFAT1c-EFP in all cell types examined. Although the EC50 values of 
GnRH effects on the receptors were similar in the three cell types, results here revealed 
that signalling is cell-context dependent. For example, the PKC inhibitor caused a 
marked reduction in ppERK in LβT2 cells compared to HeLa or MCF-7 cells. There 
was no evidence for EGFR transactivation mediating GnRH signalling to ERK. EGFR 
undergoes a rapid agonist-induced internalisation [280, 391] that presumably 
contributes to the transient responses observed in these cells. EGF-mediated NFAT1c-





translocation of NFAT1c-EFP in HeLa cells, but not in the other two cellular models 
used. On the other hand, the PKC activator (PDBu), failed to activate NFAT1c-EFP 
(a readout for Ca2+/CaM/Cn) in any of the cellular models (Figure 3.11, Figure 3.12 
and Figure 3.13). Although early work by Jobin and Chang used PKC activator (12-
O-Tetradecanoylphorbol-13-acetate TPA) and reported that the TPA increases Ca2+ in 
goldfish pituitary cells [345]. The experimental results in this work contrast with the 
earlier finding in that PDBu does not increase the Ca2+ level in these contexts. 
Taken together these data revealed that GnRHR signalling is dependent upon cellular 
model, as demonstrated by the differences in response kinetics (compare ppERK 
responses in HeLa or MCF-7 to LβT2 cells) and by the sensitivity to pharmacological 
inhibition (Figure 4.10). The idea of cell-context dependent GnRHR signalling is not 
novel [6, 110, 120, 145, 392-398]. However, interpreting published results are 
complicated. This is because GnRH effects have been monitored using different 
methods, in different cell types and by different groups. The work here was performed 
by a single experimentalist, using similar methods, and it was conducted as internally 
controlled comparisons of different cell lines, different stimuli and different inhibitors. 
The obtained results from these better-controlled studies revealed that the concept of 
cell context-dependency was not limited to GnRHR signalling but it was also seen for 
EGF signalling.  
Signalling through mouse GnRHR can be differently constructed in these genetically 
different cell lines. HeLa and MCF-7 cells had to be transduced with the Ad for 
GnRHR expression. An implication of this is the possibility that GnRHR signalling 
mechanism could be affected, especially, these cells are derived from cancer cells that 





that express the endogenous GnRHR in addition to αGSU and LHβ. Thus, this cell 
seems to be optimal for GnRHR signalling mechanism study, but the use of SV-40 
oncogenes to drive their proliferation could impact GnRHR signalling. Therefore, it 
could be concluded that there is no single ideal cellular model for GnRHR signalling 
studies and that the optimal approach could be to use different cell types, primary 
cultures, studies on animal models (in vivo), and clinical data.  
To sum up, the data in Chapters 3 and 4 show that GnRH signalling is, in fact, 
dependent upon cellular model, extending earlier work by showing that this is the case 
in internally controlled experiments using identical experimental measures. The cell 
context-dependency was observed by comparing response kinetics (Figure 3.4 and 
Figure 3.7), and sensitivity to pharmacological inhibition (Figure 4.1, Figure 4.4 and 
Figure 4.7) and was also seen in responses to EGF (Figure 3.12). However, although 
using different inhibitors have helped us in mapping the signaling network, it tells us 
nothing about the amount of information transferring through specific pathways or 
effectors in the GnRHR signalling system. Thus, an information theoretic approaches 
to investigation of GnRHR signalling were used in the following chapter. 
 
7.2. Exploring cell-cell variability and its impact on information transfer with 
fixed cells. 
The work described in Chapters 3 and 4 address context-dependence of GnRH 
signalling in population averaged responses and compared its effect in genetically 
distinct cell lines. However, studies on single cells revealed marked cell-cell variation 
in response to GnRH [153], suggesting difference in the arrangement of GnRHR 





0experiments reported in Chapters 5 and 6 were performed to evaluate this variability 
and mainly its impact on information transfer [152].  
The high content imaging platform used in this study provides the possibility to obtain 
the same experimental measures for each individual cell. These individual cell 
responses were used to quantify transferred information via GnRHRs to ERK or 
NFAT. Transmitted information was quantified using MI which is a statistical 
measure that takes cell-cell variability into account [283, 298]. The results revealed 
that most available information about GnRH concentration in the environment was 
lost through signalling. This is consistent with other studies that reported loss of 
information via other signalling pathways in other systems [298-300, 399], but it is 
nevertheless surprising as it indicates that a single gonadotrope cannot even 
unambiguously distinguish between two GnRH concentrations, despite the fact that 
GnRH concentration-response curves are graded over a broad range of hormone 
concentrations. The low MI values were recorded in the three cellular models 
revealing comparable information transfer via endogenous and heterologous 
expressed GnRHR. The loss of information was not limited to the ppERK cascade as 
similar results were obtained from consideration of information transfer between 
GnRHRs and NFAT irrespective of the cellular model used (Figure 5.9). A recent 
work studied the impact of GnRHR number on transferred information to ppERK in 
Ad mGnRHR transduced HeLa cells, and the transmitted information between PDBu 
and ppERK [152]. The main conclusion was that I(ppERK; GnRH) could be increased 
by increasing the GnRHR number [152]. Furthermore, a loss of information was 
reported between ppERK and PDBu (PKC activator), implying that factors other than 





The low MI values raised two distinct questions a) how do cells mitigate the loss of 
information? and b) do the experimental conditions contribute to underestimation of 
information transfer. For the former question, and as GnRHR engage a bifurcating 
signalling system, cells might gain additional information by sensing multiple 
pathways within the network. However, although sensing both pathways showed a 
significant increase in information transferred (Figure 5.1 and Figure 5.2 as an 
example), the increases were small, and still, most available information about GnRH 
concentration in the environment is lost through the cascade. Thus, the other 
concerned (the technical issue) was considered and the methods used (e.g. 1°Ab and 
2°Ab dilution, acquisition time and cell number) were optimised to maximise MI 
estimates. This revealed that MI values were not underestimated by using sub-optimal 
assay conditions (Figure 5.7 and Figure 5.8). As described in Chapter 3, activating 
TKRs by EGF caused the activation of both ERK and NFAT cascades in HeLa cells. 
It is possible that cells could sense their environment more reliably via other 
pathways/receptors than the once considered. This model has been applied before to 
estimate information transfer via EGF receptor to ERK [298]. Thus, the introduced 
model here can be used to consider other pathways or receptors (e.g. PACAP, 
Oxytocin) for further research in signalling mechanism.  
The main conclusion drawn from the data in Chapter 5 is that a significant amount of 
information is lost through GnRHR signalling to ERK and NFAT, irrespective of the 
cellular model used and although information transfer was increased by joint sensing, 
the increases were limited. As shown in HeLa cells (For example, Figure 5.1), the 
estimated MI value was high at early time point (5 min) and reduced thereafter (by 60 
min), and this means that the 60 min snapshot data underestimate the information 





underestimate the information transferred over this period. In other words, by ignoring 
response dynamics, information transfer might be underestimated, and cells could 
sense information over time. This was the focus of the work documented in Chapter 
6.   
 
7.3. Exploring cell-cell variability and its impact on information transfer in live 
cells 
The experimental results at the previous chapter have indicated three key points; 1) 
the loss of information is not restricted to ERK or NFAT cascade, 2) joint sensing is 
a mechanism that cells could use to mitigate such loss, 3) the low MI values are not 
related to the techniques used. However, it is possible that the use of fixed cells and 
snapshot data had caused underestimation of information transfer. Indeed a stochastic 
modelling was proposed by Margaritis and et al., where they predicted I(ppERK; S) 
using snapshot data and compared with I(ppERK; S) value taking trajectory into count 
[152]. The system input was 3 Bits, and the snapshot MI value had a maximum of 1.4 
Bits, but this was increased to 2.8 Bits with trajectory consideration [152].  
This possibility was explored using live cell monitoring of Ca2+ responses and Ca2+ 
driven NFAT1c-EFP translocation in LβT2 cells. In fact, gaining additional 
information by sensing responses dynamics over time was explored previously in 
HeLa cells by our group [153]. The main differences here are that LβT2 cells express 
the endogenous receptor, so the variability that might be introduced due to Ad 
mGnRHR transduction is avoided. Another difference is that in this study cells were 
stimulated automatically rather than manually using INCell analyser 2200, therefore, 





aspect of the work here is that using the automated injection allowed us also to follow 
rapid Ca2+ responses. The experimental results revealed that such snapshot data do 
indeed underestimate information transfer. This is evident from calculated MI value 
that was a maximum of ~0.4 Bits at 30 min for NFAT1c-EFP-NF and increased to 
~0.6 Bits with trajectory consideration (Figure 6.1). 
For Ca2+ imaging data, cell-cell variability was seen in the LbT2 cell responses to 
GnRH and clear oscillations were observed in a small number of cells. Rapid and 
transient responses were induced by the highest concentrations of GnRH (Figure 6.2). 
The maximum responses were at 24 sec of stimulation followed by a gradual reduction 
toward plateau levels. The population averaged responses were consistent with the 
single cell responses. With 2.45 Bits of system input, calculated MI values were ~0.8 
Bits at 24 sec and increased to 1 Bit with trajectory consideration. Accordingly, the 
maximum estimates for information transfer via GnRHR are higher with the Ca2+ 
sensor than with the NFAT1c-EFP translocation reporter. The Ca2+ imaging data like 
the NFAT1c-EFP translocation data suggest that most information is lost through 
signalling. However, comparison of the two results indicates that most information is 
lost through signalling, and most likely occurs early in the GnRH signalling network, 
prior to Ca2+ mobilisation. 
The data above suggest that GnRHRs engage noisy communication channels with 
most available information lost through signalling, and most likely at the level of 
GnRHR coupling to its G-protein or G-protein activation of PLC. If this was true, we 
would expect to have higher MI values with a GnRHR-independent stimulus for Ca2+ 
mobilisation. The obtained results that are presented in Figure 6.9 confirmed the above 





dependent increases in Ca2+. The single cell responses to ionomycin were like those 
described for GnRH. The maximum response was achieved within 30 sec, and the 
population averaged data were consistent with the single cell observations. The MI 
values were greater than MI values for GnRH sensing. They were maximum of 1.25 
Bits within 30 sec of stimulation and increased to 1.5 Bits by consideration of 
trajectory (Figure 6.9).  
GnRH is secreted in a pulsatile manner that is critical for normal reproductive function 
[19, 23, 261, 266], and signalling continues after GnRH pulses. This pattern of GnRH 
secretion raises two questions, 1) how much information transfer occurs after the 
GnRH pulse, and 2) how much additional information do cells gain by sensing a 
second pulse of GnRH. These questions were explored by imaging of NFAT1c-EFP 
as shown in Figure 6.6. The MI values for snapshot data in the 1st and 2nd pulses were 
~0.4 Bits and ~0.3 Bits respectively. Cells did gain a little information by sensing a 
repeated pulse but not much (~0.1 Bit), and with the consideration of response 
trajectory, these values were increased to a maximum of 0.55 Bits.  
The sources of cell-cell variation that harm transmitted information are unknown. 
Recent work developed a mixed mechanistic and probabilistic model suggested that 
if the sources of variations are relatively stable over time, the response in the 2nd pulse 
would be predicted from the response in the 1st pulse, and that cells would gain little 
or no additional information by sensing both pulses. In contrast, if the sources of 
variations are unstable over time the response of the 2nd pulse cannot be inferred from 
the 1st pulse. In this case cells would gain more information from sensing both pulses 
[153]. The LβT2 cell NFAT1c-EFP translocation data described here are in accord 





The above hypothesis was explored experimentally here by loading LβT2 cells with 
Fluo-4 (as Ca2+ indicator), then cells were received two pulses of GnRH, and the time 
between pulses was varied (10, 20, 60 and 90 min). The population averaged 
responses were dependent on GnRH concentration. As expected, GnRH caused a rapid 
increase in Ca2+ (Figure 6.2), and the maximum responses typically occurred within 1 
min of stimulation for each pulse. However, the MI values calculated for the 1st and 
2nd pulse were comparable and did not differ significantly with different inter-pulse 
intervals. Most importantly, the additional information from sensing a 2nd pulse was 
low (0.06-0.2 Bits) for all time intervals, as summarised in Figure 6.7. Consequently, 
from the NFAT1c-EFP translocation data and Ca2+ imaging data, we can argue against 
the possibility that repeated pulses increase the reliability of GnRH sensing. 
 
7.4. The meaning of MI  
Information theory-derived statistical approaches are the novel aspect used in this 
work to quantify the amount of information transfer through signalling pathways. This 
approach came to eminence in 2011/2012 with a number of publications that 
explained the use of computational approaches for such quantification [124, 265, 266, 
273, 274, 289-291, 367, 368]. The main aspect of this approach is that information 
can be defined as uncertainty [292]. The term information had been previously used 
in the field of signal transduction but in an undefined way. There was a common 
assumption that when an inhibitor reduces a response, this equates to a reduction in 
information transfer through signalling network. However, it is possible that the 
reduction in the population averaged response is mirrored by a reduction in cell-cell 





the system input can be inferred from the output (i.e. information transfer would not 
be reduced). Thus, experimental work is needed to investigate if the partial reduction 
of GnRH effects on pERK by PKC inhibition is correlated with a reduction in 
information transfer. In a similar way, it would be of interest to pre-treat cells with 
GnRH and investigate if homologous desensitisation (as measured by population 
averaged responses) is associated with impaired GnRH sensing (as measured by MI). 
Generally, the use of information theory in signalling studies has highlighted a 
fundamental point, which is that response size cannot safely be equated to information 
transfer as it “information transferred” is also affected by noise in biochemical 
signalling networks. 
Here, the MI between system inputs and outputs has been used to measure information 
transfer between stimulus (e.g. GnRH concentrations) and responses (e.g. ppERK). 
The merits of this measure are that MI does consider cell-cell variability and response 
size. It also, unaffected by non-linear input-output relationships that are common in 
signal-transduction pathways providing us with more reliable measures [125]. 
However, MI values are dependent on the input distribution. For example, in this 
work, we have used 8 different concentrations of GnRH to provide the full range of 
the concentration-response curve (e.g. 0 and 10-12-10-6 M GnRH). MI is measured in 
Bits where I Bit of information can resolve two different values (8 different 
concentration provides 3 Bits). However, MI values would be expected to be lower 
with a lower concentration of GnRH (e.g. 0 and 10-18-10-12 M GnRH) and higher with 
a higher concentration of GnRH (e.g. 0 and 10-7-10-2 M GnRH). The main point is that 
MI values measured are input distribution dependent. Thus, an alternative approach 
would be quantifying the information transduction capacity of a signalling channel. In 





signalling network can transfer with any input distribution. This is computationally 
demanding, but a recent approach named SLEMI (Statistical Learning Based 
Estimation of Mutual Information) provides algorithms to do this (i.e. for quantifying 
information capacity of a signalling channel) [400]. It would certainly be of interest 
in future work to estimate the capacity of GnRHR signalling channels, as opposed to 
information transfer. 
The underestimation of snapshot data (in MI estimates) has highlighted the 
requirement for live cell imaging in order to take response trajectories into account. 
This is evident in Chapter 6, where live cell imaging revealed maximal I(NFAT1c-
EFP; GnRH) values of approximately 0.4 Bits, whereas estimates taking trajectory 
into account increased to >0.5 Bits (Figure 6.1). However, consideration of the 
response trajectory was limited to 3-4 time points (see appendix, table 3). This, in turn, 
may lead to significant underestimation of the potential information available from 
sensing response trajectories. The aforementioned SLEMI approach simplifies the 
computation, facilitating the consideration of multidimensional system outputs. It may 
therefore be advantageous to use this technique in estimating MI as this should enable 
consideration of more or all time points. Alternatively, transcriptional reporters could 
be developed further. Here, the responses of NFAT-RE-asRed were imaged after a 
period of 8 hr GnRH stimulation. This 8 hr NFAT-RE-asRed transcriptional response 
could be sensitive to the time-course of NFAT translocation in each cell. So, although 
correction for the expression level of the reporter construct would be needed, further 
research could be undertaken to ask if MI values and information capacity calculated 
for upstream readouts and consideration of trajectory are any higher than those 





The work on this thesis was focusing on sensing GnRH although pituitary 
gonadotrophs and gonadotroph-derived cell lines are regulated by many other 
endocrine, paracrine and autocrine factors (e.g. growth factors, nucleotides, gonadal 
steroids, and other peptides like oxytocin and PACAP). The significance of such 
stimuli for the physiology of gonadotrophs and the pathways through which they act, 
are often poorly defined. Therefore, in future work, it would be of interest to use MI 
and information capacity to explore the ability of gonadotrophs to sense these inputs. 
Preliminary attempts using oxytocin and PACAP yielded unexpected results as both 
stimuli failed to increase Ca2+ in LβT2 cells (unpublished data). The SLEMI approach 
mentioned earlier has been developed to consider multiple variables (i.e. inputs and 
outputs). This can be many time points (as outlined above), and it could also be 
different responses. Thus, the consideration of joint sensing could be extended to 
consider more than two pathways or various inputs. 
The reasons for cell-cell heterogeneity is unknown. Regarding GnRH signalling, the 
most likely possibilities are that it reflects cell-cell variation in concentrations of 
GnRHR or its effectors. In fact, in this work, the I(Ca2+; ionomycin) values were found 
to be higher than I(Ca2+; GnRH) values, as shown in Figure 6.2 and Figure 6.7. These 
findings revealed that loss of information is related to noise upstream (i.e. at the level 
of the GnRHR and its upstream effectors). Moreover, the obtained results here showed 
that cells gained little information from sensing a 2nd pulse of GnRH (Figure 6.4), 
suggesting that the features that cause cell-cell heterogeneity are relatively stable at 
least during the time-course examined in this work. Apart from these conclusions, 
nothing is really known about the reasons for cell-cell variability in responses to 
GnRH. This is an important issue for future research, and the work could be extended 





is no reliable antibody for GnRHR quantification (McArdle, personal 
communication), accordingly, the work could be performed in a heterologous 
expression system (HeLa cells) using epitope-tagged GnRHR (e.g. HA-tagged 
GnRHR). HA-GnRHR, total ERK, and ppERK could then be measured in the same 
cells, and the cells could be binned according to the expression level of GnRHR and 
ERK. This would help in defining their effect on the I(ppERK; GnRH). Alternatively, 
the expression level of ppERK could be normalised to total ERK (on a cell by cell 
basis) to ask if this would increase MI values. A more advanced statistical approach 
would be to consider the response to GnRH in samples of the cell population selected 
to have identical average total ERK concentrations, but with different variation in total 
ERK concentrations. By doing this we could define the robustness of transfer 
information to heterogeneity in the concentration of ERK. Such a method could 
actually be applied for any other effector that can be measured in single cells. In fact, 
this was the aim of a preliminary study (MSc student project Christopher Benson, 
supervised by McArdle and Alobaid) although, at the time of writing, the data analysis 
has not yet been undertaken. 
A recurring observation in this work is that most available information about GnRH 
concentration is lost through signalling network, raising the question of whether 
information transfer had been underestimated. Sensing joint pathways and trajectory 
have been considered here. Cells might also gain additional information by sensing 
signalling in neighbouring cells, and the mathematical approach can be used to 
calculate the MI between ppERK levels (as an example) in adjacent cells. In fact, this 
was performed in LβT2 cells where cells were stimulated with GnRH and MI values 
were calculated for neighbour sensing. These values were higher for pairs of cells that 





(unpublished data). This is consistent with cells obtaining information by sensing their 
neighbours, but in these experiments, there were technical problems (most probably 
related to uneven illumination of the cells). Thus, in future experiments it would be 
worthwhile repeating the experiment with better control of illumination. 
As final consideration, the concern about loss information (i.e. how and where it is 
underestimated) could be misplaced. It is possible that the maximum amount of 
information transferred through GnRHR signalling is only 1 Bit. Most cellular 
decisions made by cells are binary [401], and these require only 1Bit of information. 
In the case of gonadotrophs, and as gonadotropin secretion is the most important 
activity, it is not clear if this activity is binary (all or nothing response) at the level of 
single cells. As explained early, the population average measures are graded over a 
broad range of stimulus concentration, but at the single cell, it might be still be binary. 
Furthermore, GnRH is secreted in a pulsatile manner, and blood circulation studies 
revealed that low nM GnRH pulses are interrupted by intervals of low pM 
concentrations. Thus, it might be that gonadotrophs in vivo only need to distinguish 
between these two states and have adapted to convey just the 1 Bit of information 
needed to do so. 
 
7.5. Summary of the general conclusion 
The main aim of the work performed here was to advance our understanding of GnRH 
signalling by exploring differences in responses between different cell types as well 
as between individual cells of a given cell type. The use of the mathematical approach 
(MI calculation) in addition to the conventional approach has provided us with 





signalling. GnRH effects mediated by GnRHR are dependent upon cellular model, as 
shown by the differences in response kinetics and by the sensitivity to 
pharmacological inhibition. Most information about GnRH concentration in the 
environment is lost through GnRHR signalling. The MI values differed between HeLa 
cells and LβT2 cells, extending the concept of cell context-dependent GnRH 
signalling to the amount of information transferred through GnRHR. The live cell 
imaging revealed that snapshot data underestimated information transfer over time 
and that cells gain more information when the trajectory is considered. The repeated 
pulse experiments data revealed that cells did not gain much information by sensing 
additional GnRH pulses. The most striking data were probably those from the live 
cells Ca2+ imaging experiments. These data suggest that the GnRHR and its upstream 
effectors are a signalling node at which information loss occurs, and that the unknown 
sources of cell-cell variation are relatively stable over time.  
Further experiments have been suggested here and further research should be 
undertaken to investigate (for example) the reasons underlying the cell-cell 
heterogeneity, which would shed further light on the mechanism of GnRHR 
signalling. Finally, in future experiments, it would also be of value to define the 
maximum amount of information that the GnRHR signalling network can transfer 







1. Optimisation of cell tracking protocols. 
For live cell imaging experiments, cells were loaded with Ca2+-sensitive dye and/or 
transduced with Ad NFAT1c-EFP. They were then imaged at different time points 
before, during and after stimulation as described in Chapter 2. Then, a cell tracking 
algorithm (provided by Dr. Margaritis Voliotis) was used to track individual cells over 
time. In its simplest form, the tracking algorithm matches the geometric centre of the 
nuclei between sequential images in the time stack (i.e. tracking is based on the x-y 
position of the nuclei) but in preliminary experiments, the use of alternative cell 
measures (nuclear area and nuclear stain intensity) were also considered. The tracking 
algorithm also includes a “probability of error” function. When this function is set too 
low there is a higher probability of errors in tracking. On the other hand, when it is set 
too high, there is higher confidence in the accuracy of the tracking but fewer cells are 
tracked. Table 1 shows the number of cells tracked using different cell measures and 
at different error probabilities in LβT2 cells receiving a single pulse of GnRH. Table 
2 shows similar data but for cells receiving two pulses of GnRH. Note that, the tracked 
cells number is lower with two pulses than with single pulse. This is related to the 
physical movement associated with removing the plate and washing the cells 
(compare tables 1 and 2). Furthermore, the tracked cells number is not increased by 
consideration of nuclear measures. Consequently, for the experiments shown in this 
thesis cells were tracked based on the x- and y-co-ordinate alone, and with a 















Table 1. Number of cells tracked after a single pulse of GnRH. 
Data from a representative experiment where cells received a single pulse of 0-10-12-
10-7 M GnRH and were tracked with probability of varied, and on the basis of the cell 
measures indicated. These were all calculated from the nuclear stain (Hoechst) using 









Table 2. Number of cells tracked after a single pulse of GnRH. 
Data from a representative experiment where cells received a two pulse of 0-10-12- 
10-7 M GnRH and were tracked with probability error of varied and based on the cell 
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2. Optimising assessments of MI taking response trajectory into account. 
 
For Ca2+ imaging experiments, LβT2 cells or Ad GnRHR transduced HeLa cells were 
loaded with Fluo-4 AM or Rhod-3 AM and stimulated with varied concentrations of 
GnRH. Cells were then imaged at different time points and the response of each 
individual cells were tracked. MI values were then calculated from Fluo-4 AM or 
Rhod-3 AM fluorescence at individual time-points using either single cell measures 
of raw fluorescence intensities or fluorescence normalised to the control (pre-
stimulation) value in any given cell. In addition, MI calculated taking trajectory into 
account. To do so the response was considered to be an “N” dimensional vector, where 
N is the number of sampling points. Different time points were compared in order to 
get maximum estimates of MI. As shown in table 3, MI values were consistently 
higher with the normalised data. The consideration of 3 or 4 time-points did not 


























Table 3. Preliminary experiments for selection of time-points to be used in MI 
calculations for live cell Ca2+ imaging experiments. 
MI values were calculated using raw (b) or normalised (a) Fluo-4 fluorescence values 
in HeLa or LβT2 cells stimulated with varied concentrations of GnRH. The MI values 
were calculated taking trajectory into account by using measures at 2, 3 or 4 time-
points as specified. The values shown are the means ± SEMs from 3 separate 
experiments (these experiments are also documented in Figure 6.3 and Figure 6.4).  
Time in sec LβT2 HeLa 
140, 160 
a 1.041 ± 0.055 0.867 ± 040 
b 0.813 ± 0.007 0.639 ± 0.053 
140, 180 
a 1.023 ± 0.051 0.889 ± 050 
b 0.829 ± 0.029 0.712 ± 0.084 
140,300 
a 0.986 ± 0.036 1.015 ± 054 
b 0.791 ± 0.044 0.808 ± 0.064 
140,700 
a 0.977 ± 0.039 0.955 ± 0.027 
b 0.813 ± 0.057 0.738 ± 0.053 
140,160,300 
a 1.013 ± 0.049 0.838 ± 0.069 
b 0.661 ± 0.035 0.531 ± 0.065 
140,160,700 
a 0.928 ± 0.067 0.907 ± 0.039 
b 0.691 ± 0.052 0.607 ± 0.047 
140, 180, 300 
a 0.931 ± 0.044 0.867 ± 040 
b 0.584 ± 0.025 0.639 ± 0.053 
140, 180, 700 
a 0.946 ± 0.050 0.955 ± 0.063 
b 0.669 ± 0.016 0.683 ± 0.048 
140,300,700 
a 0.881 ± 0.071 1.007 ± 0.054 
b 0.535 ± 0.015 0.260 ± 0.153 
140,160,180,300 
 
a 0.752±0.061 0.631 ± 0.079 
b 0.250 ± 0.020 0.229 ± 0.097 
140,160,180,700 
 
a 0.781 ± 0.061 0.725 ± 0.067 
b 0.301 ± 0.046 0.329 ± 0.077 
140,160,300,700 
 
a 0.844 ± 0.055 0.819 ± 0.058 
b 0.360 ± 0.025 0.360 ± 0.079 
140,180,300,700 
a 0.797 ± 0.030 0.849 ± 0.071 





3. Tracking and exclusion in live cell experiments. 
The movement of cells during live cell experiments makes the tracking complicated. 
Accordingly, the responses of all individual tracked cells were plotted and inspected 
to remove cells that were not tracked precisely. Inspection of image stacks suggested 
that the tracking was not precise for cells that were poorly attached (i.e. cells that 
moved rapidly and did not stay in a fixed plane) and for cells that had moved close to 
one-another and indeed overlapped. Therefore, tracking algorithm allocated the wrong 
data to the cells before and after this point. Those type of cells were excluded from 
further analysis. In the case of the NFAT1c-EFP translocation experiments cells with 
very high or low starting NFAT1c-EFP ratios were also excluded because on image 
inspection they often appeared to be unhealthy (or even to be just debris from dead 
cells). By doing that around 2% or “tracked cells” were excluded from the analyses in 
Chapter 6. The figure below shows examples of NFAT1c-EFP traces in cells that were 






Figure 1. Representative single cell NFAT1c-EFP traces illustrating exclusion. 
 
This figure shows time-courses of NFAT1c-EFP-NF for individual tracked LβT2 
cells stimulated twice with 10-7 M GnRH. The duration of the 1st and 2nd pulse of 
GnRH is illustrated by the grey bars. Panels A and B show examples of cells that 
were excluded, either because inspection of the cells or the raw images indicated 
that tracking had failed, or because the time 0 NFAT1c-EFP-NF values were <0.4 
or >0.55. Approximately 5% of cells were removed in this way. Panels C and D 
show examples of the responses of cells that were considered to have been 
successfully tracked. These data are from one of the experiments incorporated in 
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